info@cpisra.org

Email: info@cpisra.org
Home » Anti-Doping

Anti-Doping

World Anti-Doping Agency

https://www.wada-ama.org/


CPISRA Anti-Doping Documents



Latest Anti-Doping News


22/01/21 WADA OFFERS NEW EDUCATION RESOURCES FOR ATHLETES AND ATHLETE SUPPORT PERSONNEL

Montreal, 21 January 2021

Dear Colleagues,

As part of the World Anti-Doping Agency’s (WADA’s) commitment to education and the development of balanced anti-doping programs worldwide, the Agency wishes to highlight three new education resources for athletes and athlete support personnel (ASP) that are available on its new and improved Anti-Doping Education and Learning Platform (ADEL), which was launched on 6 January 2021.

The Athlete Guide to the 2021 Code and the ASP Guide to the 2021 Code provide information on the significant changes within the new World Anti-Doping Code (Code) that entered into effect on 1 January 2021. The Guides also contain information regarding roles and responsibilities and the types of Anti-Doping Rule Violations under the Code. Both Guides are currently available in English, French, Spanish and Slovenian, with more languages to be released in the coming months.

The Athletes and ASP Guide to the 2021 Prohibited List, explains the main changes to the List of Prohibited Substances and Methods (List) that entered into effect on 1 January 2021. It also provides an early notification of the change in status of Glucocorticoids that will come into effect on 1 January 2022, as approved by WADA’s Executive Committee in September 2020. This Guide is currently available in English, with French and Spanish to be published shortly and other languages to be released in the coming months.

Each of the above resources is available on WADA’s ADEL Platform and can be viewed digitally or downloaded as a PDF.

About WADA’s new ADEL Platform

WADA’s new ADEL Platform provides education and learning opportunities for the anti-doping community worldwide – including athletes, coaches, parents, medical professionals and more. Anti-doping practitioners can also find learning opportunities to help them carry out their roles, and resources to support development of their anti-doping programs as part of the Code Implementation Support Program (CISP).

WADA invites all Anti-Doping Organizations to visit the new ADEL Platform and to encourage National Federations, athletes and ASP under their jurisdiction to do so as well. We also invite stakeholders to consult the ADEL Roadmap, which is updated on a monthly basis, to keep track of new courses and resources, along with information on their available languages, formats and timelines for release.

Lastly, we wish to highlight that some of our previously published resources, such as the ‘At a Glance Series’, are currently being updated in line with the 2021 Code and will be available on ADEL once finalized. We are prioritizing digital versions at this time which can be viewed on the ADEL Platform or via the ADEL by WADA Mobile App.

Should you have any questions regarding the ADEL Platform or any of the above-mentioned Guides – including how to make a request to translate our education resources – please visit the ADEL Helpdesk.

Best regards,

World Anti-Doping Agency


12/01/21 WADA PUBLISHES GUIDANCE NOTE FOR ANTI-DOPING ORGANIZATIONS REGARDING SUBSTANCES OF ABUSE UNDER 2021 WORLD ANTI-DOPING CODE

Montreal, 11 January 2021

Dear colleagues,
 
Today, the World Anti-Doping Agency (WADA) publishes a Guidance Note regarding Substances of Abuse under the revised 2021 World Anti-Doping Code (the Code), which entered into effect on 1 January 2021.
 
Pursuant to Article 4.2.3 of the Code, some substances on the 2021 List of Prohibited Substances and Prohibited Methods (2021 Prohibited List) have been identified as Substances of Abuse “because they are frequently abused in society outside the context of sport”.
 
Under Article 10.2.4.1 of the Code, regarding these substances, “if the Athlete can establish that any ingestion or Use occurred Out-of-Competition and was unrelated to sport performance, then the period of Ineligibility shall be three months Ineligibility. In addition, the period of Ineligibility calculated under this Article 10.2.4.1 may be reduced to one month if the Athlete or other Person satisfactorily completes a Substance of Abuse treatment program approved by the Anti-Doping Organization with Results Management responsibility.”
 
WADA’s Prohibited List Expert Advisory Group (ListEG) has identified the following substances as Substances of Abuse in the 2021 Prohibited List.

  • Cocaine (S.6a – Non-specified Stimulants);
  • Methylenedioxymethamphetamine (MDMA / “ecstasy”) (S.6b – Specified Stimulants);
  • Diamorphine (Heroin) (S.7 – Narcotics); and
  • Tetrahydrocannabinol (THC) (S.8 – Cannabinoids).

The Guidance Note offers direction to Anti-Doping Organizations regarding application of Code Article 4.2.3.

Should you have any questions, or wish to provide feedback, please contact WADA’s Science Department at: science@wada-ama.org.

Best regards,

World Anti-Doping Agency


12/01/2021 TRIBUTES POUR IN FOR RETIRING WADA BOARD MEMBER AND FOUNDING PRESIDENT RICHARD POUND

Montreal, 8 January 2021 – On 31 December 2020, the World Anti-Doping Agency’s (WADA’s) Founding President and longstanding advocate for clean sport, Richard Pound, came to the end of his final term on WADA’s Foundation Board (Board), having served the Agency with distinction in various capacities since its inception in 1999.

The positive contribution made by Mr. Pound to the world of sport in general and anti-doping in particular cannot be overstated. A lawyer by profession, he was instrumental in the establishment of WADA nearly 22 years ago, serving for almost nine years as the Agency’s first President. In that time, and against the odds, he oversaw the drafting and implementation of the World Anti-Doping Code (Code) which, for the first time, managed to harmonize the rules across sports and nations of the world. In what was a stellar athletic and sports administration career, that remains perhaps one of his greatest achievements.

A swimmer, who represented his native Canada at the 1960 Olympic Games in Rome, Italy, and won four medals at the 1962 Commonwealth Games in Perth, Australia, Mr. Pound applied the same commitment and will to win when it came to protecting clean sport. With integrity, honesty and an unparalleled knowledge of the subject, Mr. Pound navigated this complex and often difficult world, putting WADA on a firm footing in the early years and helping to strengthen the global anti-doping system thereafter.

Even after concluding his term as President at the end of 2007, Mr. Pound, who is today the longest-standing active member of the International Olympic Committee (IOC), remained closely involved in WADA, continuing to serve on the Board and then, in 2015, leading a ground-breaking investigation that uncovered the details of an institutionalized doping scheme within Russian athletics, and led to the Russian Anti-Doping Agency being declared non-compliant with the Code.

On the occasion of his retirement from WADA’s Board, a number of leaders from the worlds of sport, government and science have paid tribute to Mr. Pound and reflected on the significant contribution he has made.

WADA President, Witold Bańka, said: “For 21 years, the name Dick Pound has been synonymous with WADA and the campaign to protect clean sport. A trailblazer who knew the importance of bringing sports and governments together, Dick has worked tirelessly to establish that collaboration and build the harmonized, robust and fair anti-doping system we have today. Everyone who loves sport and who cherishes the values of fair play, owes a lot to Dick and what he has achieved. His knowledge, experience and leadership have been crucial to WADA’s success over two decades and we wish him well.”

Prime Minister of Canada, Justin Trudeau, said: “On behalf of all Canadians, I would like to thank and congratulate Dick Pound for his many years of service with the World Anti-Doping Agency. As the first President, Dick was instrumental in the creation of the Agency. Thanks to his past athletic background, his years of working with various Olympic sports organizations and his credibility, he was able to bring his experience and knowledge to the Agency and in the global fight against doping in sport. He also helped make our country a leader in this fight, including by establishing the headquarters in Montreal. Dick, thank you again. I wish you the best for the future.”

IOC President, Thomas Bach, said: “Richard Pound has made a great contribution for the protection of clean athletes by fighting vigorously against doping. I could experience this first-hand in my early days as an IOC member when we were working together on the then Olympic Movement Anti-Doping Code, the forerunner of the World Anti-Doping Code. There, I could appreciate his strong commitment to the integrity of sports and competitions and to the Olympic Values. This clear orientation has been and still is the guiding thread in all the positions he held, in particular as Founding President of WADA. The entire Olympic Movement owes him our gratitude for his outstanding contribution to the credibility of sport.”

Three-time Olympian and Chair of WADA’s Athlete Committee, Ben Sandford, said: “On behalf of the WADA Athlete Committee and athletes around the world, I’d like to thank Richard for the incredible contribution he has made to clean sport. His vision and leadership have been instrumental in shaping the World Anti-Doping Program and WADA into what they are today. He has helped to make sport fairer and helped us all to continue to believe in the magic of sport. We will forever be grateful for everything he has done.”

WADA Director General, Olivier Niggli, said: “Dick Pound was the right person, in the right place at the right time. Having him as President at the beginning of WADA’s existence really established the Agency and gave it the credibility that it needed and deserved. He was a pioneer. Starting from scratch, he had to dig the trenches while also managing to move things forward. He led the successful project to harmonize the anti-doping rules across all sports and all countries – I don’t think people realize what a singular achievement that was. I’m not sure that such a successful collaboration exists in any other field and Dick’s role in that was crucial. He was the life and breath of WADA in those early years. As President, he extolled all the virtues of WADA, such as integrity, transparency and independence, and the world of sport owes him an enormous debt of gratitude.”

Chairman of the Institute of National Anti-Doping Organisations, Michael Ask, said: “Mr. Pound is definitely the founding father of modern anti-doping. If it wasn’t for his foresight and political savvy, we would not have had a WADA and we would never have had a uniform set of rules as we have today with the World Anti-Doping Code. These have undoubtedly been the most important steps forward in the fight for clean sport. One has never been in doubt about Mr. Pound’s moral compass. He has always acted as a free agent expressing his opinion clearly without fear or favor. Whether you agree or disagree with his views, Mr. Pound always says what he means and means what he says. For that reason, Mr. Pound will always have my deepest respect.” 

Olympic silver medal-winning rower and President of the Canadian Olympic Committee, Tricia Smith, said: “Richard’s leadership in the establishment of WADA was truly groundbreaking. It is difficult to think of anyone who could have led the organization in those early years as well as he did, bringing the sport system together. Never one to shy away from a challenge, no matter how daunting it seemed, Richard is fearless in the pursuit of that in which he believes. We are fortunate that one of the things he believes in is sport.”

Secretary of State for Amateur Sports in the Government of Canada from 1999-2001 and Mayor of Montreal from 2013-17, the Honorable Denis Coderre, said: “Dick Pound is a true gentleman and a great leader. With him, what you see is what you get. I had the opportunity to work with Richard when I was appointed to the Prime Minister’s cabinet in 1999 so we were together at the forefront when WADA was established. I was always impressed by his dedication to and passion for sport. He was a true leader, totally devoted to the athletes and a champion of the true values of Olympism. Ethics in sports were always a priority for him. To be part of WADA’s foundation is one thing, but to ensure its sustainability is another, and this was possible because of his skillful chairmanship. I always appreciated his ability to get things done at the Board level. His style was a mixture of composure, humor, decency and class, always focusing on results, fairness and a sense of justice. He was never afraid to take the heat for the sake of accountability or to go after the cheaters no matter who they were or where they came from. I want to take this opportunity to pay tribute to a great Canadian. Thank you, Richard, for your contribution, thank you for your friendship, your righteousness and moral stand. It was a privilege, honor, and pleasure to work with you and be at your side. Montreal, Canada and the global sports community salute you.”

Director of the WADA-accredited Laboratory at the INRS Armand-Frappier Santé Biotechnologie Research Centre, Montreal, Canada and former President of the World Association of AntiDoping Scientists, Christiane Ayotte, O.C., Ph. D., said: “Richard assumed the first and crucial presidency of WADA with intelligence and passion. Always goal-oriented, he skillfully obtained approval for important decisions at the meetings he led. He understood that the Agency needed to be known and supported publicly beyond political and sporting circles. Thus, with political correctness put to one side, he became a fearsome spokesman to the media, who were eager for his catchy quotes and, in the process, he made WADA indispensable and always relevant. During his presidency, Richard was able to bring together divergent interests and opinions of the various anti-doping stakeholders, delivering the strong public support the Agency received.”


12/01/21WADA LAUNCHES NEW AND IMPROVED
ANTI-DOPING EDUCATION AND LEARNING PLATFORM (ADEL)

Montreal, 6 January 2021 – Today, the World Anti-Doping Agency (WADA) launched its Anti-Doping Education and Learning platform (ADEL), which is a new and improved version of the current Anti-Doping e-Learning platform (ADeL) that was launched in January 2018.
 
Via the new ADEL platform, WADA will provide education and learning opportunities for the anti-doping community worldwide; including: athletes, coaches, parents, medical professionals and more. Additionally, on ADEL, anti-doping practitioners will be able to find learning opportunities to help them carry out their roles; and, resources to support development of their anti-doping programs.
 
WADA Director General, Olivier Niggli, said: “WADA recognizes the power of education to its mission for doping-free sport. The launch of the new and improved ADEL is an important milestone. It demonstrates the Agency’s commitment to education and our intention to support the development of balanced anti-doping programs that include education as a core function by Anti-Doping Organizations. ADEL directly supports the objectives of the new International Standard for Education (ISE), which took effect on 1 January 2021 and is a very significant advancement in anti-doping education policy. We are very proud of these accomplishments. They are the result of a collaborative effort that we have led with stakeholders over the past few years.”
 
The ADEL platform will have a modernized look and feel; and, will feature a wider range of educational courses and resources for more target audiences as identified in the World Anti-Doping Code (Code) and the ISE. ADEL will also provide new opportunities for the anti-doping community to access technical help on a range of topics.
 
WADA Education Director, Amanda Hudson, said: “Online education is one way to reach target audiences, particularly during the COVID-19 pandemic. The new ADEL will support the needs of the anti-doping community by providing education solutions for those responsible for the development of education programs, as well as learning opportunities and technical resources for Anti-Doping Organizations to benefit from. WADA aims for ADEL to become the ‘go to’ place for Anti-Doping Organizations to access resources to support the development of their anti-doping programs and the solutions they need to enable them to educate their communities.”
 
ADEL now includes new education programs for international- and national-level athletes; athletes who are part of a Registered Testing Pool; high performance coaches; and, parents of elite athletes, which complement the Tokyo 2020 Olympics course for athletes and coaches; ADEL for Medical Professionals (MPs); and ADEL for MPs at Major Games. The platform also includes previously published resources; such as, the Athlete and Athlete Support Personnel Guides to the Significant Changes in the 2021 Code; the Athlete and Athlete Support Personnel Guide to the 2021 List, as well as, all Code Implementation Support Program (CISP) resources, including the recently published Guidelines for Education, Therapeutic Use Exemptions and Results Management. WADA aims to publish all courses and resources in English and French, with Spanish to follow; and more courses and resources will be developed in 2021.
 
The new ADEL features

  • The platform and the education content will be fully responsive to allow users to learn via a desktop, laptop, tablet or mobile phone.
  • Learning can happen on the go with the option to complete the courses offline via the ‘ADEL by WADA’ mobile app.
  • Personalized learning plans per role and/or stage of development.
  • Gamification concept, including digital badges and points to collect as users learn.
  • Centralized ADEL Academy for all education offerings.
  • Community learning by exchanging questions and answers with people working in anti-doping.
  • Simple reporting dashboard and customized reports function for Anti-Doping Organization administrators.
  • A dedicated ADEL Helpdesk page with articles to help users solve common issues as well as a dedicated place for Anti-Doping Organizations to request translations of resources.

To access the new ADEL:

To join the new ADEL webinar to learn more about the new platform:

  • Date: 21 January at 09:00 (EST).
  • How to participate: Once you have registered on ADEL, you can register for the webinar via the platform.

For more information, please visit the:

ADEL helpdesk


12/01/21 NEW YEAR MESSAGE TO STAKEHOLDERS FROM WADA PRESIDENT AND DIRECTOR GENERAL

Montreal, 7 January 2021

Dear Colleagues,

On behalf of the World Anti-Doping Agency (WADA), we wish you and yours a happy, healthy and successful New Year. We hope that you enjoyed a restful holiday season and that you join us in greeting 2021 with renewed energy.

While closing the book on 2020, we wish first of all to recognize the efforts of the global anti-doping community that pulled together to ensure the integrity of the global anti-doping system in light of the COVID-19 pandemic. Clearly, when we embarked on 2020, we had no idea of the journey that lay ahead. The pandemic challenged the anti-doping community, like society in general, to quickly put measures in place to minimize its impact; and, we did so together.

For WADA’s part, this translated mainly into producing guidance materials for athletes and Anti-Doping Organizations to ensure that testing would continue in a structured and safe way, but also that Anti-Doping Organizations would continue to use all available tools to maintain the integrity of the system when testing may be temporarily diminished. These tools include in particular education for athletes and others; the Athlete Biological Passport, which assesses the evolution of athletes’ biological profiles; intelligence received through whistleblowers, which can lead to target-testing or to launching investigations; and, sample storage for future re-analysis as science advances and detection techniques are refined.

We will continue to work with the global anti-doping community this year to ensure that any anti-doping gaps can be identified and addressed. And we will continue to use the challenges raised by the COVID-19 pandemic to further stimulate innovation to make anti-doping stronger. This is why WADA is collaborating with stakeholders to explore new sample collection and analytical techniques such as dried blood spot analysis and artificial intelligence. This collaboration continues to give us confidence that, with vaccines now being deployed worldwide, anti-doping will emerge from this pandemic more resilient.

2021 World Anti-Doping Code and International Standards

Another significant effort made by the anti-doping community over the last year has been the revision by World Anti-Doping Code (Code) Signatories of their anti-doping rules and preparations for implementation of the 2021 Code, International Standards and Athletes’ Anti-Doping Rights Act. These key documents were approved in November 2019 during the World Conference on Doping in Sport following a two-year stakeholder consultation process and entered into force on 1 January 2021.

Over the past year, WADA has supported Signatories in aligning their rules with the revised Code and has provided robust educational and informational support via our Code Implementation Support Program so that they could hit the ground running in January.

We are grateful to all our stakeholders that have contributed to this strengthened World Anti-Doping Program. We are confident that, by reinforcing our efforts as a united anti-doping community, this new Program will help us drive further progress for athletes and sport worldwide.

RUSADA Non-Compliance

Once again, we closed out the year with a major outcome related to the compliance of the Russian Anti-Doping Agency (RUSADA) – this time, with the 17 December decision by the Court of Arbitration for Sport (CAS) to declare RUSADA non-compliant with the Code for a period of two years and impose a number of significant consequences. While this decision confirms in large part the recommendation made in November 2019 by WADA’s independent Compliance Review Committee, which was unanimously accepted by the Agency’s Executive Committee (ExCo) on 9 December 2019, WADA remains disappointed that the recommendation was not upheld in its entirety. We now expect the full reasoned decision to be published by CAS shortly as per the requirements of the International Standard for Code Compliance by Signatories (ISCCS).

In looking at this case, it is important to keep in mind that the CAS decision related specifically to the manipulation of Moscow laboratory data by the Russian authorities while the data were being forensically copied by WADA’s Intelligence & Investigations Department in January 2019 as part of Operation LIMS. This manipulation was in clear contravention of critical criteria set by the ExCo when RUSADA was reinstated as compliant, under strict conditions, in September 2018. The CAS decision did not relate to the broader Russian Doping Crisis dating back to 2014. This is a key point given that the ISCCS – along with a number of amendments to the Code focusing on Signatories’ compliance – came into force on 1 April 2018 and cannot be applied retroactively. Prior to 1 April 2018, WADA did not have the proper legal basis to pursue this matter.

While the Russian Doping Crisis has been very destabilizing for athletes, their entourage, WADA and the anti-doping system, we firmly believe that WADA has adapted and shaped its strategy in such a way that the Agency and the global anti-doping system have grown stronger, and continue to transform from this major disruption. This is evidenced by developments such as the Agency having strengthened its intelligence and investigations (I&I) capability, including with the launch of a very successful Speak Up! whistleblower program; and, having expanded its compliance monitoring program, including through introduction of the ISCCS, which was upheld by the recent CAS decision.

WADA Governance Reforms

In parallel with these developments, we continue to progress with our wide-ranging governance reforms, which were approved by WADA’s Foundation Board (Board) in November 2018 and are being introduced according to the agreed schedule. Of the 70 reform recommendations made by a WADA Governance Reforms Working Group in November 2018, all have now been actioned to some degree – the vast majority having been fully implemented. In particular, WADA now has an independent President and Vice-President; there is at least one athlete and one representative of National Anti-Doping Organizations (NADOs) on each Standing Committee (except for the independent Compliance Review Committee as it relates to NADOs); and, there is a limit of three terms of three years each for members of the ExCo, Board and Standing Committees. There is now also a Nominations Committee to ensure that the right people in terms of skills and independence serve in senior governance roles within WADA.

These reforms will continue in 2021. A few weeks ago, in December 2020, the Board appointed two additional independent members to the ExCo. With the addition of these two members, the ExCo will be composed of four independent members (including the President and the Vice-President), five representatives of Governments and five of the Sport Movement, with active or former athletes represented in each of these categories. In addition, in November 2020, the ExCo created a new Working Group on the Review of WADA Governance Reforms. An essential part of the work of this Group will be to monitor the effect of the ongoing governance reforms and propose additional reforms going forward. This will involve in particular a wide-ranging consultation with stakeholders in the coming months.

But we will not stop here. While more than one third of our current ExCo and Board members are active and former international-level athletes, work is underway to further enhance athlete representation within WADA. Discussions are also ongoing regarding the introduction of a WADA Code of Ethics and formation of an Independent Ethics Board or similar structure.

We are determined to ensure that WADA’s governance model continues to evolve with best practice over time.

Working Together for Clean Sport

Moving forward, much of our work will be guided by our 2020-2024 Strategic Plan. This Plan, which reflects the feedback of key stakeholders within the anti-doping ecosystem, acknowledges that WADA is completely different to what it was a few years ago. It also reflects a consensus that WADA must go further to build bridges and unite efforts to protect athletes and the integrity of sports globally.

Guided by the Strategic Plan, which has been defined with athletes at the center, WADA is and will be looking for every opportunity to meaningfully engage with athletes to enhance the global anti-doping system. We support our Athlete Committee –which is chaired by three-time Olympian in skeleton, Ben Sandford of New Zealand — in carrying out its mandate to provide athlete perspectives to WADA on all relevant anti-doping matters. The Athlete Committee will continue its work in 2021 to come up with reform proposals so that they can become a truly representative body. We both and senior WADA staff will continue to meet with individual athletes and groups that represent different sports, regions of the world and perspectives. The numerous meetings held in 2020 with athletes and athlete groups; as well as, with athletes that sit on the WADA Board, ExCo, Athlete Committee and expert committees; were very constructive, and the general feedback from these discussions was very supportive of WADA’s work and new Strategic Plan.  

In the meantime, our 140+ talented and committed team members worldwide will continue to engage and collaborate with stakeholders and to work tirelessly to protect the integrity of sport. We will continue to further develop key anti-doping areas – from education, science, and innovations in our Anti-Doping Administration & Management System (ADAMS), to I&I and compliance monitoring. We will be sure to mobilize the very best contributions from the anti-doping community and to inspire ourselves from successes in other fields and areas of business.

We are committed to engaging all stakeholders in further developing anti-doping; to enhancing anti-doping capacity and community worldwide; and to securing the additional funding that is required to further enable doping-free sport. We believe that with the support of the anti-doping community, we will achieve more progress together in 2021 and beyond.

Once again, we thank you for your commitment to clean sport and wish you all a healthy and happy New Year.


Sincerely,


05/01/21 WADA REMINDS STAKEHOLDERS THAT
THE 2021 WORLD ANTI-DOPING CODE, INTERNATIONAL STANDARDS AND ATHLETES’ ANTI-DOPING RIGHTS ACT ARE NOW IN FORCE

Montreal, 1 January 2021 – The World Anti-Doping Agency reminds stakeholders that, effective today, the 2021 World Anti-Doping Code (Code); the following International Standards (Standards); and, the Athletes’ Anti-Doping Rights Act (Act) have entered into force. The documents, which were subject to a two-year stakeholder consultation process, were approved on 7 November 2019 during the Agency’s World Conference on Doping in Sport that was held in Katowice, Poland. 

  1. International Standard for Code Compliance by Signatories (ISCCS)
  2. International Standard for Education (ISE) (New)
  3. International Standard for Laboratories (ISL)
  4. International Standard for the Protection of Privacy and Personal Information (ISPPPI)
  5. International Standard for Results Management (ISRM) (New)
  6. International Standard for Testing and Investigations (ISTI)
  7. International Standard for Therapeutic Use Exemptions (ISTUE)

As it relates to the International Standard for the List of Prohibited Substances and Methods (Prohibited List), it is reviewed annually via a separate stakeholder consultation process; and, was published separately earlier today.
 
The 2021 Code, which follows on from previous versions that entered into effect in 2004, 2009 and 2015, includes a number of important changes to global anti-doping policies, rules and regulations within Anti-Doping Organizations (ADOs) around the world. It works in conjunction with the eight Standards that foster consistency among ADOs in technical areas. The Athletes’ Anti-Doping Rights Act, which was developed by WADA’s Athlete Committee in consultation with thousands of athletes and stakeholders worldwide, is based on the 2021 Code and Standards and aims to ensure that athlete rights within anti-doping are clearly set out, accessible, and universally applicable.
 
WADA Director General, Olivier Niggli said: “WADA is grateful to its stakeholders worldwide, which contributed significantly to this strengthened World Anti-Doping Program that takes effect today. Beyond harmonizing and coordinating anti-doping programs worldwide, its purpose is to protect athletes’ fundamental right to participate in doping-free sport and to promote health, fairness and equality for athletes worldwide. I am convinced that, by reinforcing our efforts as a united anti-doping community, this new Program will help us drive further progress for athletes and sport worldwide.”
 
Code Implementation Support Program
 
WADA also wishes to draw your attention to the Agency’s Code Implementation Support Program (CISP), which was launched on 4 May 2020 and provides resources to prepare Code Signatories and other stakeholders for implementation of the new Code and Standards. 
 
Obtaining printed copies of the Code
 
In keeping with WADA’s sustainability efforts, in recent years the Agency has minimized print in favor of making its publications available digitally. However, given the importance of the Code, which will live for a number of years and be used on a daily basis by the Agency’s stakeholders:

  • At the end of November, WADA mailed a limited quantity of printed English or French copies to Code Signatories;
  • The Agency has made English and French print-ready versions available on our website (as linked above) for stakeholders to print locally; and
  • We are putting a mechanism in place for stakeholders and others that may wish to purchase printed copies in English and/or French; regarding which, we will provide more information on our website in the coming days.

Should you have questions or feedback regarding the Code, the Standards and/or the Act, please contact code@wada-ama.org; or, questions or feedback related to CISP, please contact 2021CISP@wada-ama.org.


05/01/21 WADA 2021 LIST OF PROHIBITED SUBSTANCES AND METHODS NOW IN FORCE

Agency calls on athletes and all stakeholders to note List modifications concerning substances and methods

Montreal, 1 January 2021 – The World Anti-Doping Agency (WADA) reminds athletes and all other stakeholders that its 2021 List of Prohibited Substances and Methods (List) enters into force today (1 January). The 2021 List, which has been redesigned in order to improve navigation and usability for athletes and their support personnel, was approved by WADA’s Executive Committee (ExCo) during its meeting on 14-15 September 2020 and was first published on 30 September 2020.

The List, which is one of the eight International Standards that are mandatory for all Signatories of the World Anti-Doping Code (Code), designates what substances and methods are prohibited both in- and out-of-competition, and which substances are banned in particular sports.

WADA Director General Olivier Niggli said: “WADA kindly ask athletes, their entourage and all other stakeholders to review the List carefully and to take particular note of this year’s modifications to avoid inadvertent use of substances and methods that are prohibited in sport for 2021.”

The List’s annual revision process is led by WADA, beginning with an initial meeting in January and concluding with the publication of the List by 1 October. This is an extensive consultation process that includes WADA’s List Expert Group gathering information, circulating a draft List among stakeholders, taking their submissions into consideration and revising the draft, followed by review by the Agency’s Health, Medical and Research (HMR) Committee.

The HMR Committee then makes its recommendation to the WADA Executive Committee, which approves the List during its September meeting.

For a substance or method to be added to the List, it must be determined that it meets two of the following three criteria:

  1. It has the potential to enhance or enhances sport performance
  2. It represents an actual or potential health risk to the athletes
  3. It violates the spirit of sport

It should be noted that for athletes who have a legitimate medical reason for using a prohibited substance or method that is on the List, they may be accommodated if they meet the criteria outlined in the International Standard for Therapeutic Use Exemptions (ISTUE). The TUE Program is a rigorous and necessary part of elite sport which has overwhelming acceptance from athletes, physicians and anti-doping stakeholders.

To view the changes made in the  2021 Prohibited List as compared to the 2020 version, please see the 2021 Summary of Modifications and Explanatory Notes.

Languages and Formats

The 2021 Prohibited List; the 2021 Summary of Modifications and Explanatory Notes; and the  2021 Monitoring Program are available for download on WADA’s website in multiple languages.

Stakeholders wishing to translate the List into other languages are kindly asked to signal their interest to info@wada-ama.org. WADA will then provide the necessary files and, once the translation is finalized, will make the List available on the Agency’s website.

The List’s mobile-friendly digital edition can be accessed here.


05/01/21 WADA STATEMENT FOLLOWING SWISS FEDERAL TRIBUNAL DECISION TO UPHOLD SUN YANG’S APPLICATION FOR REVISION OF CAS AWARD

Montreal, 23 December 2020 – The World Anti-Doping Agency (WADA) has been informed of the decision of the Swiss Federal Tribunal to uphold the revision application filed by Chinese swimmer Sun Yang and to set aside the 20 February 2020 award of a Court of Arbitration for Sport (CAS) Panel. The case is in relation to WADA’s successful appeal against the original Fédération Internationale de Natation (FINA) disciplinary panel decision following an incident that led to a doping control involving Sun Yang not being completed as planned.

The Swiss Federal Tribunal’s decision upholds a challenge against the Chair of the CAS Panel and makes no comment on the substance of this case.

In the CAS award, WADA clearly prevailed on the substance of the case as it was able to show that there were a number of aspects of the original FINA decision that were incorrect under the World Anti-Doping Code and the related International Standard for Testing and Investigations. WADA will take steps to present its case robustly again when the matter returns to the CAS Panel, which will be chaired by a different president.

At this stage, WADA has not received the Tribunal’s full reasoned decision and therefore cannot comment further.


05/01/21 WADA RELEASES LABORATORY TECHNICAL LETTERS FOR 2021

Montreal, 22 December 2020

Dear Colleagues,

The World Anti-Doping Agency (WADA) publishes today the following Technical Letters (TLs) for 2021 and the Summary of Modifications which were approved by WADA’s Executive Committee, via circulatory vote, on 21 December 2020.

This particular review of WADA’s TLs was triggered by the need to bring the below TLs in line with the 2021 World Anti-Doping Code (Code) and the 2021 International Standard for Laboratories (ISL) which both come into force on 1 January 2021.

Under the ISL, WADA’s TLs provide specific instructions to the WADA-accredited Laboratories, WADA-approved Laboratories and other stakeholders regarding the analysis, interpretation and reporting of results for particular Prohibited Substance(s) and/or Prohibited Method(s), or the application of specific laboratory procedures. As part of WADA’s mandate to enhance anti-doping activities under the Code, TLs undergo periodic revisions to reflect scientific and technological advances in the performance of anti-doping tests and the reporting of test results. They are refined and revised in consultation with WADA stakeholders.

2021 TECHNICAL LETTERS

1. TL01 – Meclofenoxate
In this new version of the TL, an explanatory comment regarding the pharmacokinetics of CPAHs herbicides was included in the introduction, and reporting levels of meclofenoxate and 4-CPA are now provided in the section related to Analysis and Reporting Requirements. Additional guidance for the “B” Confirmation Procedure was included. Terms and definitions have been updated where relevant.

2. TL02 – Mebeverine Metabolism
In this new version of the TL, two mebeverine-specific Metabolites have been specified (mebeverine acid and desmethyl mebeverine acid), replacing the p-methoxy-ethylamphetamine, p-OH-ethylamphetamine and p-methoxy-amphetamine metabolites, which have been removed from the Reporting Requirements. Terms and definitions have been updated where relevant.

3. TL03 – Zilpaterol
In this new version of the TL, articles have been reorganized to facilitate interpretation. Terms and definitions have been updated where relevant.

4. TL04 – Zeranol
In this new version of the TL, articles have been reorganized to facilitate interpretation. Terms and definitions have been updated where relevant.

5. TL05 – Oxilofrine
In this new version of the TL, additional analysis and requirements were included to address whether the oxilofrine finding is consistent with the metabolization of ephedrine. Therefore, a specific minimum reporting level has been established for oxilofrine when detected in the presence of ephedrine. Terms and definitions have been updated where relevant.

6. TL06 – Possible Metabolism of Proguanil into Chlorazanil 
In this new version of the TL, articles have been reorganized to facilitate interpretation. The “Scientific Background” information has been removed, and the relevant information moved into the Introduction article. A scientific publication regarding the formation of the diuretic chlorazanil from the antimalarial drug proguanil has been included as a reference. Other terms and definitions have been updated where relevant.

7. TL07 – Andarine – Flutamide
In this new version of the TL, the Analysis and Reporting requirements have been updated to clarify the specific case for which an Adverse Analytical Finding (AAF) for andarine shall be reported. In addition, a comment specifying that the Laboratories shall not report an AAF for andarine based only on the presence of O-dephenylandarine has been included. Terms and definitions have been updated where relevant.

8. TL08 – Use of Internal Standards
In this new version of the TL, articles have been reorganized to facilitate interpretation. Terms and definitions have been updated where relevant.

9. TL09 – Oxethazaine
In this new version of the TL, articles have been reorganized to facilitate interpretation. Terms and definitions have been updated where relevant.

10. TL10 – In situ Formation of Exogenous Compounds
In this new version of the TL, the requirements regarding prednisolone and prednisone analysis have been removed. Terms and definitions have been updated where relevant.

11. TL11 – Oxymorphone
In this new version of the TL, the Reporting Requirements now include the mandatory analysis of methylnatrexone by LC-MS before reporting an AAF for oxymorphone. Terms and definitions have been updated where relevant.

12. TL12 – Enobosarm
In this new version of the TL, the TL name has been updated from “TL12 – Ostarine” to “TL12 – Enobosarm” to be aligned with the Selective Androgen Receptor Modulators’ (SARMs) nomenclature used in the Prohibited List. The Analysis and Reporting requirements have been updated to clarify the specific case for which an enobosarm AAF shall be reported. In addition, a comment was included specifying that the Laboratories shall not report an AAF for enobosarm based only on the presence of O-dephenylandarine. Terms and definitions have been updated where relevant.

13. TL13 – Trimetazidine
In this new version of the TL, the Analysis and Reporting Requirements article includes additional guidance that the Laboratories shall consider before reporting an AAF for trimetazidine. Therefore, the instruction to consult the WADA Science Department for trimetazidine suspicious findings has been removed. Terms and definitions have been updated where relevant.

14. TL14 – Difference in “A” and “B” Sample Urine Characteristics
In this new version of the TL, terms and definitions have been updated where relevant.

15. TL15 – Hydromorphone
In this new version of the TL, terms and definitions have been updated where relevant.

16. TL16 – Tretoquinol
In this new version of the TL, the instruction to report an AAF for tretoquinol only if the sample has been collected after 15 January 2019 has been removed. In addition, the instruction to record samples in which the tretoquinol concentration is estimated below 20 ng/mL has been also removed. Terms and definitions have been updated where relevant.

17. TL17 – Detection of Tulobuterol in the Presence of Bupropion
In this new version of the TL, relevant articles have been reorganized to facilitate interpretation. Terms and definitions have been updated where relevant.

18. TL18 – Testolactone
In this new version of the TL, terms and definitions have been updated where relevant.

19. TL19 – Prednisone and Prednisolone
In this new version of the TL, updates were necessary to align the TL with the new TD2021IRMS. The reference to TL10 has been removed from the Introduction and updates have been made on terms and definitions, where relevant, for consistency with the TD2021IRMS.

20. TL20 – Specific Substances with a Steroid Structure
In this new version of the TL, additional substances have been included, which the Laboratories shall consider before reporting a result as an AAF. In addition, since the new TD2021IRMS does not include specific criteria for the GC/C/IRMS analysis of the substances mentioned in this TL, the recommendation to perform GC/C/IRMS analysis has been removed. Terms and definitions have been updated where relevant.

21. TL21 – 6-oxo and Metabolites
In this new version of the TL, terms and definitions have been updated where relevant.

22. TL22 – Ethylmorphine
In this new version of the TL, the WADA Laboratory Expert Group (LabEG) proposed to postpone the effective date of the TL22 until 1 May 2021 due to the lack of commercial sources of the norethylmorphine reference material. Several sources for the reference material have been identified and availability is expected soon. WADA is monitoring these efforts.

DEADLINES

Please note that all WADA-accredited Laboratories are required to implement these TLs in their procedures by the following deadlines:

1 January 2021:

  • TL01 – Meclofenoxate
  • TL03 – Zilpaterol
  • TL04 – Zeranol
  • TL06 – Possible Metabolism of Proguanil into Chlorazanil
  • TL07 – Andarine – Flutamide
  • TL08 – Use of Internal Standards
  • TL09 – Oxethazaine
  • TL10 – In Situ Formation of Exogenous Compounds
  • TL12 – Enobosarm
  • TL13 – Trimetazidine
  • TL14 – Difference in “A” and “B” Sample Urine Characteristics
  • TL15 – Hydromorphone
  • TL16 – Tretroquinol
  • TL17 – Detection of Tulobuterol in the Presence of Bupropion
  • TL18 – Testolactone
  • TL19 – Prednisone and Prednisolone
  • TL20 – Specific Substances with a Steroid Structure
  • TL21 – 6-oxo and metabolites

1 April 2021:

  • TL02 – Mebeverine Metabolism
  • TL05 – Oxilofrine
  • TL11 – Oxymorphone

1 May 2021:

  • TL22 – Ethylmorphine

The above TLs are available and indexed on WADA’s website.

Should you have any questions or comments regarding the 2021 Technical Letters, please feel free to contact WADA’s Science Department at: science@wada-ama.org.

Best regards,

World Anti-Doping Agency


05/01/21 WADA RELEASES LABORATORY TECHNICAL DOCUMENTS FOR 2021

Montreal, 22 December 2020

Dear Colleagues,

The World Anti-Doping Agency (WADA) publishes today the following Technical Documents (TDs) for 2021 and Summaries of Modifications which were approved by WADA’s Executive Committee, via circulatory vote, on 21 December 2020.

This particular review of WADA’s TDs was triggered by the need to bring the following ones in line with the 2021 World Anti-Doping Code (Code) and the 2021 International Standard for Laboratories (ISL), which both come into force on 1 January 2021.

Under the ISL, WADA’s TDs are issued to provide direction to WADA-accredited Laboratories, WADA-approved Laboratories and other stakeholders on specific technical or procedural issues. As part of WADA’s mandate to enhance anti-doping activities under the World Anti-Doping Code, TDs undergo periodic revisions to reflect scientific and technological advances in the performance of anti-doping tests and the reporting of test results. They are refined and revised in consultation with WADA stakeholders.

2021 TECHNICAL DOCUMENTS

1. TD2021BAR – Analytical Requirements for the Hematological Module of the Athlete Biological Passport.

The TD2021BAR replaces the former TD2019BAR. In this revised version of the TD, relevant definitions have been updated and further clarification introduced, where relevant, to facilitate interpretation.

2. TD2021CG/LH – Analysis, Reporting and Management of Urinary human Chorionic Gonadotrophin (hCG) and Luteinizing Hormone (LH) Findings in Male Athletes.

The TD2021CG/LH replaces the former TD2019CG/LH, which has been modified to include the following main changes: the possible use of total hCG assays for the initial testing procedure has been reintroduced to facilitate the analytical strategy; and further clarifications regarding the selection of hCG assays for the initial testing and confirmation procedures, as well as the management of reported hCG results, are now provided. Terms and definitions have been updated where relevant.

3. TD2021DL – Decision Limits for the Confirmatory Quantification of Exogenous Threshold Substances by Chromatography-based Analytical Methods.

The TD2021DL replaces the former TD2019DL Version 2, which has been modified to include the following main changes: sections have been reorganized to facilitate interpretation; the title has been adjusted to better reflect the revised scope of the TD, which has been redirected towards the confirmatory quantification of exogenous threshold substances when using Chromatography-based methods; the previous section on method validation has been removed since it is now well described in other documents; the applicable Decision Limits (DLs) and concentration levels of the exogenous threshold substances shall be reported to three significant figures; the examples in the text were updated accordingly; terms and definitions have been updated where relevant; and finally, a new Annex B was created to detail the values for the specific gravity-adjusted DLs.

4. TD2021EPO – Harmonization of Analysis and Reporting of Erythropoietin (EPO) and other Erythropoietin-Receptor Agonists (ERAs) by Polyacrylamide Gel Electrophoretic (PAGE) Analytical Methods.

The TD2021EPO replaces the former TD2014EPO, which has been modified to include the following main changes: adjustment of the title to reflect the current classification of these erythropoiesis stimulating agents in the 2021 Prohibited List; addition of test sensitivity controls as an additional, optional requirement for initial testing and confirmation procedures; definition of minimum required performance limits (MRPL) for detection of ERAs; mandatory immunopurification of ERAs before PAGE analysis; use of discontinuous transfer buffers for immunoblotting; use of a biotinylated primary anti-EPO antibody; and conditions to report an Atypical Finding for ERAs. Terms and definitions have been updated where relevant.

5. TD2021GH – Human Growth Hormone (hGH) Isoform Differential Immunoassays for Doping Control Analyses.

The TD2021GH replaces the former TD2019GH, which has been modified to include minimal changes that primarily affect its formatting as well as the updating of terms and definitions where relevant.

6. TD2021IDCR – Minimum Criteria for Chromatographic-Mass Spectrometric Confirmation of the Identity of Analytes for Doping Control Purposes.

The TD2021IDCR replaces the former TD2015IDCR, which has been modified to include the following main changes: clarifications have been provided regarding the selection and use of the applied Reference Diagnostic Ion in order to obtain the Retention Time and to calculate the Relative Abundances of the Analyte’s Diagnostic Ions; and the definitions of Reference Diagnostic Ion, Reference Specimen, Retention Time and Relative Retention Time have been included to facilitate interpretation. Other terms and definitions have been updated where relevant.

7. TD2021IRMS – Detection of Synthetic Forms of Prohibited Substances by GC/C/IRMS.

The TD2021IRMS replaces the former TD2019IRMS, which has been modified to include the following main changes: adjustment of the title to better reflect the revised scope of the TD, which has been expanded to include the analysis of other prohibited substances in addition to endogenous anabolic androgenic steroids (EAAS); addition of new target compounds (TC): 6a-hydroxy-androstenedione, epiandrosterone sulfate, prednisone and prednisolone; addition of pregnanetriol (PT) as an endogenous reference compound (ERC); calculation of absolute Δδ13C values; revision of uc_Max requirements; requirement to consider results obtained with two different ERCs for reporting an Adverse Analytical Finding (with an updated Annex A on Selection and Use of ERCs); and review of some interpretation criteria (e.g. for A and Etio) in Annex B. Terms and definitions have been updated where relevant.
 
8. TD2021LCOC – Laboratory Internal Chain of Custody.

The TD2021LCOC replaces the former TD2009LCOC, which has been modified to include the following main change: the TD has been completely reorganized to incorporate specific requirements for the maintenance and recording of chain of custody for sample reception, sample handling, aliquots, storage and sample transfers, including the use of electronic chain of custody systems. Terms and definitions have been updated where relevant.

9. TD2021LDOC – Laboratory Documentation Packages.

The TD2021LDOC replaces the former TD2019LDOC, which has been modified to include the following main changes: requirements for specific methods including Urine ABP, GC/C/IRMS, EPO and Blood ABP have been revised; and each annex has been updated based on the revised versions of the relevant TDs. Comments have been incorporated where relevant to provide further clarification of the requirements. Terms and definitions have been updated where relevant.

10. TD2021NA – Harmonization of Analysis and Reporting of 19-Norsteroids Related to Nandrolone.

The TD2021NA replaces the former TD2019NA, which has been modified to include the following main changes: better clarification of the possible endogenous origins of urinary 19-NA; better description of GC/C/IRMS performance characteristics and requirements when applied to 19-NA; instructions on the analysis to be performed when there are indications of 5a-reductase inhibitor activity in the sample; guidance to discriminate between oral consumption and injection of norsteroid preparations based on the pharmacokinetics of 19-NA excretion; and enhanced guidance for results interpretation and reporting in a tabulated form.

11. TD2021EAAS – Measuring and Reporting of Endogenous Anabolic Androgenic Steroid (EAAS) Markers of the Urinary Steroid Profile.

The TD2021EAAS replaces the former TD2018EAAS, which has been modified to include the following main changes: adjustment of the title to better reflect the scope of the TD; reorganization of different sections to facilitate interpretation; definition of reporting limits for non-prohibited substances that may alter the steroid profile; revision of the modalities of confirmation procedure requests (CPR); and steroid profile reporting requirements for “A” and “B” samples. Terms and definitions have been updated where relevant.

12. TD2021APMU – Athlete Passport Management Unit (APMU) Requirements and Procedures.

The TD2021APMU replaces the former TD2019APMU, which has been modified to include the following main changes: modifications have been introduced regarding the review of ATPF-CPR notifications for samples in which factors impacting the steroid profile have been reported; the management of SSP-CPR notifications has been transferred to the APMU, including revised criteria for triggering SSP-CPR notifications; steps to identify urine exchange (tampering) have been included; and the section dedicated to the analysis of steroid esters has been shifted from the TDEAAS to this new version of TDAPMU. Terms and definitions have been updated where relevant.
 
DEADLINES

Please note that all WADA-accredited Laboratories, WADA-approved Laboratories (for TD2021BAR, TD2021LDOC (Annex E) and TD2021LCOC) and APMUs (for TD2021APMU) are required to implement these TDs in their procedures by the following deadlines:

1 April 2021:

  • TD2021BAR
  • TD2021CG/LH
  • TD2021DL
  • TD2021GH
  • TD2021IDCR
  • TD2021LCOC
  • TD2021LDOC
  • TD2021NA
  • TD2021EAAS
  • TD2021APMU (for APMUs only)

1 May 2021:

  • TD2021EPO
  • TD2021IRMS

The above TDs are available and indexed on WADA’s website.

Should you have any questions or comments regarding the 2021 Technical Documents, please feel free to contact WADA’s Science Department at: science@wada-ama.org.

Best regards,

World Anti-Doping Agency


21/12/20 WADA RELEASES UPDATED GUIDELINES TO COMPLEMENT THE 2021 INTERNATIONAL STANDARD FOR THERAPEUTIC USE EXEMPTIONS

Montreal, 18 December 2020

Dear Colleagues,

The World Anti-Doping Agency (WADA) releases updated Guidelines for Therapeutic Use Exemptions (TUEs) to support Anti-Doping Organizations (ADOs) and other stakeholders in their implementation and application of the revised International Standard for Therapeutic Use Exemptions (ISTUE), which comes into force on 1 January 2021.

The new ISTUE Guidelines provide detailed information and examples for athletes, ADOs, physicians and Athlete Support Personnel to guide them when a TUE may be required to use a Prohibited Substance or Method due to an illness or a medical condition. These Guidelines have been updated in accordance with the 2021 World Anti-Doping Code (Code) and ISTUE. While the Guidelines are initially being published in English, the official French version will be published in early 2021.

The Guidelines can be found on WADA’s website and on the Agency’s Anti-Doping eLearning Platform (ADEL), as part of the Code Implementation Support Program (CISP), which provides additional resources to support the implementation of the ISTUE, as well as the revised Code and other International Standards that enter into force on 1 January 2021.

WADA guidelines provide Code Signatories with recommended practices for several aspects of anti-doping programs. While these guidelines are not mandatory, they offer technical guidance to ADOs in the implementation of their anti-doping programs. As with all guidelines under the World Anti-Doping Program, they are subject to ongoing review.

Should you have any questions regarding the Guidelines for Therapeutic Use Exemptions, or wish to provide feedback, please contact WADA’s Medical Unit at: medical@wada-ama.org.

Best regards,

World Anti-Doping Agency


21/12/20 WADA PUBLISHES 2019 TESTING
FIGURES REPORT

Report Highlights

  • A 5.5% increase in the overall number of samples analyzed: 263,519 in 2018 to 278,047 in 2019.
     
  • A slight decrease in the total percentage of Adverse Analytical Findings (AAFs): 1.05% in 2018 (2,774 AAFs from 263,519 samples) to 0.97% in 2019 (2,702 AAFs from 278,047 samples).
     
  • About 60% of WADA-accredited Laboratories saw an increase in the total number of samples recorded.
     
  • An almost similar total number and percentage of non-Athlete Biological Passport (ABP) blood samples analyzed: 9.3% in 2018 (24,495 of 263,519) and 9.1% in 2019 (25,339 of 278,047).
     
  • An increase of 16% in the number of ABP blood samples tested: 31,265 in 2018 to 36,401 in 2019.
  • An increase in AAFs reported for Erythropoiesis Stimulating Agents (ESAs), Growth Hormone (GH) and Growth Hormone Releasing Factors (GHRFs).
     

Montreal, 18 December 2020 – The World Anti-Doping Agency (WADA) today published its 2019 Testing Figures Report (2019 Report), which summarizes the results of all the samples WADA-accredited Laboratories analyzed and reported in WADA’s Anti-Doping Administration and Management System (ADAMS) in 2019.

This is the fifth set of global testing figures under the version of the World Anti-Doping Code (Code) that came into effect in January 2015. The 2019 Report – which includes an Executive Summary and sub-reports by Laboratory, Sport, Testing Authority and Athlete Biological Passport (ABP) Blood Analysis – includes in- and out-of-competition urine samples; blood and ABP blood data; and, the resulting AAFs and Atypical Findings (ATFs).

WADA Director General Olivier Niggli said: “WADA’s Annual Testing Figures Report is a key tool for information sharing between Anti-Doping Organizations. It provides the anti-doping community with a wealth of data allowing them to assess their anti-doping strategies and identify potential patterns of doping or areas of improvement.

“The 2019 Report, which encompasses all doping control samples analyzed and reported by WADA-accredited and -approved Laboratories around the world in 2019, also contains enhanced data on gender and Regional Anti-Doping Organization testing following stakeholder questions on these areas. Anti-Doping Organizations will be able to use this comprehensive Report, and the valuable intelligence contained within it, to adapt their anti-doping programs and ensure that their programs are as intelligent as possible and rooted in solid data.”

To help with the interpretation of the 2019 Report, we provide a comprehensive Question and Answer document. Of particular importance, please note that:

  • One single result does not necessarily correspond to one athlete. Results may correspond to multiple findings regarding the same athlete or measurements performed on the same athlete, such as in the case of longitudinal studies of testosterone.
     
  • The number of AAFs in the Report may not correspond with the number of Anti-Doping Rule Violations (ADRVs) reported by Anti-Doping Organizations (ADOs). This is because all results are subject to a results management process conducted by ADOs, which includes matching results with Therapeutic Use Exemptions (TUEs), and longitudinal studies which can result in no case to answer or no sanction.
  • As usual, this Report does not illustrate statistics on ADRVs, which are reported via a separate ADRV Report – the 2018 version of which was released earlier in December 2020. The ADRV Report reveals analytical and non-analytical cases and the outcomes of results management, which is a process that can take a long time given that it may include investigations, appeals and other processes
     

17/12/20 WADA STATEMENT ON COURT OF ARBITRATION DECISION TO DECLARE RUSSIAN ANTI-DOPING AGENCY AS NON-COMPLIANT

Montreal, 17 December 2020 

The World Anti-Doping Agency (WADA) acknowledges the ruling today by the Court of Arbitration for Sport (CAS) to declare the Russian Anti-Doping Agency (RUSADA) non-compliant with the World Anti-Doping Code (Code) for a period of two years and to impose significant consequences. This decision confirms in large part the recommendation made in November 2019 by WADA’s independent Compliance Review Committee (CRC), which was unanimously accepted by the Agency’s Executive Committee (ExCo) on 9 December 2019.

Today’s CAS ruling is a clear endorsement of WADA’s assertion that data from the Moscow Laboratory were intentionally altered prior to and while they were being forensically copied by WADA Intelligence and Investigations (I&I) in January 2019 as part of Operation LIMS, in contravention of critical criteria set by the ExCo when RUSADA was reinstated as compliant, under strict conditions, in September 2018.

WADA President Witold Bańka said: “WADA is pleased to have won this landmark case. We left no stone unturned in investigating this very complex matter and in presenting our case before CAS. The Panel has clearly upheld our findings that the Russian authorities brazenly and illegally manipulated the Moscow Laboratory data in an effort to cover up an institutionalized doping scheme. In the face of continual resistance and denial from Russia, we clearly proved our case, in accordance with due process. In that regard, this ruling is an important moment for clean sport and athletes all over the world.

“We are, however, disappointed that the CAS Panel did not endorse each and every one of our recommended consequences for the four-year period we requested. We believe they were proportionate and reasonable, but ultimately WADA is not the judge but the prosecutor and we must respect the decision of the Panel. These are still the strongest set of consequences ever imposed on any country for doping-related offences and the award clearly endorses the resolute, process-driven approach taken by WADA in dealing effectively with this case. Russia will not be permitted to participate in, bid for or host any covered event, including two editions of the Olympic and Paralympic Games and many other major events, for the next two years. The Russian flag will not fly nor its anthem played. This sends a clear message that institutionalized cheating and concerted efforts to subvert the global anti-doping system will not be tolerated.

“The egregious manipulation by the Russian authorities of data retrieved by WADA Intelligence and Investigations from the Moscow Laboratory was the latest in a long list of offences and it has led today to significant consequences for the authorities. Russian authorities were afforded every opportunity to get their house in order and re-join the global anti-doping community for the good of their athletes and the integrity of sport, but they chose instead to continue on their path of deception and denial.”

WADA Director General Olivier Niggli said: “Today, the global anti-doping program is much stronger than it was at the time of the Sochi Olympic and Paralympic Games in 2014, and with the revised World Anti-Doping Code that comes into force on 1 January 2021, the program will be even stronger. The CAS ruling was made possible by the enhancements that have been put in place by WADA since the end of 2014 when the Russian doping program was first exposed. In particular, WADA’s acquisition of investigative powers in 2015 and the growth of our independent Intelligence and Investigations Department have proven to be a game-changer, while the International Standard for Compliance by Signatories (ISCCS) that entered into effect in April 2018 has stood up to this rigorous test. This CAS decision in such a high-profile and complex case demonstrates that the legal framework underpinning anti-doping works and works well.

“WADA’s determination to act resolutely and lawfully in the face of the Russian doping crisis was the correct approach. The diligence of our investigators, the vision of the independent Compliance Review Committee and our ability to take action via the Compliance Standard have enabled WADA to make the right decisions at every stage.

“WADA can now focus its energy on ensuring that those athletes, who were identified as potentially violating the rules as part of our wide-ranging Operation LIMS investigation, are brought to justice. WADA will continue to follow up with the International Federations to which we provided evidence packages in April 2020 as part of Operation LIMS to ensure those cases are dealt with swiftly and appropriately. If they are not, we will continue to exercise our independent right of appeal to CAS.

“It is also crucial that a credible, operationally independent and efficient anti-doping system prevails in Russia for the good of all athletes. To that end, we welcome the CAS Panel’s confirmation that a condition of RUSADA’s reinstatement once the two-year period has elapsed will be that WADA remains satisfied that RUSADA’s operational independence is being respected and there is no improper outside interference.”

As per Article 10.4.1 of the ISCCS, WADA expects the full reasoned decision will be publicly reported by CAS next week.


15/12/20 WADA ISSUES CALL FOR PROPOSALS FOR 2021 SCIENTIFIC RESEARCH GRANTS

Montreal, 15 December 2020

Dear Colleagues,

The World Anti-Doping Agency (WADA) is pleased to issue a Call for Proposals for 2021 Scientific Research Grants.

Science is key to driving advances in anti-doping. Innovative research helps the anti-doping community identify new trends in doping, new drugs, new delivery mechanisms and new methods of detection.   

Since 2001, WADA has committed more than US$ 83 million to helping researchers around the world develop breakthroughs in anti-doping science. These grants are critical because they increase the volume of research dedicated to developing new and improved detection methods for performance-enhancing substances and methods as well as attract high level researchers to this cause.

Scientists interested in submitting research projects are invited to submit their applications via the Agency’s WADAGrants platform by 1 March 2021 (24:00 GMT).

Learn more about the 2021 Scientific Research Grants Program and the application process.

Obtenga más información sobre la Convocatoria de subvenciones de investigación 2021 y el procedimiento de solicitud.

Best regards,

World Anti-Doping Agency


08/12/20 WADA PUBLISHES UPDATED THERAPEUTIC USE EXEMPTION APPLICATION FORM IN SUPPORT OF THE
2021 INTERNATIONAL STANDARD FOR
THERAPEUTIC USE EXEMPTIONS

Montreal, 8 December 2020

Dear Colleagues,

Today, the World Anti-Doping Agency (WADA) publishes an updated template of the Therapeutic Use Exemption (TUE) Application Form to support Anti-Doping Organizations (ADOs) in their implementation of the 2021 International Standard for Therapeutic Use Exemptions (ISTUE), which comes into force on 1 January 2021. The French and Spanish versions will be published on WADA’s website in the coming weeks. 

The updated TUE Application Form has been improved to assist athletes and their physicians with the TUE application process – including detailing the diagnoses and reasons behind the request for a TUE.

The Form may be modified by ADOs to include additional requests for information; however, no sections or items may be removed, including the new TUE Privacy notice. Similarly, ADOs may translate the Form into other languages; although, the existing English or French text must be retained. 

Should you have any questions regarding the Form, please feel free to contact WADA’s Medical Department at: medical@wada-ama.org.

Best regards,

World Anti-Doping Agency


04/12/20 WADA’s 2019 TESTING FIGURES REPORT: FOR AFO REVIEW

Montreal, 4 December 2020

Dear Colleagues,

Article 14.5 of the World Anti-Doping Code (Code) stipulates that the World Anti-Doping Agency (WADA) shall act as a central clearinghouse for Doping Control Testing data and results. Accordingly, on an annual basis, the Agency publishes reports which consolidate data that have been reported by WADA-accredited laboratories via the Agency’s Anti-Doping Administration and Management System (ADAMS).

Today, we are pleased to provide WADA’s 2019 Testing Figures Report which is broken down into the following four sub-reports. They represent analysis conducted by the WADA-accredited laboratories in 2019, in- and out-of-competition, for urine, blood, and the Athlete Biological Passport (ABP).

The sub-reports are:

  1. Laboratory report
  2. Sport report
  3. Testing Authority report
  4. ABP (blood analysis)

WADA is providing you, Anti-Doping Organizations (ADOs), with these reports in advance of their public distribution, inviting you to review your respective testing data and verify the data via ADAMS. We would ask you to provide comments no later than 14 December 2020 via WADAConnect, the Agency’s online consultation platform. Easy to use, WADAConnect will prompt you to create a user account and input your comments.

[For further information related to WADAConnect, please refer to the simple user guide.]

Furthermore, and in order to facilitate this process, the Agency would encourage you to refer to the Reporting Guide to Monitor Testing, which will guide you in compiling and verifying your respective results in ADAMS, including the Adverse Analytical Findings (AAFs) and Atypical Findings (ATFs) related to samples from your testing programs.

Should you have any questions regarding the Testing Figures Report, please contact statistics@wada-ama.org.

We thank you for your cooperation and remain available to respond to any questions that you may have in this regard.

Best regards,

World Anti-Doping Agency


03/12/20 WADA EXECUTIVE COMMITTEE WELCOMES TWO ADDITIONAL INDEPENDENT MEMBERS

Montreal, 3 December 2020 – During a two-week circulatory vote that followed its 12 November virtual meeting, the Foundation Board (Board) of the World Anti-Doping Agency (WADA) confirmed the recommendations of both the Agency’s Nominations Committee and Executive Committee (ExCo) and appointed Gabriella Battaini-Dragoni and Patricia Sangenis as two additional independent members of the ExCo.
 
Originally from Italy, Ms. Battaina-Dragoni is the current Deputy Secretary General of the Council of Europe (COE), and will retire from this position in the coming weeks. From 2011-12, she was COE’s Director General of Programs and was Director General of Education, Culture and Heritage, Youth and Sport from 2004-11. A strong proponent of ethics in sports, she played a leading role in the planning and promotion of a number of COE’s sports integrity initiatives that sit alongside its longstanding Anti-Doping Convention. She is currently representing the COE on WADA’s Board – a seat she will relinquish due to her appointment to the ExCo.
 
Dr. Sangenis is a reputed sports physician from Argentina. For more than 20 years, she helped to deliver medical services and doping control for various sporting events, including at the Olympic and Paralympic Games, and she is a former member of the International Olympic Committee Medical and Scientific Commission. Through her work as a practitioner and academic, she has been a strong advocate for sport and physical activity, especially among women and girls, with the aim of achieving equal opportunities, not only in terms of participation, but also as it relates to health, leadership and other areas.
 
The additional independent members’ terms will commence on 1 March 2021. From that date, therefore, WADA’s ExCo will be composed of four independent members (including the President and the Vice-President), five representatives of Governments and five of the Sport Movement, with active or former athletes represented in each of these categories. Currently, one third of the members of both WADA’s ExCo and Board are active or former international-level athletes.
 
As such, the full ExCo will consist next year of:

  1. Witold Bańka (Independent Chair, WADA President)
  2. Yang Yang (Independent Vice-Chair, WADA Vice-President)
  3. Patricia Sangenis (Independent)
  4. Gabriella Battaini-Dragoni (Independent)
  5. Ugur Erderner (International Olympic Committee)
  6. Jiri Kejval (Association of National Olympic Committees)
  7. Ingmar de Vos (Association of Summer Olympic International Federations)
  8. Nenad Lalovic (Global Association of International Sports Federations)
  9. Danka Bartekova (IOC Athletes Commission)
  10. Amira El Fadil (Public Authorities – Africa)
  11. Andrea Sotomayor (Public Authorities – Americas)
  12. Tanose Taido (Public Authorities – Asia)
  13. Dan Kersch (Public Authorities – Europe)
  14. Grant Robertson (Public Authorities – Oceania)

This change is the latest in a wide-ranging series of governance reforms implemented by WADA since November 2018 to ensure the Agency’s governance remains fit for purpose and can adapt to future challenges. Of the 70 reform recommendations made by the WADA Governance Reforms Working Group in November 2018, all have now been actioned to some degree – the vast majority having been fully implemented. In addition to the four independent ExCo members, there is at least one athlete and one representative of National Anti-Doping Organizations (NADOs) on each Standing Committee (except, as it relates to NADOs, for the independent Compliance Review Committee), and there is a limit of three terms of three years each for members of the ExCo, Board and Standing Committees.
 
In addition, work continues on additional athlete representation within WADA’s governance, as well as the introduction of a WADA Code of Ethics and formation of an Independent Ethics Board or similar structure. A draft of the Code of Ethics has been developed with the objective of it being approved by the Board in May 2021.
 
On 11 November 2020, the ExCo approved the composition of a new Working Group on the Review of WADA Governance Reforms to monitor the effect of the ongoing reforms and propose additional reforms going forward following a broad stakeholder consultation. This Group includes five governance experts and one expert athlete (nominated by WADA’s Athlete Committee), with the possibility of expanding the Group to include another expert athlete.
 
WADA President Witold Bańka said: “The significant progress WADA has made on governance reform continues and I would like to welcome Dr. Sangenis and Ms. Battaini-Dragoni as strong, independent voices on the ExCo. WADA’s governance reform is expanding. With the establishment of the new Working Group, the governance model will be further strengthened on an ongoing basis. It is vital that WADA is not static and that our governance continues to evolve in line with international best practice.”
 
2021 Budget
 
As part of its circulatory vote, the Board also approved the 2021 WADA budget, which was endorsed by the Agency’s Finance and Administration Committee at its meeting in August and recommended by the ExCo on 11 November. The agreed budget is USD 43,371,517, representing an 8% increase as compared to 2020, which was accepted by the Board in May 2018 as part of a four-year series of annual increases from 2019-22. 
 
WADA Investigations Policy
 
Lastly, the Board approved amendments to the WADA Investigation Policy, as recommended by the ExCo at its November meeting. The amendments refer primarily to the timing of publication of WADA’s investigative findings and the need for transparency to help lift the veil on doping schemes while also protecting the identity of whistleblowers and not compromising any ongoing results management processes or law enforcement activities.


02/12/20 WADA WELCOMES ADDITIONAL CONTRIBUTIONS FROM GOVERNMENTS OF CHINA, EGYPT, INDIA AND SAUDI ARABIA

Montreal, 2 December 2020 – The World Anti-Doping Agency (WADA) today welcomes additional contributions totaling close to USD2.6 million from the Governments of China, Egypt, India and Saudi Arabia, which will be dedicated to the Agency’s scientific research and intelligence and investigations (I&I) activities.

The contributions are additional to the Governments’ annual contributions to WADA’s regular budget, which are matched by the International Olympic Committee (IOC) on behalf of the Sports Movement, and are part of an initiative announced in November 2019 by IOC President Thomas Bach to further strengthen WADA’s scientific research and I&I programs. Under this initiative, additional contributions provided by Governments are matched by the IOC, which means that these contributions will yield almost USD5.2 million extra for the global anti-doping system.

WADA President Witold Bańka said: “This is a massive boost for WADA and for Clean Sport. The Agency is grateful to the Governments of China, Egypt, India and Saudi Arabia for supporting the protection of sport in this way. These generous contributions can be seen as a strong commitment from these nations and will be put to good use enhancing scientific research, as well as the work of WADA’s independent Intelligence and Investigations Department. Both areas have delivered significant achievements in recent years and these additional resources will contribute greatly towards WADA’s mission for doping-free sport.

“Thanks are of course also due to the IOC for launching this initiative and generously matching these amounts, ensuring that every dollar invested by Governments brings two dollars into the system. This collaborative initiative is proving to be very successful and demonstrates the strength of the partnership between the Sports Movement and Public Authorities when it comes to anti-doping. I encourage other Governments to take advantage of this opportunity that the IOC has offered.”

Specifically, the Government of India has pledged an additional USD1 million, Saudi Arabia USD500,000 and Egypt USD100,000, while WADA has already received the USD992,694 pledged by the Chinese Government. China, Saudi Arabia and Egypt have previously made similar additional contributions and, in the past four years, outside of this particular initiative, WADA has also received additional contributions from the Governments of Australia, Azerbaijan, Brazil, Denmark, France, Japan, Kuwait, Poland and the USA, as well as three different levels of Government in Canada, the City of Lausanne and the Canton de Vaud in Switzerland.


17/11/20 WADA STATEMENT ON U.S. SENATE’S PASSING OF THE RODCHENKOV ANTI-DOPING ACT

Montreal, 17 November 2020 – The World Anti-Doping Agency (WADA) maintains its concern following yesterday’s decision by the United States (U.S.) Senate to pass the Rodchenkov Anti-Doping Act of 2019 (Rodchenkov Act).

WADA supports Governments who use their legislative powers to protect athletes in the fight against doping in sport. However, while recognizing positive elements of this legislation, WADA and other stakeholders continue to believe that some very important elements of the Act will have unintended consequences and will disrupt the global legal anti-doping framework recognized to date by 190 nations, including the U.S., through the UNESCO International Convention Against Doping in Sport. WADA and many other organizations representing governments and sports around the world, including from within the Council of Europe, the International Olympic Committee and a number of Anti-Doping Organizations, have expressed concerns around the issue of extraterritoriality in the Act as it will undermine the fight against doping worldwide.

No nation has ever before asserted criminal jurisdiction over doping offences that occurred outside its national borders – and for good reason. It is likely to lead to overlapping laws in different jurisdictions that will compromise having a single set of anti-doping rules for all sports and all Anti-Doping Organizations under the World Anti-Doping Code (Code). This will have negative consequences as harmonization of the rules is at the very core of the global anti-doping system.

WADA remains concerned that by unilaterally exerting U.S. criminal jurisdiction over all global doping activity, the Act will likely undermine clean sport by jeopardizing critical partnerships and cooperation between nations. Further, the Act could impede the capacity to benefit from whistleblowers by exposing them to possible prosecution and preventing ‘substantial assistance’ deals in line with the provisions of the Code.

This Act may lead to other nations adopting similar legislation, thereby subjecting U.S. citizens and sport bodies to similar extraterritorial jurisdictions and criminal sanctions, many of which may be political in nature or imposed to discriminate against specific nationalities. This will be detrimental to anti-doping efforts everywhere, including in the U.S.

WADA President Witold Bańka said: “We join other stakeholders around the globe in asking why this U.S. legislation, which purports to protect athletes and claims jurisdiction overseas, specifically excludes the hugely popular and influential professional and college leagues. Nearly half a million athletes compete in U.S. college sports, and thousands more in the professional leagues. These leagues were originally included in the Act but were subsequently removed without explanation. Why are those who surround the athletes in these associations and leagues now exempt from the scope of this legislation? If it is not good enough for American sports, why is it being imposed on the rest of the world?

“While the Act was passed without consultation with international anti-doping partners, WADA will seek to work with U.S. authorities on implementing this legislation to ensure that the global anti-doping system, which has evolved for 20 years in close collaboration with the U.S., is not upended, that WADA’s mandated investigative capacity is not diminished, and that the negative impact of this Act is minimized.”


16/11/20 WADA PUBLISHES ADO SURVEY OUTCOMES
CONCERNING IMPACT OF COVID-19 ON
ANTI-DOPING PROGRAMS WORLDWIDE

Montreal, 16 November 2020

Dear colleagues,

The World Anti-Doping Agency (WADA) is pleased to share the outcomes of a surveythat the Agency issued on 2 September 2020 to Anti-Doping Organizations (ADOs) worldwide for completion by 18 September 2020. The survey, which was aimed at assessing the impact that COVID-19 was having on anti-doping programs worldwide, is part of a broader review to also determine what lessons can be learned from the situation; gather feedback on the COVID-19 Guidance for Resuming Testing document issued by WADA on 6 May 2020; and, determine the impact that COVID-19 was having on sample collection, shipment and the sample analytical process.

The survey was issued to 247 ADOs and nearly half of them responded. Of the respondents:

  • 75% were National Anti-Doping Organizations (NADOs);
  • 10% were International Federations (IFs); and
  • 15% were ‘Other’ (e.g., Regional Anti-Doping Organizations).

WADA is extremely grateful to all who took the time to complete the survey. As you will see from the survey results, responses showed that the guidance documents that WADA developed and shared with ADOs in the early stages of the pandemic were very useful. The feedback received is assisting WADA in determining the improvements that can be made to these documents; as well as, the global anti-doping system; in particular, how we can continue to adapt and be better prepared should similar public health crises arise in the future.

In short, the survey provided feedback on a number of key areas that have or are in the process of being addressed including:

  • That information and guidance documents be updated as promptly as possible. WADA is working with key stakeholders to update guidance documents for ADOs. In particular, the Strategic Testing Expert Group is in the process of updating the COVID-19 Guidance for Resuming Testing document, which WADA intends to publish late November 2020 in the dedicated COVID-19 section of WADA’s website. This will provide further assistance to ADOs as they continue to test/resume testing during the pandemic including guidance on in-competition testing, blood testing, storage of samples, and B sample analysis — all with the continued focus on the health and safety of athletes and sample collection personnel.
     
  • Requests for flexibility around compliance matters. The independent Compliance Review Committee (CRC) announced flexibility around compliance matters due to the exceptional nature of the situation. This was communicated to Code Signatories after each of the meetings of the CRC since March 2020 and will be further reviewed during the next CRC meeting in early 2021.
     
  • That there be priority testing. WADA is working with the anti-doping community to ensure that the priority for testing is on athletes that are due to compete in upcoming major events, including: the Olympic and Paralympic Games in Tokyo, World Championships and other major events.
     
  • That there be ongoing support for the 2021 World Anti-Doping Code (Code) implementation. WADA will continue to support ADOs with their implementation of the 2021 Code and International Standards via its Code Implementation Support Program (CISP) that includes numerous live webinars, guideline documents and other supporting documentation (e.g., factsheets, checklists, templates, etc.) – all that are available on WADA’s Anti-Doping e-Learning platform (ADeL). In addition, we encourage all ADOs to continue engaging with the relevant WADA Departments as well as the WADA Regional Offices for direct assistance and support.

Should you have any questions, please feel free to contact us at SandH@wada-ama.org.

Thank you again to all that participated in the survey — best regards,

World Anti-Doping Agency


13/11/20 2018 ADRVs REPORT ‘PRE-RELEASE’ CONSULTATION

Montreal, 13 November 2020

Dear Colleagues,

In accordance with Articles 14.4 and 14.5 of the World Anti-Doping Code (Code), WADA, acting as a central clearinghouse for doping control testing results, annually publishes statistical reports summarizing the information that it receives from Anti-Doping Organizations (ADOs).

Today, we are pleased to provide ADOs with a ‘pre-release’ of the 2018 Anti-Doping Rule Violations (ADRVs) Report, which is presented in the following four sections, and includes analytical ADRVs as a result of Adverse Analytical Findings (AAFs) reported by the WADA-accredited laboratories and non-analytical ADRVs reported to WADA by ADOs:

  • Section 1: Outcomes of 2018 AAFs by Sport Category
  • Section 2: Outcomes of 2018 AAFs by Testing Authority Category
  • Section 3: Report of 2018 Non-Analytical ADRVs
  • Section 4: Report of 2018 Total Analytical and Non-Analytical ADRVs

WADA provides the Report to you in advance of public distribution so that you can review and/or comment on the data of your respective ADO before it is published. Accordingly, should you wish to comment, kindly do so no later than 23 November 2020 via WADAConnect, the Agency’s online consultation platform. Easy to use, WADAConnect will prompt you to create a user account and input your comments. For further information related to WADAConnect, please refer to the simple user guide.

Should you have any other questions or comments concerning the 2018 ADRVs Report, we invite you to contact statistics@wada-ama.org.

Best regards,

World Anti-Doping Agency


12/11/20 WADA EXECUTIVE COMMITTEE AND FOUNDATION BOARD EXPAND UPON AGENCY’S GOVERNANCE REFORMS

Montreal, 12 November 2020 – The World Anti-Doping Agency’s (WADA’s) Executive Committee (ExCo) and Foundation Board (Board) met virtually yesterday (11 November) and today (12 November), respectively.The 38-member Board is WADA’s highest policy-making body. It delegates the management and running of the Agency to the 12-member ExCo. Accordingly, the ExCo takes decisions of its own and makes recommendations to the Board for decisions concerning the performance of certain activities and the administration of assets.
 
Given the virtual nature of this week’s meetings due to COVID-19, decisions stemming from the Board meeting, which was open to the media and observers as per WADA’s Statutes, will be made via a two-week circulatory voting process. This will ensure the integrity of the voting process and mitigate any difficulties that may arise from holding a virtual meeting with such a large group of participants. WADA will then publicly communicate the decisions once they are confirmed. The major decisions taken by the ExCo are outlined below.
 
A Tribute to John Fahey
 
The Board meeting opened with a moment of silence in memory of former WADA President John Fahey, who passed away on 12 September in Australia at the age of 75. Mr. Fahey, who was admired and respected across the worlds of sport and politics, served with distinction as WADA President from 2008-13.
 
Advancing and Expanding Governance Reform
 
The ExCo and Board received a progress report on the implementation and timing of WADA’s wide-ranging governance reforms, which were approved by the Board in November 2018 and are being introduced according to the agreed schedule. Of the 70 reform recommendations made by the WADA Governance Reforms Working Group in November 2018, all have now been actioned to some degree – the vast majority having been fully implemented. In particular, WADA now has an independent President and Vice-President, there is at least one athlete and one representative of National Anti-Doping Organizations (NADOs) on each Standing Committee (except for the independent Compliance Review Committee as it relates to NADOs), and there is a limit of three terms of three years each for members of the ExCo, Board and Standing Committees.
 
Yesterday, the ExCo:

  • Endorsed the recommendation made by the Agency’s Nominations Committee for the appointment of two additional independent members of the ExCo (for consideration by the Board via circulatory vote) and recommended to the Board to approve this proposal. With the addition of these two members, going forward the ExCo will be composed of four independent members (including the President and the Vice-President), five representatives of Governments and five of the Sport Movement, with active or former athletes represented in each of these categories. Currently, one third of the members of both WADA’s ExCo and Board are active or former international-level athletes;
  • Streamlined the governance of the Agency’s Expert Advisory Groups and Working Groups; and
  • Approved the composition of a new Working Group on the Review of WADA Governance Reforms to ensure that the Agency continues to evolve in line with international best practice. This Group includes five governance experts (two proposed by Governments, two by the Sport Movement, and one independent Chair) and one expert athlete (nominated by WADA’s Athlete Committee), with the possibility of expanding the Group to include another expert athlete. Beginning its work immediately, it will be responsible for monitoring the effect of the ongoing reforms and for proposing additional governance reforms going forward. An essential part of the work of the Group will be to consult all stakeholders, including athletes and NADOs, using a wide-ranging consultation process in the same spirit as the one used for past World Anti-Doping Code reviews. The members of the Group are:
     
    • Prof. Ulrich Haas (Independent Chair, Germany)
    • Maria Clarke (New Zealand)
    • Adam Pengilly (Athlete, UK)
    • Romano Subiotto (Italy/UK)
    • An Vermeersch (Belgium)
    • Michael Vesper (Germany)

In addition, work continues on additional athlete representation within WADA’s governance (as outlined below), as well as the introduction of a WADA Code of Ethics and formation of an Independent Ethics Board or similar structure. A draft of the Code of Ethics has been developed with the objective of an approval during the Foundation Board in May 2021.
 
WADA President Witold Bańka said: “WADA continues to progress with its wide-ranging governance reforms to remain fit for purpose and to be able to adapt to challenges that lie ahead. I was pleased that during these last two days, the ExCo and Board recognized the progress that has been made to date while remaining focused on the next steps. A large number of members from both the Sports Movement and Governments around the world voiced their appreciation for how these significant reforms were being implemented. In particular, they welcomed the addition of independent members to the Executive Committee and the formation of the new Working Group on the Review of WADA Governance Reforms that will ensure that we keep up this momentum of change.”
 
2021 Standing Committees
 
Following a rigorous process of nomination and consideration, the ExCo approved a number of new or renewed members of each of the five Standing Committees for 2021, with the exception of the Public Authority representative on the Compliance Review Committee that will be recommended for approval in December 2020. More than half (27 out of 53) of the appointed members are women, and 33 countries from the five continents are represented on the 2021 Committees. The full list of the 2021 Standing Committee members will be published shortly.
 
Athlete Representation
 
Both the ExCo and Board were updated on the work of all Standing Committees. In particular, the Athlete Committee Chair, Ben Sandford, outlined the work of the Athlete Representation Working Group – a subset of the Athlete Committee – that is reviewing the current governance of the Athlete Committee and looking at ways to further enhance athlete representation at WADA. Ben Sandford also updated the ExCo on the current work conducted on the concept of an ombudsperson(s) resource for anti-doping.
 
President Bańka updated the ExCo and Board on his initiative to meet regularly with athlete groups, in line with WADA’s new Five-Year Strategic Plan that places athlete engagement at the heart of the organization’s activities. Since launching the initiative, and despite the restrictions imposed by the COVID-19 pandemic, Mr. Bańka has managed to hold productive virtual meetings with hundreds of athletes from various athlete commissions and groups worldwide. He said that a key outcome of the exercise will be to help establish how to ensure athlete perspectives can best be represented within WADA.
 
COVID-19
 
WADA Management updated the ExCo and Board regarding COVID-19’s impact on the global anti-doping system. Members were presented with a summary of the results of a WADA survey of Anti-Doping Organizations that sought information on the impact of the pandemic and feedback on the usefulness of WADA’s guidance documents, which are publicly available on a dedicated section of the WADA website. This survey will be made public in the coming days.
 
WADA Director General Olivier Niggli said: “It is encouraging to see how committed the anti-doping community is to maintaining the integrity of the global anti-doping system in the face of COVID-19. While public health remains everybody’s number-one priority and testing is only one of multiple anti-doping tools, the number of tests has continued to raise during the last months, and the level of out-of-competition testing in September was at about 80% of the figures of September 2019. WADA will continue to work with Anti-Doping Organizations worldwide and provide any support they may need to help them return to full power in all of their anti-doping activities.”
 
International Weightlifting Federation (IWF)
 
The Director of WADA’s Intelligence and Investigations (I&I) Department, Gunter Younger, reported to the Board in relation to his team’s ongoing investigation into the IWF and the sport of weightlifting, which has been running since August 2017. The investigation includes a probe of a high-ranking member of the IWF (Operation Outreach), Romanian weightlifters and others (Operation Heir), allegations of improper practices by some national weightlifting federations (Operation Extra) and a ground-breaking investigation into the global practice of urine substitution by weightlifters and the use of doppelgängers (Operation Arrow). Provisional outcomes of this significant investigation were published last month.
 
The positive outcomes from this investigation were only possible due to a combination of brave whistleblowers bringing evidence to WADA via the ‘Speak Up!’ program and the diligence and skill of investigators.
 
2021 Budget
 
The ExCo recommended that the Board adopt the 2021 WADA budget endorsed by the Agency’s Finance Committee at its meeting in August. The proposed budget, which is USD 43,371,517, represents an 8% increase as compared to 2020, as accepted by the Board in May 2018 as part of a four-year series of annual increases from 2019-22. The Board will consider the recommendation via circulatory vote.
 
Asia Public Authorities representative and President of the Saudi Arabian Anti-Doping Committee, Mohammed Saleh Al Konbaz, informed the meeting that the Saudi Government intended to make an additional contribution to WADA of USD500,000 as part of an initiative put in place last year by IOC President Thomas Bach to boost funding for the Agency’s science and investigations budgets. Additional contributions provided by Governments under this scheme are matched by the IOC, which means that Mr. Al Konbaz’s announcement represents USD1 million that will be added to the global protection of clean sport.
 
Board decisions will be announced once the two-week circulatory voting period has elapsed. In the meantime, WADA will publish more detailed information on the decisions taken by the ExCo in the coming days.


9/11/20 WADA PUBLISHES GUIDE TO STRENGTHENING NATIONAL ANTI-DOPING ORGANIZATIONS’ OPERATIONAL INDEPENDENCE

Montreal, 9 November 2020

Dear Colleagues,

The World Anti-Doping Agency (WADA) has published a Guide for the Operational Independence of National Anti-Doping Organizations (NADOs) that will support them in strengthening and reinforcing their operational independence as required by the revised World Anti-Doping Code (Code) that was approved in November 2019 and comes into force on 1 January 2021.

Following an exhaustive consultation process, Article 20.5.1 of the 2021 Code will ensure that NADOs are independent from sport and government in their operational decisions and activities by prohibiting any operational involvement by anyone who is at the same time involved in the management or operations of any International Federation, National Federation, Major Event Organization, National Olympic Committee, National Paralympic Committee, or Government department with responsibility for sport or anti-doping.

WADA Director General Olivier Niggli said: “Operational independence is crucial for NADOs as they seek to deliver anti-doping programs without undue influence from governments or sports. Bringing this requirement under the terms of the World Anti-Doping Code makes this independence a condition of their ongoing compliance. Just as WADA is operationally independent from both those stakeholders, so must be Anti-Doping Organizations at the national level, in accordance with international best practice. I would like to thank NADOs for their overwhelming support on this issue and, through this Guide, we are delighted to be able to support them as they deliver on the strengthened provision.”

WADA Director, Program Development and NADO/RADO Relations, Tom May said: “The majority of NADOs operate independently from Governments and sport. However, in a situation where a NADO’s operational independence is not evident or is being threatened, we now have the tools to follow up and ensure this independence is protected. This Guide provides clear direction regarding these requirements to the anti-doping community and we look forward to working with NADOs on implementing these principles.”

Responding to a number of requests from NADOs, this Guide outlines the regulatory and practical measures that should be in place to ensure they can comply with the 2021 Code when it comes into force. The Guide is made up of two parts. Part one sets out mandatory provisions that are found in the Code and that will be monitored by WADA for the purposes of compliance. Part two sets out recommended aspects that NADOs are encouraged to adopt as best practice, providing examples of how these measures can best be implemented.

During the drafting process, the Guide was shared with WADA’s NADO Advisory Group, representatives of the Monitoring Group of the Anti-Doping Convention of the Council of Europe, as well as three Regional Anti-Doping Organizations for review. Feedback received was incorporated into the final version of the document, which was presented to the independent Compliance Review Committee (CRC) at its meeting in early October. The CRC welcomed the development of the Guide and supported WADA’s efforts in clarifying the requirements of NADO operational independence to its stakeholders.

In addition to this Guide, WADA will provide assistance and develop practical tools to support NADOs in enhancing their operational independence. This includes a comprehensive webinar on the topic, which is scheduled for December.

For further information on the Guide, please contact WADA at WADAProgramDevelopment@wada-ama.org.

Best regards,

World Anti-Doping Agency


7/11/20 JOINT STATEMENT FROM WADA AND THE U.S. OFFICE OF NATIONAL DRUG CONTROL POLICY

Montreal, 7 November 2020 – Yesterday, the World Anti-Doping Agency (WADA) President, Witold Bańka, and the Director of the White House Office of National Drug Control Policy (ONDCP) in the United States (and an Americas public authority representative on WADA’s Foundation Board), the Honorable James W. Carroll, held a virtual meeting to discuss matters of interest to the two organizations with the goal of better working together for the good of athletes and the global anti-doping system.
 
In what was a very positive meeting, the two organizations agreed that the U.S. Government was vital for the protection of clean sport around the world, and that they would pursue strong and open bilateral communication going forward.
 
Mr. Banka and Mr. Carroll were united in the view that this was an important meeting, where WADA and the ONDCP were able to discuss a number of areas of mutual concern in an open and honest way. Mr. Carroll reaffirmed the U.S. Government’s commitment to work with WADA, from within WADA. They both agreed that the partnership between WADA and the U.S. Government was vitally important for the protection of clean sport around the world. As such, they committed to strengthening this partnership going forward and saw this meeting as an important step along a renewed path of dialogue and collaboration.
 
The main topics covered in the meeting included:

  • The ongoing reforms to WADA’s governance, including U.S. Government and athlete representation within WADA’s committee structures;
  • How the two organizations can work together to strengthen and harmonize the anti-doping system in the U.S.; and
  • The impact of COVID-19 on the global anti-doping system.

6/11/20 WADA STRATEGIC TESTING EXPERT GROUP EVALUATES IMPACT OF COVID-19

Montreal, 6 November 2020

Dear Colleagues,

During four virtual meetings in October 2020, the World Anti-Doping Agency’s (WADA’s) newly established Strategic Testing Expert Group focused its discussions on the impact that COVID-19 has had on global testing programs and evaluated how the anti-doping community can continually improve the ways in which it plans, collects and analyzes doping control samples to maximize detection efficiency and deterrence.

The Expert Group discussed the impact that COVID-19 has had on athletes; global anti-doping testing programs (in particular, by reviewing 2020 testing statistics); and, WADA-accredited laboratories. During these meetings, five National Anti-Doping Organizations (from China, Denmark, the Netherlands, Norway and the United States) presented the alternative sample collection strategies that they had developed and piloted during the pandemic, which enabled the collection of samples to continue during these difficult times.

In the interest of providing greater insight to stakeholders regarding the matters covered during these meetings, we are pleased to share a Summary of Outcomes.

The Expert Group also discussed the feedback received from stakeholders via WADA’s ‘Survey on the Impact of COVID-19 on ADOs’, which the Agency carried out in September. As a result of the feedback received, which will be published in full in the coming days, the May 2020 ‘COVID-19 Guidance for Resuming Testing’ will be revised and replaced by a ‘Guidance for Testing During COVID-19’ document in late November 2020. More details on this work are contained within the Summary of Outcomes document.

Should you have any questions regarding the work of the Expert Group and the outcomes of its discussions, we invite you to contact WADA at SandH@wada-ama.org

Best regards,

World Anti-Doping Agency


5/11/20 WADA AWAITS RESULT OF CAS HEARING WITH RUSSIAN ANTI-DOPING AGENCY

Montreal, 5 November 2020 – The four-day arbitration procedure between the World Anti-Doping Agency (WADA) and the Russian Anti-Doping Agency (RUSADA) before the Court of Arbitration for Sport (CAS) concluded today in Lausanne, Switzerland.

WADA President Witold Bańka said: “WADA is satisfied with how we presented our case and we now look forward to receiving the decision of the Panel. As at every other stage, we are following due process in relation to RUSADA’s compliance procedure as we continue to deal effectively with this complex matter.”

The hearing related to the unanimous WADA Executive Committee (ExCo) decision of 9 December 2019, to endorse the recommendation made by the independent Compliance Review Committee that RUSADA be declared non-compliant with the World Anti-Doping Code for a period of four years, with a range of consequences attached. This followed the results of an investigation that alleged data from the Moscow Laboratory was intentionally altered prior to and while it was being forensically copied by WADA in January 2019, in contravention of RUSADA’s reinstatement conditions, approved by the ExCo in September 2018.

Due to COVID-19 restrictions in place around the world, the hearing took place in a mixed format with arbitrators, parties, legal representatives and witnesses attending either in person or virtually, via a video link. WADA had requested that the hearing be held in public but for that to happen all parties were required to be in agreement and that was not the case.

The procedure was conducted by a CAS Arbitral Panel composed of Judge Mark Williams (Australia, President), Prof. Luigi Fumagalli (Italy) and Dr. Hamid Gharavi (France / Iran). As confirmed by CAS, the Panel will announce its decision at a later date and, until that time, WADA will make no further comment.


3/11/20 WADA POSTPONES 2021 ANNUAL SYMPOSIUM DUE TO ONGOING UNCERTAINTY LINKED TO COVID-19

Montreal, 3 November 2020

Dear Colleagues,

The World Anti-Doping Agency (WADA) regrets to announce that, due to ongoing uncertainty linked to COVID-19, the Agency is postponing its 2021 Annual Symposium that was to be held on 17-18 March 2021 in Lausanne, Switzerland. WADA would kindly ask stakeholders to take note that the Agency has tentatively booked the SwissTech Convention Center in Lausanne for an in-person or hybrid (in-person and virtual) Symposium on 19-20 October 2021.

WADA’s Annual Symposium, which is traditionally the biggest gathering on the anti-doping calendar, is designed for anti-doping practitioners from International Federations, National and Regional Anti-Doping Organizations and Major Event Organizations; representatives from Athlete Commissions, Governments, WADA-accredited laboratories and Athlete Passport Management Units; as well as, other stakeholders such as service providers, researchers and the media – all that are integral to clean sport.

WADA Director General Olivier Niggli said: “WADA is disappointed that its Annual Symposium has been disrupted once again by COVID-19. Given the importance for WADA and the anti-doping community to come together in person, especially following such a long period of social distancing, we hoped to be able to offer a Symposium with in-person and virtual participation in March next year. However, with the current health situation around the world, and the restrictions imposed in Switzerland on gatherings, we were simply not confident that we would be able to offer a program and networking experience that participants value and are accustomed to.

“Therefore, similar to what WADA did this year after the 2020 edition was cancelled due to COVID-19, we will ensure that key issues that would have been covered will be presented and discussed via alternative means, including webinars.”

In the meantime, WADA has tentatively booked dates for an in-person or hybrid Symposium on 19-20 October 2021. We therefore kindly ask our stakeholders to save these dates and we will keep you regularly informed of our plans next year.

Should you have any questions regarding the Symposium, please contact WADA’s Events Manager, Ms. Anais Lefevre, at anais.lefevre@wada-ama.org.

We hope to be able to see you in person again soon.

Best regards,

World Anti-Doping Agency


2/11/20 SÃO TOMÉ AND PRÍNCIPE BECOMES 190TH COUNTRY TO RATIFY UNESCO ANTI-DOPING CONVENTION

Montreal, 2 November 2020 – The World Anti-Doping Agency (WADA) is pleased to announce that the African nation of São Tomé and Príncipe has become the 190th State Party to ratify the UNESCO International Convention against Doping in Sport (UNESCO Convention). This leaves just five countries worldwide that have yet to complete their ratification of the UNESCO Convention.

WADA President Witold Bańka said: “It is always a moment of celebration for WADA and clean sport when another nation signs up as a State Party to the UNESCO Convention. It demonstrates to us and the rest of the world that São Tomé and Príncipe is serious about its commitment to anti-doping.

“The aim of the UNESCO Convention is to bring nations together, united in the common mission of protecting sport. It has assisted WADA in its efforts to bring consistency and harmonization to anti-doping policy around the globe. Almost all Governments of the world have now pledged their support to clean sport and it is vitally important that they implement it effectively in their respective countries for the good of athletes everywhere.

“São Tomé and Príncipe is the second African country to ratify the UNESCO Convention within the past 12 months, which shows an increasing level of dedication to clean sport in the region. We sincerely hope that the outstanding nations from Africa and other regions will follow in due course.”

The Convention, which was adopted on 19 October 2005, is the practical instrument by which governments formalize their commitment to the fight against doping. It allows governments to align their domestic policies with the World Anti-Doping Code, thus harmonizing the rules governing anti-doping in sport and public legislation. Under UNESCO standards, the Convention has set records in terms of the speed with which it was prepared, adopted and ratified.

See the complete list of countries that have ratified the UNESCO Convention.


30/10/20 WADA PREPARED FOR CAS HEARING WITH RUSSIAN ANTI-DOPING AGENCY

Montreal, 30 October 2020 – The World Anti-Doping Agency’s (WADA’s) arbitration procedure with the Russian Anti-Doping Agency (RUSADA) will be heard before the Court of Arbitration for Sport (CAS) from 2-5 November in Lausanne, Switzerland.

WADA President Witold Bańka said: “WADA has left no stone unturned in preparation for this hearing and we are looking forward to having the opportunity to present our case clearly and fairly to the Panel. I remain convinced that the WADA Executive Committee made the right recommendation in this case last December. As at every other stage, we are following due process in relation to RUSADA’s compliance procedure as we continue to deal effectively with this complex matter.”

The hearing relates to the unanimous WADA Executive Committee (ExCo) decision of 9 December 2019, to endorse the recommendation made by the independent Compliance Review Committee that RUSADA be declared non-compliant with the World Anti-Doping Code for a period of four years, with a range of consequences attached. This followed the results of an investigation that alleged data from the Moscow Laboratory was intentionally altered prior to and while it was being forensically copied by WADA in January 2019, in contravention of RUSADA’s reinstatement conditions, approved by the ExCo in September 2018.

Due to COVID-19 restrictions in place around the world, the hearing will take place in a mixed format with parties, legal representatives and witnesses attending either in person or virtually, via a video link. WADA had requested that the hearing be held in public but for that to happen all parties were required to be in agreement and that was not the case.

WADA will not be holding any media briefing or conference prior to the arbitral award being announced by CAS.


23/10/20 WADA PUBLISHES REVISED POLICY FOR THE ACCEPTANCE OF NEW WORLD ANTI-DOPING CODE SIGNATORIES

Montreal, 23 October 2020 – Today, the World Anti-Doping Agency (WADA) publishes its revised Policy for the Acceptance of New World Anti-Doping Code Signatories (Signatory Policy), which was approved by the Agency’s Executive Committee (ExCo) during its meeting of 14-15 September 2020.

The revised Signatory Policy, which will come into force on 1 January 2021, has been reviewed to ensure that it aligns with the 2021 World Anti-Doping Code (Code). It is intended to enable organizations that are committed to protecting clean athletes to become Code Signatories. The Policy relates specifically to Code Article 23.1, which outlines the entities that may become Signatories to the Code.

It was determined that the current Signatory Policy – which has been in effect since November 2017 – needed to be reviewed and updated. Therefore, in May 2019, it was agreed that a working group, composed of WADA stakeholder representatives of the Sports Movement and Public Authorities, be established to consider the matter and develop proposed revisions to the Policy. The revisions that were included within the revised Policy reflect the consensus reached by the group. They aim at finding the right balance between protecting the pyramidal model of sport and allowing WADA to accept, as Code Signatories, organizations that are of sufficient relevance in the world of sport; and, are committed to protecting clean athletes, regardless of their status within the Sports Movement.

In summary, the revised Signatory Policy establishes a process whereby an applicant will be assessed in a collaborative manner between WADA Management and a newly created “Signatory Expert Group”, convened as required. As outlined in the Terms of Reference, such a Group would be comprised of one representative from the Sports Movement and one from the Public Authorities; as well as an independent Chair proposed by WADA Management to be approved by the WADA ExCo.

Once WADA Management and the Signatory Expert Group (or, in case of disagreement, the WADA ExCo) determine that the criteria of assessment are met, WADA Management will review the anti-doping program of the applicant through a Code Compliance Questionnaire and review its anti-doping rules. If the applicant’s anti-doping program has no critical non-conformities with the Code and the International Standards or all of its critical non-conformities are corrected within the relevant deadline(s), the applicant shall be accepted as a Signatory by WADA Management.


22/10/20 WADA DEVELOPS NEW METHOD OF IDENTIFYING SAMPLE TAMPERING AS PART OF WEIGHTLIFTING INVESTIGATION

Montreal, 22 October 2020 – The World Anti-Doping Agency (WADA) has developed a new method of detecting the prohibited practice of urine substitution at the point of collection and the use of sample surrogates or ‘doppelgängers’, following a ground-breaking investigation into the sport of weightlifting.
 
After more than three years examining the activities of the International Weightlifting Federation (IWF) and the sport as a whole, WADA’s independent Intelligence and Investigations (I&I) Department today publishes the provisional findings of what is still an ongoing investigation.
 
Launched in August 2017, WADA I&I’s investigation into weightlifting has four pillars, namely:

  1. Operation Outreach, looking into claims that a high-ranking member of the IWF was paid to promote Russian interests and to protect Russian athletes from detection;
  2. Operation Heir, investigating allegations of an organized doping and protection scheme operating within Romanian weightlifting;
  3. Operation Extra, dealing with the complex process of collection, collation and assessment of all weightlifting intelligence received by WADA I&I; and
  4. Operation Arrow, a covert investigation into the practice of urine substitution at the point of collection.

This investigation has focused not just on athletes but also on others who might have been involved in facilitating this deception, including doping control officers, coaches, other athlete support personnel and officials. In 2019, WADA I&I successfully sought the support of multiple law enforcement agencies to investigate some of the allegations mentioned in the report. These law enforcement agencies approved today’s publication of this provisional report.

As it relates to Operation Arrow, the new methodology to refine the identification of potential substitute urine was developed by WADA I&I with assistance in part from confidential sources and analysis experts. This methodology has so far allowed investigators to identify, through DNA profile analysis, cases of suspected urine substitution involving 18 weightlifters from six countries. These cases will be presented to the International Testing Agency (ITA), to which the IWF has now delegated the conduct of its anti-doping program, for results management. WADA I&I found evidence of ‘doppelgängers’ being used to impersonate athletes during the sample collection process, ensuring clean urine was fraudulently provided.

WADA President Witold Bańka said: “WADA is appalled by what its Intelligence and Investigations Department has uncovered in this investigation. For too long, clean weightlifters have had to deal with an entrenched culture of doping in their sport, where the promotion of fear ensured that the truth remained hidden and that those who wanted to do the right thing were isolated. Once again this has shown the importance of whistleblower information and the positive difference that can be made when people with information have the courage to come forward. Intelligence from well-placed confidential sources, coupled with the diligent work of WADA Intelligence and Investigations, is delivering significant results across a host of investigations.

“WADA will continue to do all it can to help provide clean weightlifters with a safe and healthy environment for their sport. To do that more effectively in general, I believe this report shows clearly that it is time to start a discussion as to whether WADA should be granted additional powers of investigation, including unfettered access to all relevant internal documents and servers within the organization under investigation.”

WADA Director of I&I, Gunter Younger said: “In all we do, WADA Intelligence and Investigations seeks justice for athletes and for clean sport. The investigation into weightlifting has been complex, difficult and time-consuming with many obstacles placed in our way. The fear and silence that pervades this sport has been a significant impediment. Therefore, it has been very encouraging to receive such a large volume of intelligence as we did via WADA’s confidential whistleblower platform, ‘Speak up!’ The success of this investigation is down in large part to the bravery of those whistleblowers.

“We also commit to identifying other new investigative methods for our partners in the fight against doping. We want to detect doping wherever and however it occurs. The methodology applied as part of Operation Arrow in identifying cases of urine substitution can easily be applied to sports other than weightlifting. We will share the learnings and methodologies with Anti-Doping Organizations, laboratories and Athlete Passport Management Units to ensure a global and united effort to address urine substitution.”

Intelligence gathering within the sport of weightlifting continues. Following the McLaren IWF Investigation, which provided additional information to WADA I&I, WADA I&I is working closely with the ITA to ensure that all relevant intelligence is being thoroughly pursued (in addition to the 18 specific cases highlighted above). While the ITA is the IWF’s delegated independent investigative authority, as a Signatory to the World Anti-Doping Code, the IWF remains ultimately responsible and is subject to WADA I&I’s follow-up procedures, including through the Agency’s Compliance Monitoring Program*.

A further report will be published in due course, upon the completion of all outstanding law enforcement and I&I investigations. 


*In addition, as announced on 15 June 2020, WADA continues to be in close contact with the ITA to monitor the management of pending weightlifting cases following the information obtained by the McLaren IWF Investigation.


17/09/20 WADA TO HOST SIX ADDITIONAL ‘LIVE’ WEBINARS IN OCTOBER

Montreal, 17 September 2020

Dear Colleagues,

The World Anti-Doping Agency (WADA) publishes today the Agency’s ‘live’ webinar schedule for October, which encompasses webinars being offered as part of the following previously announced series:

  • A series that is part of WADA’s 2021 Code Implementation Support Program (CISP), which was launched on 4 May; and
  • A series that is athlete-led for athletes, which was announced by WADA on 11 June

The webinars are being hosted in English: 

Date/TimeSession TitleSpeakersWebinar Series & Target audienceRegistration Link
2 Oct
9:00 EDT
The Athletes’ Anti-Doping Rights ActBen Sandford, Chair, WADA Athlete CommitteeAthlete Series

For Athletes
Register here
8 Oct
9:00 EDT
The Revised Social Science Research Grant ProgramTony Cunningham, Senior Manager, Education, WADA

Ani Meliksetyan, Coordinator, Policy and Research, Education, WADA
For Social Science ResearchersRegister here
14 Oct
 
09:00 EDT
The International Standard for Code Compliance by Signatories & the Future of WADA’s Compliance Monitoring ProgramKevin Haynes, Deputy Director (Audits & Monitoring Program), Standards & Harmonization, WADA

Tim Ricketts, Director, Standards & Harmonization, WADA

Ruta Smaiziene, Manager, Code Compliance, WADA

Emiliano Simonelli, Chief Compliance Manager, WADA (Moderator)
CISP Series

For Anti-Doping Organizations (ADOs)
Register here
21 Oct
10:00 EDT

Preparing for a WADA Audit: How to Respond to International Standard for Protection of Privacy and Personal Information (ISPPPI) Questions
Karine Henrie, Senior Manager, Standards and Harmonization, WADA

Marissa Sunio, Manager, Legal Affairs, WADA

Frédérique Horwood, Lead Counsel, Privacy and Data Governance, WADA (Moderator)
CISP Series

For ADOs
Register here
28 Oct
10:00 EDT
The Training, Accreditation and Re-Accreditation of Sample Collection PersonnelKarine Henrie, Senior Manager, Standards and Harmonization, WADA

Emma Price, Head of Testing, UK Anti-Doping
CISP Series

For ADOs
Register here
29 Oct
07:00 EDT
2021 Prohibited List and beyondDr. Audrey Kinahan, Chair, WADA List Expert Group

Dr. Olivier Rabin, Senior Executive Director, Sciences and International Partnerships, WADA
CISP Series

For All stakeholders
Register here

We also take the opportunity below to remind stakeholders of the remaining webinars to be held in September:

Date / TimeSession TitleSpeakersWebinar Series & Target audienceRegistration Link
28 Sept
09:00 EDT

Key changes to the International Standard for Therapeutic Use Exemptions (ISTUE) 2021: Presentation of cases
 
Dr. Alan Vernec, Medical Director, WADA

Sam Pool, 2021 Code Implementation Project Manager, UK Anti-Doping
CISP Series

For TUE Physicians

Register here
29 Sept
8:00 EDT

International Standard for Laboratories (ISL) 2021 (Version 11): Impact for Laboratories
Dr. Osquel Barroso, Senior Deputy Director, Laboratories, WADA

Adam Klevinas, Lawyer, Klevinas Sports Legal Solutions

Dr. Katja Mjøsund, Member, WADA TUE Expert Group; Chair, FINCIS TUE Committee
 
CISP Series

For Laboratories

Register here

To register for any or all of the above webinars, please simply view the registration instructions in the ‘Registration Link’ sections of the above tables.

Every mid-month, WADA communicates its live webinar schedule for the following month, prompting stakeholders to register and participate.

Should you have any questions regarding the above, please contact WADA at: selva.balasingam@wada-ama.org.

Best regards,

World Anti-Doping Agency


15/09/20 WADA EXECUTIVE COMMITTEE PAVES
THE WAY FOR FURTHER WADA GOVERNANCE REFORMS

Montreal, 15 September 2020 – The World Anti-Doping Agency’s (WADA’s) Executive Committee (ExCo) held its third meeting of the year on 14-15 September, during which it received updates on WADA’s progress on key priorities and took a number of decisions, including approval of the List of Prohibited Substances and Methods (List) for 2021.

WADA is composed of a 38-member Foundation Board (Board), which is the Agency’s highest policy-making body, and the 12-person ExCo, to which the Board delegates the management and running of the Agency. The Board and ExCo are composed equally of representatives from the Sports Movement, including athletes, and Governments.

The ExCo meeting, which was held virtually due to COVID-19, opened with a moment of silence in memory of former WADA President John Fahey, who passed away on 12 September in Australia at the age of 75. Mr. Fahey served with distinction as President from 2008-13 and will be greatly missed by his colleagues and friends at the Agency.

After the meeting, WADA President and Chair of the ExCo Witold Bańka, said: “I am very encouraged by the level of engagement and solidarity that was expressed by Executive Committee members over the past couple of days. Representatives both from Governments and the Sports Movement were united in emphasizing the importance to continue to strengthen WADA and to support it in the delivery of its mission in the service of athletes.

“Members of the Executive Committee clearly reiterated their support for the current model of equal partnership between the Governments and Sports Movement that has proven to be successful since WADA was formed 21 years ago. In addition, members expressed their acceptance of the nature and timing of the governance reforms that are being implemented, as well as the way forward for additional reforms to be made in the future.

“As we continue to strengthen WADA’s governance, the Executive Committee is showing real leadership in ensuring the Agency is equipped to do its job effectively for clean sport around the world.”

Governance Reforms

The ExCo received a progress report on the implementation and timing of WADA’s wide-ranging governance reforms, which were approved by the Board in November 2018 and are being introduced according to the agreed schedule.  

When the reforms were approved in 2018, the Board indicated that there should be an ongoing review process installed by WADA to monitor the effect of the reforms, as well as to propose additional, appropriate reforms going forward. While the implemented reforms and those in progress are bringing far-reaching improvements to WADA’s governance structure, the ExCo has decided to maintain the forward momentum provided by these changes and has agreed to establish an expert Working Group on the Review of WADA Governance Reforms now in order to ensure WADA continues to evolve in line with international best practice.

The ExCo agreed that the group would be composed of one independent expert as chairperson, two experts nominated from each of the Sports Movement and the Governments, and one athlete. The composition of this Working Group will be finalized in November this year. Also in November, the Board, which has ultimate authority on governance matters, is scheduled in particular to appoint two independent ExCo members and discuss the ongoing development of a WADA Code of Ethics. As further reforms unfold, there will be broad consultation to allow all stakeholders to contribute to the shape of WADA’s governance so as to ensure it remains fit for the future.

U.S. ONCDP Report and Rodchenkov Act

The ExCo received an update regarding ongoing discussions between WADA and the U.S. Office of National Drug Control Policy (ONDCP) in relation to the possibility of the ONDCP withdrawing its WADA funding unless the Agency agreed to a number of demands related to WADA governance.

Mr Bańka said: “It is very important that WADA and the U.S. authorities work together to further strengthen anti-doping and again, I state my willingness to be part of constructive discussions in order to ensure collaboration between the U.S. and the global anti-doping community.”

There was overwhelming support among ExCo members to maintain the model of equal partnership between the Sports Movement and Governments and, on that basis, for dialogue between WADA and the U.S to be restored.

The meeting also received an update on the status of the Rodchenkov Anti-Doping Act that is currently before the U.S. Senate for consideration. There remain widely held concerns among other governments, the Sports Movement, and other anti-doping stakeholders over the Act’s extra-territoriality, its negative unintended consequences and the fact that it was amended specifically to exclude the American professional leagues and college sports, which account for more than half a million athletes within the U.S.

COVID-19

The ExCo received an update regarding the state of the global anti-doping program during the ongoing COVID-19 pandemic. As restrictions are being lifted in a growing number of countries around the world, more and more Anti-Doping Organizations (ADOs) are resuming their testing programs, following the guidance provided by WADA and the various government and health authorities.

WADA Director General Olivier Niggli said: “Following the initial global slowdown, anti-doping work has intensified quickly in recent weeks with more than 11,000 samples collected in July and in excess of 13,000 in August. The Anti-Doping Organizations are to be commended for their hard work at this difficult time as they seek to return their global testing programs to full power. As announced on 9 September, we have established a 10-person Strategic Testing Expert Group that is, among other activities, collecting and assessing feedback from ADOs on their testing programs during the COVID-19 pandemic. It is important that we build a global picture so that lessons can be learned from this unprecedented time and the global anti-doping community can respond effectively to similar public health crises should they arise in the future.”

WADA will continue to publish updates regarding its response to COVID-19 as the situation evolves and will formally update the ExCo again at its next meeting in November.

Athletes

While each Standing Committee Chair reported on the progress achieved in their respective areas of work, WADA’s Athlete Committee Chair, Ben Sandford, outlined the work of the Athlete Representation Working Group – a subset of the Athlete Committee – that is looking at ways to further develop athlete representation at WADA, as well as discussions around the concept of an ombudsperson(s) resource for anti-doping and its project that is delivering a series of informational webinars for athletes.

WADA’s President reported on his initiative to meet regularly with athlete groups, in line with WADA’s new five-year Strategic Plan that places athlete engagement at the heart of the organization’s activities. Since launching the initiative and despite the restrictions imposed by the COVID-19 pandemic, Mr. Bańka has managed to hold productive virtual meetings with hundreds of athletes from various athlete commissions worldwide. A key outcome of the exercise will be to establish how to ensure athlete perspectives can best be represented within WADA and how linkages might be improved between these athlete members and their WADA Athlete Committee colleagues, and ultimately all athletes affected by anti-doping.

RUSADA

The meeting received an update on the current situation with the Russian Anti-Doping Agency (RUSADA), including the recent dismissal of its Director General, Yuriy Ganus. While RUSADA’s appeal of WADA’s assertion of non-compliance and related consequences will be heard by the Court of Arbitration for Sport in early November, WADA is communicating with the authorities in Russia to ensure it has all of the information needed to assess the latest situation. WADA continues to monitor closely RUSADA’s programs and activities, including testing, to ensure its operational independence is maintained, and will continue to provide regular updates to the Agency’s independent Compliance Review Committee.

2021 Prohibited List and other International Standards

The ExCo approved the 2021 List, which will be published before 1 October 2020, and which will come into effect on 1 January 2021. Updated annually, the List designates what substances and methods are prohibited both in and out of competition under the World Anti-Doping Code (Code). Following input from the WADA Athlete Committee, the List has undergone a dynamic redesign that has also made it more user-friendly and easier to navigate for athletes.

Beyond approval of the 2021 List, which contains minor changes from the current 2020 List, the ExCo approved the revised International Standard for Laboratories and International Standard for the Protection of Privacy and Personal Information that were subject to public consultation and will also come into force on 1 January 2021.

Research Grants 

The ExCo approved funding recommendations for research proposals for WADA’s 2020 call for scientific research grants. A total of 19 projects were selected for funding amounting to USD 2,585,833. Details of these projects will be published on WADA’s website in the coming months once the individual contracts are signed.

Policy for Acceptance of New Code Signatories

The ExCo approved a revised policy for the acceptance of new Signatories to the Code, which will be applied by WADA as per Article 23.1.3 of the revised Code when it comes into effect on 1 January 2021. The revision is intended to enable more organizations that are committed to protecting clean athletes, regardless of their status within the Sports Movement, to become Signatories.

Social Science Research

The ExCo approved the Social Science Research Strategy 2020-24, which was developed by WADA in collaboration with the Social Science Research Review Panel and overseen by the Education Committee. The strategy widens the scope of WADA’s social science research activities, moving these beyond a grant program and enhancing the benefits that social science research can bring to the efforts of the anti-doping community to protect clean sport.

WADA will publish the new Social Science Research Strategy 2020-24, as well as the other documents approved by the ExCo and mentioned above, in the coming weeks.


09/09/20 NEW WADA STRATEGIC TESTING EXPERT GROUP REVIEWS LESSONS LEARNED FROM COVID-19 PANDEMIC TO BE READY FOR FUTURE SIMILAR CRISES

Montreal, 9 September 2020 – As the World Anti-Doping Agency (WADA) continues to provide leadership to the Clean Sport community during the COVID-19 pandemic, a multi-disciplinary testing expert group has been formed to identify lessons that can be learned from this unprecedented time and ensure the global anti-doping community can respond effectively to potential similar public health crises in the future.
 
Restrictions are being lifted in a growing number of countries around the world and, as a result, Anti-Doping Organizations (ADOs) are resuming their testing programs, following the guidance provided by WADA and the various health authorities. In line with a commitment given on 6 May, WADA has established a 10-person Strategic Testing Expert Group that is, among other activities, collecting and assessing feedback from ADOs on their testing programs during the COVID-19 pandemic.
 
WADA Director General Olivier Niggli said: “WADA and the Clean Sport community’s first priority during the coronavirus pandemic has always been the health and safety of athletes, doping control personnel and the general public. This is reflected in the reduction of testing programs in many parts of the world over the past months. However, now that activities are resuming in a growing number of countries, it is encouraging that anti-doping work has intensified quickly with more than 11,000 samples collected in July. Anti-Doping Organizations are to be congratulated for their efforts as they show their commitment to returning to full power while continuing to follow the advice of health authorities.
 
“To understand the impact of the pandemic on global anti-doping programs, WADA has launched a broad review to identify what lessons can be learned and what improvements can be made to the global anti-doping system should similar public health crises arise in the future. While the situation continues to evolve, we remain ready to assist Anti-Doping Organizations in supporting and monitoring their anti-doping programs.”

As part of the review, last week, WADA sent a survey to ADOs seeking the latest information on their testing programs, in order to build a global picture.
 
The survey is focused on three main areas:

  1. The impact that COVID-19 has had on ADO programs;
  2. ADO views on the COVID-19 Guidance for Resuming Testing document issued by WADA on 6 May, which outlines how the anti-doping community can best operate testing programs in this challenging environment in line with globally recommended health and hygiene procedures and the International Standard for Testing and Investigations; and
  3. The impact that COVID-19 has had on sample shipment and analysis.

The survey outcomes will assist WADA in identifying ways in which the anti-doping community can continue to adapt and be better prepared for similar situations in the future. This may also include developing temporary rules or amendments to the applicable International Standards or the inclusion of specific procedures within an existing WADA Guideline or other guidance document.
 
The Strategic Testing Expert Group is chaired by Matt Fedoruk from the United States Anti-Doping Agency and is made up of anti-doping professionals with a broad range of scientific, medical, legal and other relevant expertise, including an athlete representative.
 
WADA will continue to publish updates regarding its response to COVID-19 as the situation evolves.


04/09/20 WADA CALLS FOR UNITY TO PROTECT
CLEAN ATHLETES

Montreal, 4 September 2020 – Ahead of a meeting of the World Anti-Doping Agency (WADA) Executive Committee on 14-15 September, several representatives of the Governments of the world contacted WADA to express their concerns relative to threats from the United States Government to withdraw funding from the Agency if WADA did not fulfill a number of conditions.

These Governments have identified what they consider to be a weakness in the rules whereby a Government can unilaterally refuse to meet its agreed funding commitments without facing any significant consequences. They feel that what is happening with the U.S. Government could create a negative precedent internationally that could be replicated and would jeopardize the entire global anti-doping system.
 
As a result, these Governments have asked WADA to look at the possibility of amending its rules so that nations which go against the principles of the UNESCO Convention Against Doping in Sport in this way would potentially trigger sanctions under the International Standard for Code Compliance by Signatories.  
 
WADA President Witold Bańka said: “This matter has been raised by some concerned Governments, not by WADA’s leadership, and as is the case with any proposal raised by a stakeholder, WADA has an obligation to consider it carefully. We will examine the rules to see if they need to be strengthened in light of the current situation. As always, due process will be followed and this will be a matter for discussion and consultation.
 
“My focus remains absolutely on the welfare of athletes and, for their sakes, we must continue to protect the anti-doping system that has served clean athletes. Fairness for athletes all over the world remains my number-one priority. I will never let clean athletes become hostages of political games. Under the International Standard for Code Compliance by Signatories there are many possible consequences that do not impact the athletes.
 
“In this critical time for anti-doping, we need unity, not division. I still stand ready to work with the U.S. Government on this and I am hopeful that it will continue to contribute to the global anti-doping program. But what our stakeholders are telling us is that this episode has highlighted the need for more commitment and accountability within the clean sport community. The only way to preserve the global system is for everyone involved to stand united and work together to make it stronger.”

03/09/20 WADA PRESIDENT’S OPEN LETTER
TO ATHLETES

Warsaw, 3 September 2020 

Dear Fellow Athletes,

Just over two years have passed since I announced my decision to run for the presidency of the World Anti-Doping Agency (WADA); and, a little over six months since I took up the position. When I entered the race for this position as a former athlete and lifelong sports person, I was ready to face all odds. From the beginning, given the nature of the business, I knew that it would not be a quiet cruise but rather a boat sailing on the stormy sea. The only thing I hoped for, just as every true athlete does, was the opportunity to take up new challenges; to fulfil my mission in a spirit of  honesty and mutual respect with stakeholders; and, for the Agency and I to be assessed fairly.

Today, I am prepared to reflect on the complex landscape in which WADA and I personally are operating. As I still feel and think like an athlete, I would like to share these thoughts with you, my fellow athletes.

WADA was established in 1999 as a unique platform for cooperation between Governments and the Sports Movement, following the failure of actions taken by each of these parties individually. The forces were united to fight doping, the greatest threat to modern sport, more effectively and persistently. For over 20 years, this organization has matured and assumed new responsibilities, setting new standards for the operations of Anti-Doping Organizations worldwide; and, above all – it has tried to meet the increasing expectations of our stakeholders with limited financial means. Of course, mistakes have not been avoided, but only those who do nothing make no mistakes.

Today, WADA covers many areas, from setting the rules and monitoring compliance; education; and, scientific and social science research; to development of anti-doping programs; building anti-doping capacity around the world; and, carrying out investigations. It can rely on a highly professional and extremely committed staff of international experts and many equally qualified volunteers within its governance structure.

I think that this experiment that started in 1999, which probably not everyone believed in at the time, turned out to be successful. Therefore, as the new president of WADA, who has already had the opportunity to get to know the Agency from the inside but remains objective in his opinions, I am dedicated to further developing this experiment. I believe that only in the spirit of collaboration between Governments and the Sports Movement is it possible to combat doping in sport effectively. This unique construction best serves its most important stakeholder, the athletes around the world.

Today, it is difficult for me to imagine WADA without our public authority stakeholders that engage with their law enforcement agencies and support the fight against doping in their respective countries; just as, I cannot imagine the Agency without the Sports Movement stakeholders ensuring that unified rules are applied across all sports and in all competitions. Is it a perfect construction? I will answer in the words of the eminent British politician, Winston Churchill, who once said of democracy that “…No one pretends that it is perfect or all-wise. Indeed, it has been said that it is the worst form of government except for all those other forms that have been tried from time to time.

Today, WADA is often targeted by political attacks and games. Various arguments are used in these attacks — ranging from how our activities are financed and who can legitimately represent stakeholder interests to allegations of a lack of transparency. I can assure you that I will not allow WADA to get bogged down in these political games; and that, control of WADA is not for sale, no matter what stakeholder we are dealing with.

Some critics of WADA allege a lack of transparency. However, I have the impression that the loudest criticism comes from those who, unfortunately, are not known for being particularly transparent themselves. WADA’s Foundation Board (Board) meetings are open to the media; and, in the future, I want them to be streamed online. Today, on WADA’s website, one can find the Agency’s statutes; the verbatim minutes of WADA’s Board and Executive Committee (ExCo)annual reports; a full list of our annual contributions from governments; our Five-Year Strategic Plan; information on WADA’s governance along with its members/representatives; media releases; and, a wide array of other communications. Every year, WADA responds to thousands of external inquiries from the media, athletes and the general public. Isn’t this transparency?

Could we do more? Of course. However, we also have some limitations. For example, we cannot publish information about pending investigations in order to protect the integrity of the work conducted, as is normal practice in law enforcement, or about developing compliance cases with the World Anti-Doping Code in order to comply with the rules and processes of International Standards. However, I promise you that this information is progressively being made public as soon as it becomes possible without compromising outcomes. This also applies to the Russian Anti-Doping Agency (RUSADA) case, which is currently being reviewed by the Court of Arbitration for Sport (CAS) and for which we asked for a public hearing.

I would expect similar transparency from our critics. For them to be transparent. To publish their governing documents. To tell the world who finances them and who their members are. I am sure that the athlete community would also like to know.

You may think that this letter is a response to criticism. It is not. Criticism is normal to public life; and no organization, especially one as important as WADA, can avoid it. I can assure you that I am not afraid of criticism because every difficult decision gives rise to it and yet, I continue to make such decisions. I do however believe that criticism should be honest and constructive. This is what my sports career has taught me. Constructive criticism can help an athlete to motivate himself or herself and improve his or her performance. Therefore, I can assure you that WADA and I personally take honest criticism very seriously. We value all stakeholder input and feedback; in particular, from you, the athletes.

WADA is an organization that is constantly changing thanks to fruitful collaboration with its stakeholders. In November 2018, WADA’s Board approved governance reforms. As a result, a Nominations Committee was formed to ensure the right people in terms of skills and independence serve in senior governance roles within WADA. A term limit was also introduced for members of the Board, ExCo and all five of our Standing Committees. Only persons who meet the independence criteria may currently apply for the positions of President and Vice President of WADA. As part of the reform, the ExCo will soon be expanded to include two independent members. Moreover, a minimum of one seat for athlete representation has been guaranteed in all Standing Committees; and, one seat for National Anti-Doping Organizations in all Standing Committees except the Athlete Committee and the Compliance Review Committee.

WADA’s Athlete Committee is working on a concept to develop an ombudsperson’s office, which I personally support strongly. Its members are also working on transforming the Committee from an advisory body to a representative body, with the view to a representative of the Committee being appointed to WADA’s ExCo. Already, however, the athletes and former athletes who sit on the most important bodies of WADA, on the ExCo and the Board, constitute over one third of the composition. And this is not the end of the governance reforms.

Meanwhile, I have also read public comments pointing out that we lack “independent” athletes within the governance structure. But what does it mean to “be an independent athlete”? What makes one organization dependent and another independent when both are financed and therefore are dependent on someone? Why are some athletes considered to be better, more worthy, representatives of the athlete community than others? Who wants to create division within our community and for what purpose?

I would like to know the answers to these questions. As a former athlete who has completely resigned from all government functions previously held; and, who has never belonged to a governing body of any sports federation, I consider myself an independent athlete. Moreover, as a person who lost litres of sweat on an athletics track, then served sports in my country as a minister, I always carried the ideals of fair sportsmanship at heart; and therefore, I consider myself a worthy representative of the athlete community at WADA. I also believe that all my colleagues on the ExCo and the Board; who have represented their countries in different sports arenas around the world — sometimes with much more success than I — have the right to consider themselves athlete representatives. And no one, no critic, can take that right away from them. There are no better and worse athletes, more and less worthy to represent us as athlete representatives within WADA.

When I look at the long way that WADA has come over the past two decades, it saddens me that there is a lot of politics at play; battles for positions and influence around the activities of this organization; and, far too little thinking about the values at the core of the Agency’s mission. WADA was created to ensure that all athletes could participate on an equal footing, under fair conditions, without doping, and respecting each other. Today, political disputes obscure this goal.

However, I remember what brought me to WADA, the mission that I wanted and still want to pursue. I firmly believe that we need to put more efforts into further strengthening the global anti-doping system. I do not want athletes to compete with others who are not subject to robust doping control programs just because their countries do not have the resources to put such programs in place. I am talking to many ministers to increase their contribution to the fight against doping in sport, including financial. I have established the Anti-Doping Solidarity Fund, which is intended to raise private funds to strengthen anti-doping capacity in the regions that need such assistance. Soon, WADA will begin its first partnership program with private companies in the field of education. And this is only the beginning. I promise you that I will continue this mission because I believe this is the true purpose of WADA, because I came to WADA not to play political games but to serve you, my fellow athletes.

Concluding my letter, I would like to invite everyone to work hand in hand with me to advance our common mission. For several months now I have been engaging with athletes individually, including via social media; have been holding virtual meetings with athlete committees and groups; and, going forward, have many similar meetings planned. I am doing this because I strongly believe that WADA exists for athletes; that we need you on board; and, that we are accountable to you in carrying out our mission.

Therefore, I strongly encourage you to speak up about Clean Sport. Speak loudly in your countries and in your sports. Criticize us if we deserve it but support our mission.  Please do not be indifferent because, for WADA, you are MOST IMPORTANT. For me, you are MOST IMPORTANT.

Thank you,

Witold Banka
President


24/08/20 WADA REMINDS WORLD ANTI-DOPING CODE SIGNATORIES TO REVISE THEIR ANTI-DOPING RULES FOR 2021

Dear Colleagues,

On 13 December 2019, in connection with the launch of its 2021 Code Implementation Support Program (CISP), the World Anti-Doping Agency (WADA) announced publication, in English, of its 2021 Model Rules for Code Signatories (Model Rules), which are intended to help National Anti-Doping Organizations, International Federations, Major Event Organizations and National Olympic Committees in drafting their new anti-doping rules in line with the 2021 World Anti-Doping Code (Code). These Model Rules have since been made available in French as well.

In order to ensure that anti-doping rules continue to be harmonized worldwide, which is critical to providing athletes with a level playing field, all Code Signatories are required to have drafted and adopted anti-doping rules in line with the 2021 Code by 1 January 2021. Therefore, WADA wishes to remind all Signatories that have not yet done so to take action as soon as possible; and, to send their draft anti-doping rules to compliance@wada-ama.org. Once received, WADA will verify the rules to ensure that they are in line with the 2021 Code; provide feedback if they are not; and ultimately, approve them before the Signatory starts its internal process of adoption of the rules.

We also wish to remind Code Signatories that WADA is required to address cases where Signatories do not have anti-doping rules in line with the 2021 Code by 1 January 2021 as potential instances of non-compliance.

Should you have any questions or require support, please contact us at compliance@wada-ama.org.

Thank you for your cooperation and best regards,

World Anti-Doping Agency


07/08/20 WADA UPDATE ON AGENCY’S COMPLIANCE MONITORING ACTIVITIES IN LIGHT OF COVID-19

Dear Colleagues,
[World Anti-Doping Code Signatories]

We are writing to you to provide you with an update on the World Anti-Doping Agency’s (WADA) monitoring of World Anti-Doping Code (Code) Signatories’ compliance following the latest meeting of WADA’s independent Compliance Review Committee (CRC), held on 4 and 5 August 2020 by conference call.

The Committee focused on the impact of the current COVID-19 pandemic on anti-doping programs worldwide and acknowledged the ongoing complexities affecting Anti-Doping Organizations (ADOs) in this unprecedented and unpredictable situation. 

The CRC members were pleased to hear that many ADOs had resumed their activities. They also expressed the expectation that, as sport activities, including competitions, gradually resume after suspension or restriction, anti-doping activities will be ramped up in parallel. The CRC advised WADA to maintain its compliance monitoring activities in a robust but flexible manner during this time. In the case where serious non-conformities are not resolved by a Signatory who is in a position to do so, WADA has the option to apply the “fast track” compliance procedure as detailed in Article 9.5 of the International Standard for Code Compliance by Signatories (ISCCS).

WADA thus encourages all ADOs to continue to advance their anti-doping programs, to the extent possible, and remains available to assist all Code Signatories.

Regarding the continuation of the temporary measures in effect during this time, the CRC endorsed WADA Management’s proposal to prolong them as part of the Agency’s monitoring of Signatory compliance with the Code. Therefore, there will be no change to the measures that were announced by the CRC in April 2020, which are:

  • the postponement of a number of deadlines (and the consequent freezing of the related enforcement procedures) for ADOs to meet ongoing compliance requirements and complete corrective actions under the ISCCS; and
  • a general degree of adaptability in WADA’s compliance monitoring program during the period. This will include the introduction of “virtual” compliance audits due to travel restrictions limiting the opportunity to conduct in-person audits. These virtual audits, which WADA will start to pilot from September 2020, will involve WADA requesting in advance from the audited ADO a number of documents for review. The virtual audit will then be conducted over a 3- or 4-day period for several hours each day, and WADA will provide any corrective actions identified in a Corrective Action Report (CAR). This is a new WADA initiative to maintain robust monitoring activities during this period. 

The CRC will review these temporary measures and discuss WADA’s longer term plans for Signatory compliance monitoring at its next meeting, scheduled for 6 and 7 October 2020.

We thank you very much for your continued commitment to doping-free sport in these challenging times and invite you to contact us at compliance@wada-ama.org if you have any questions regarding this communication or Code compliance in general.

Sincerely,

World Anti-Doping Agency


23/07/20 WADA LAUNCHES NEW e-LEARNING COURSE FOR ATHLETES AND COACHES HEADING TO TOKYO 2020 GAMES

Montreal, 23 July 2020 – With exactly one year to go until the start of the postponed Tokyo 2020 Olympic Games, the World Anti-Doping Agency (WADA) is pleased to launch a new interactive education course on its Anti-Doping eLearning Platform (ADeL) for athletes and coaches aiming to attend the Tokyo 2020 Olympic Games.

The new course, entitled ‘ADeL for Tokyo 2020 Olympics’, was developed by WADA in collaboration with the International Olympic Committee (IOC) and the International Testing Agency (ITA), and demonstrates the organizations’ commitment to educate and support athletes and their coaches in the build-up to the Games.

Athletes and coaches taking the new course will gain an understanding of the Tokyo 2020 anti-doping rules, procedures and requirements – including how to check medications and apply for a Therapeutic Use Exemption (TUE), how to provide whereabouts information, and explanations of the athletes’ rights and responsibilities during the testing process. The course will also allow athletes and coaches to identify key information, such as important dates that they need to be aware of and which organization has jurisdiction over them during the Games.

WADA Director of Education, Amanda Hudson, said: “With 12 months to go, WADA is pleased to share this new addition to our education solutions that Anti-Doping Organizations can use to educate their athletes and support personnel. ‘ADeL for Tokyo 2020 Olympics’ enables Anti-Doping Organizations to help prepare their national team athletes and coaches on all things anti-doping at the Games. We all want a clean Games and to protect athletes. We therefore encourage Anti-Doping Organizations to utilize this new interactive eLearning course as well as our additional course specifically for medical professionals to educate those heading to Tokyo.

“Athletes and support personnel at the Tokyo 2020 Games next year will participate under the new International Standard for Education (ISE). The Standard promotes the principle that those hoping to compete and participate at major events, such as the Olympic Games, should be educated prior to the event. WADA, along with the IOC and ITA, want to support this principle and ensure that every athlete is given the opportunity to understand the anti-doping program that will be in place for the Games, whether this is their very first Games or if they are seasoned Olympians.”

WADA and the IOC, had previously launched the ‘ADeL for Medical Professionals at Major Games’ course which is a mandatory requirement for all medical professionals attending the Games.

IOC Medical and Scientific Director, Dr Richard Budgett, said: “This course builds on the success of the ‘ADeL for Medical Professionals at Major Games’ course and will be an important part of the preparation for the Games for athletes and their support staff. It complements the pre-Games testing program and reflects the importance of education for the protection of clean athletes.”

During the Games, the ITA will independently manage the anti-doping program on behalf of the IOC. The ITA will therefore coordinate testing activities on-site together with processing of TUEs, Athlete Biological Passport notifications and Results Management. As part of this important program, athletes and Athlete Support Personnel will play a key role in ensuring that the Games are clean – and their work starts now with the release of this new education course that can be completed pre-Games.

ITA Director General, Benjamin Cohen, said: “The ITA is delighted to collaborate with WADA and the IOC in the development of this important education initiative for all athletes and coaches preparing for Tokyo. It will ensure that all team members understand, and know how to comply with, the extensive measures that have been put in place to protect them against doping and to ensure a clean Games.”

Completion of this course – which includes a certificate for those who achieve a score of 80% or higher – is highly recommended. WADA, the IOC and the ITA strongly encourage all National Olympic Committees to work in close collaboration with their National or Regional Anti-Doping Organization and their National Federations to ensure that athletes and coaches are properly educated in advance of the Games – a principle that the International Standard for Education, which comes into force on 1 January 2021, reinforces.


21/07/20 WADA SUSPENDS ACCREDITATION OF NEW DELHI LABORATORY FOR ANOTHER PERIOD OF UP TO SIX MONTHS

Montreal, 21 July 2020 – The World Anti-Doping Agency (WADA) has suspended the accreditation of the National Dope Testing Laboratory (NDTL) in New Delhi, India, for a second period of up to six months.

An original six-month suspension was imposed in August 2019 due to non-conformities with the International Standard for Laboratories (ISL) identified during a WADA site visit, including in relation to the laboratory’s isotope ratio mass spectrometry (GC/C/IRMS) analytical method, as regulated by the relevant WADA Technical Document (TD2016IRMS).

In February 2020, when the six-month suspension period elapsed and some outstanding non-conformities had not been addressed successfully, WADA’s Laboratory Expert Group (LabEG) recommended the initiation of further disciplinary proceedings against the laboratory based on the outstanding non-conformities. These disciplinary proceedings were carried out by an independent Disciplinary Committee that was mandated to make a recommendation to the Chair of the WADA Executive Committee regarding the status of the NDTL’s accreditation, while the laboratory remained suspended. The disciplinary process is now complete and the second six-month suspension began on 17 July 2020.

Pursuant to Article 13.7 of the World Anti-Doping Code, the NDTL may appeal this decision to the Court of Arbitration for Sport within 21 days of receipt of notice.

The suspension prohibits the NDTL from carrying out any anti-doping activities, including all analyses of urine and blood samples. During the period of suspension, if the laboratory satisfies the LabEG in meeting the requirements, it may apply for reinstatement prior to the expiry of the six-month suspension period. Should the laboratory not address the non-conformities by the end of the six-month suspension period, WADA may extend the suspension of the laboratory’s accreditation for up to an additional six months.

In accordance with the ISL, WADA is responsible for accrediting and re-accrediting anti-doping laboratories, thereby ensuring that they maintain the highest quality standards. This monitoring process is conducted in conjunction with International Organization for Standardization (ISO) assessment by independent national accreditation bodies that are full members of the International Laboratory Accreditation Cooperation (ILAC).


03/07/20 REMINDER: WADA INVITES STAKEHOLDERS TO NOMINATE CANDIDATES FOR 2021 STANDING COMMITTEE MEMBER VACANCIES

Montreal, 3 July 2020 – On 11 May 2020, the World Anti-Doping Agency (WADA) announced that it was seeking nominations for candidates to fill a number of vacant member positions on its five Standing Committees for 2021 as listed below; and, today, we wish to remind you that the deadline for submitting nominations is 25 September 2020.

We would also ask you to take particular note that, since WADA’s May announcement, one member of the Compliance Review Committee (CRC) has indicated that, due to a change in employment, they are unable to continue their term beyond the end of 2020; and therefore, this additional vacancy is now listed in the table below.

The Standing Committees, which report into WADA’s Executive Committee (ExCo), play a key advisory role in policy and priority development for the Agency. The successful candidates will be approved by WADA’s ExCo on 11 November 2020 and take office on 1 January 2021 for three-year terms.

Aside from outlining the vacancies below, WADA is pleased to provide links to the current Terms of Reference (TOR) for each Standing Committee that outline the scope of work and functioning of each Committee.
 

Committees [Terms of Reference (TOR)]Vacant positions
Athlete Committee [TOR)]Two positions
Compliance Review Committee (CRC) [TOR]
 
Three positions:One representing athletes;One independent compliance expert; 

(It should be noted that WADA’s Nominations Committee can also recruit additional candidates for the above CRC positions.)
 One representing Public Authorities (term of two years only, i.e. 2021-2022, to fulfil the remaining years on the current term of the departing member).

(It should be noted that, with regards to this CRC position, the Nominations Committee does not fulfill a role.)
Education Committee [TOR]Four positions
Finance and Administration Committee [TOR]Four positions
Health, Medical and Research Committee [TOR]Four positions

WADA President Witold Bańka said: “WADA encourages its stakeholders to consider their respective regions and organizations and to nominate suitable candidates for the vacant positions on WADA’s 2021 Standing Committees. Having diverse and committed Committee members with the expertise to advise WADA Management and the Executive Committee is crucial to advancing the Agency’s mission as the leader of Clean Sport.”

This call for nominations is in accordance with WADA’s governance reforms that were approved by WADA’s Foundation Board (Board) in November 2018 and formalized by the Board in November 2019; and which, require the Agency, on an annual basis, to announce its call for nominations six months prior to when the decision will be taken by the ExCo.

How to submit nominations

To be considered, all nominations must include the following and be forwarded by Friday, 25 September 2020, to Mr. Olivier Niggli, WADA Director General (c/o marjorie.chinnarassen@wada-ama.org):

  • an updated curriculum vitae, which fully outlines the candidate’s experience and expertise; and
  • a letter of endorsement from one of WADA’s current Board members or a recognized WADA stakeholder group.

Any questions should also be directed to Mr. Niggli, c/o Ms. Chinnarassen.


02/07/20 WADA PUBLISHES ITS FIVE-YEAR STRATEGIC PLAN UNDER THE THEME ‘LEADING ANTI-DOPING IN A NEW ERA’

Montreal, 2 July 2020 – Today, the World Anti-Doping Agency (WADA) publishes its Five-Year Strategic Plan, which lays the foundation for WADA’s strategic activity for 2020-2024 as the Agency is ‘Leading Anti-Doping in a New Era’.
 
The Strategic Plan was agreed by WADA’s Executive Committee (ExCo) when they met virtually on 15 May 2020; and, was subsequently approved unanimously by the Agency’s Foundation Board by circulatory vote.
 
Our journey of reflection and discovery
 
In May 2019, WADA initiated development of the Strategic Plan with a commitment to soliciting feedback from key stakeholders within the anti-doping ecosystem; such as: athletes; representatives of the Sports Movement and Governments of the world; industry influencers; as well as, National Anti-Doping Organizations and WADA-accredited laboratories. The feedback acknowledged how much WADA had achieved over its 20-year history; how the Agency’s growth had helped spur on the global movement for doping-free sport; and, it also identified a number of areas where WADA could improve or focus more.
 
WADA President Witold Banka said: “WADA is now in a completely different place than it was a few years ago thanks to the governance reform that the Agency initiated and to the strengthening of its compliance monitoring activities. While stakeholders recognize these achievements, there is consensus that WADA must go further to build bridges and unite efforts to protect athletes and the integrity of sports globally; and that, the Agency’s resources are not reflecting the magnitude of the challenges that we face.”
 
“The Strategic Priorities laid out in the Strategic Plan have been defined with athletes at the center and will shape the transformational journey that WADA will take over the next five years. Day in, day out, the Agency will continue to collaborate with athletes and all our partners worldwide to strengthen the World Anti-Doping Program. I am very committed to this Plan; most notably, to engaging and empowering athletes in developing Clean Sport; to building anti-doping capacity and community worldwide; and, to securing the additional funding that is required to deliver on Leading Anti-Doping in a New Era. I am confident that, with stakeholder collaboration and unity, we will succeed.”
 
Our Strategic Priorities
 
WADA defined the following Strategic Priorities, which address the key issues and challenges identified via our internal and external consultation: 

  1. Lead: Lead by example by taking bold steps to proactively tackle emerging issues with agility and innovative solutions across all facets of anti-doping.
  2. Grow Impact: Expand the reach and impact of anti-doping programs by enhancing capacity building and knowledge sharing between Anti-Doping Organizations and empowering local program delivery.
  3. Be Athlete-Centered:  Engage and empower athletes to contribute to the development of anti-doping policies, build an easier anti-doping journey for athletes, and increase the contribution that our programs deliver for athletes and their entourage so that they can build healthy and sustainable careers in sport.
  4. Collaborate and Unite:  Engage and collaborate with everyone involved in anti-doping, in particular with the sports movement and public authorities, to increase support, unity and coherence in everyone’s efforts.
  5. Be Visible: Raise awareness and shape a proactive narrative that will demonstrate the positive impact of doping-free sport and WADA’s role.
  6. Perform: Provide greater value to our stakeholders by reducing operational complexities and maximizing impact and cost-effectiveness.

WADA Director General Olivier Niggli said: “Over the years, the WADA team has worked diligently with stakeholders to develop the World Anti-Doping Program. Although doping scandals in recent years have tested the resolve and unity of the anti-doping community, they ultimately served as a catalyst to strengthen the Program. They also demonstrated the persistent challenges of doping in sports worldwide; and, the importance and the need of reinforcing WADA’s leadership and capacity so that it can collaboratively deliver on its global mission for doping-free sport.”
 
“We are now engaging our 140+ talented and committed team members worldwide around the Strategic Plan. We want to be sure to mobilize the very best contributions from all of us in Leading Anti-Doping in a New Era.


30/06/20 WADA INVITES APPLICATIONS FOR RESEARCH PROJECTS ON THE DEVELOPMENT OF DRIED BLOOD SPOT TESTING

Montreal, 30 June 2020 – The World Anti-Doping Agency (WADA) – along with several stakeholders including the China Anti-Doping Agency (CHINADA), the International Olympic Committee (IOC), the International Testing Agency (ITA) and the United States Anti-Doping Agency (USADA) – announces a Request for Applications (RFA) on the development of dried blood spot (DBS) testing.

This RFA is connected to the announcement made by WADA on 3 October 2019, which outlined that the Agency was collaborating with Anti-Doping Organizations from around the world to further the development and implementation of this exciting method for drug testing in sport.
 
In this context, and for the further development of DBS testing, this RFA for targeted research projects identifies the following relevant areas of research in the development of DBS as a new sample type for anti-doping testing:

  1. Discovery and/or validation of new discriminant biomarkers or biomarkers of confounding factors of the haematological module of the Athlete Biological Passport (ABP) in DBS;
  2. Study of the potential advantages of turning to dried plasma spots instead of DBS for testing for prohibited substances; and
  3. Development and validation of a new analytical method for the detection and quantification of human chorionic gonadotrophin (hCG) in DBS.

To submit applications, individuals are asked to create an account on the WADAGrants platform.

Please note that this RFA has different objectives, timelines and eligibility criteria from the RFA released by WADA and the Fonds de recherche du Québec on 17 June 2020 for targeted research projects that aim to develop biomarkers of doping.

The deadline for proposal submission is 31 August 2020 (24:00 GMT).

For further information, please contact WADA’s DBS Project Manager, Léonie Egli at: DBS@wada-ama.org.


23/06/20 SAVE THE DATES FOR WADA’s 2021 ANNUAL SYMPOSIUM AND THERAPEUTIC USE EXEMPTION SYMPOSIUM 

Montreal, 23 June 2020

Dear Colleagues,

While uncertainty continues due to COVID-19, for planning purposes, the World Anti-Doping Agency (WADA) kindly asks its stakeholders to ‘save the date’ for two important WADA events to be held next year:

  1. The 2021 Annual Symposium, which is scheduled to be held on Wednesday, 17 March and Thursday, 18 March 2021 at the SwissTech Convention Center in Lausanne, Switzerland.

    This 16th edition, which will be themed ‘Partnering to Deliver Clean Sport for Athletes in a New Era’ will, once again, be a unique and practical event that offers anti-doping stakeholders the opportunity to interact and learn from one another. The Symposium is designed for anti-doping practitioners from International Federations, National and Regional Anti-Doping Organizations and Major Event Organizations; representatives from Athlete Commissions, Governments, WADA-accredited laboratories and Athlete Passport Management Units; as well as, other stakeholders such as service providers, researchers and the media – all that are integral to clean sport.

    In keeping with the theme, we particularly encourage the participation of Anti-Doping Organizations’ athletes and athlete representatives. Given that the International Olympic Committee and the International Paralympic Committee will both be holding major Athlete Forums in 2021 that will feature discussions on anti-doping, WADA has opted not to hold an additional full-day Athlete Session as part of the Symposium in 2021; however, athletes and athlete matters will be front and center in the two-day agenda.

    More details regarding the Annual Symposium, including a draft agenda and logistical information, will be provided when registration opens during the fourth quarter of 2020.
     
  2. The Therapeutic Use Exemption (TUE) Symposium, which is scheduled to be held from Wednesday, 21 April to Friday, 23 April in Incheon, South Korea.

    This fifth edition of WADA’s TUE Symposium will be hosted by the Korea Anti-Doping Agency (KADA); and, will convene physicians and representatives of National Anti-Doping Organizations, International Federations, Major Event Organizations and other international sports organizations from around the globe to discuss medical conditions and the TUE process.

    The primary objective of the Symposium is to harmonize the approach to TUEs, which ensure that athletes with legitimate medical conditions may participate in sport despite their need for a prohibited substance or method. The Symposium will discuss the revised 2021 International Standard for TUEs that will enter into effect on 1 January 2021; and, include interactive discussions on medical cases; medico-legal issues; retroactive TUEs; and, the challenges regarding global harmonization of practices, with the goal of ensuring that fairness is maintained and athletes are afforded similar opportunities, regardless of their sport, geographical location or specific medical issues. 

WADA is committed to ensuring the health and safety of the stakeholder community and the Agency’s staff. Accordingly, the Agency will continue to monitor the evolution of the pandemic; and, base its decisions regarding whether to hold these large-scale gatherings in person or through virtual means on directives issued by public health authorities.

The Agency hopes to have the pleasure of welcoming you in Lausanne and Incheon in 2021.

Best regards,

World Anti-Doping Agency


19/06/20 WADA PUBLISHES ‘LIVE’ WEBINAR SCHEDULE FOR JULY

Montreal, 19 June 2020

Dear Colleagues,

The World Anti-Doping Agency (WADA) is pleased to publish the Agency’s ‘live’ webinar schedule for July, which encompasses all webinars being offered as part of the following previously announced series. Unless otherwise noted, the webinars are being hosted in English only.

  1. A series that is part of WADA’s 2021 Code Implementation Support Program (CISP), which was launched on 4 May;
  2. A series that is being offered in place of some of the sessions that would have otherwise been delivered during the Agency’s Annual Symposium, which was due to be held in March 2020 but was cancelled due to COVID-19;
  3. A series that is athlete-led for athletes, which was announced by WADA on 11 June;
  4. A series announced on 28 May, which is being offered by the Agency’s Africa Office, to assist anti-doping stakeholders in the region with the development and implementation of robust anti-doping programs; and
  5. A series announced on 19 May, which is being hosted by the Agency’s Latin America Office, to assist Spanish-speaking anti-doping stakeholders around the world with their implementation of the 2021 World Anti-Doping Code.
Date/
Time
Session TitleSpeakers Webinar Series & Target audienceRegistration Link
2 July
10:00 EDT

SESIÓN 6: Casos prácticos (in Spanish)

Session 6: Case workshop
Maria Jose Pesce Cutri, Director, WADA Latin America Office

Tharinda Puth, Manager, Legal Affairs, WADA

Emiliano Simonelli, Chief Compliance Manager, WADA

Juan Lauria, Manager, WADA Latin America Office
Spanish-language Series

NADOs and members of Disciplinary/
Appeal Panels

By invitation only

Please contact WADA’s Latin America Office Coordinator, Edna Serra at edna.serra@wada-ama.org
3 July
09:00 EDT

COVID-19 and Clean Sport
Ben Sandford, Chair, WADA Athlete Committee

Dr. Alan Vernec, Medical Director, WADA

Dr. Andrea Gotzmann, Chairwoman of the Executive Board, National Anti-Doping Agency of Germany

Benjamin Cohen, Director General, International Testing Agency

Tim Ricketts, Director, Standards & Harmonization, WADA

Athlete Series

Athletes

Register here
6 July 2020
09:00 EDT

Anti-Doping Knowledge for Medical Practitioners (in English)

Webinar on anti-doping knowledge and TUEs for Medical Practitioners and Team Doctors
Katia Alloun, Manager, Therapeutic Use Exemptions (TUEs), WADA

Yoko Dozono, Manager, TUEs, WADA

African Series

Medical Practitioners, Team Doctors, TUE Coordinators, RADO Managers

Please contact WADA’s Africa Office Manager, Sameh Elray at sameh.elray@wada-ama.org
7 July 2020
10:00 EDT

Anti-Doping Knowledge for Medical Practitioners (in French)

Webinar on anti-doping knowledge and TUEs for Medical Practitioners and Team Doctors
Katia Alloun, Manager, TUEs, WADA
African Series

Medical Practitioners, Team Doctors, TUE Coordinators, RADO Managers

Please contact WADA’s Africa Office Manager, Sameh Elray at sameh.elray@wada-ama.org
8 July
 
08:30 EDT
Anti-Doping Administration & Management System (ADAMS): WADA’s new Paperless Doping Control System and the Progress of the Next Gen TransformationStuart Kemp, Deputy Chief Operating Officer, WADA Chaya Ndiaye, Senior Manager & ADAMS Team Lead, WADAAnnual Symposium Series

All stakeholders
Register here
9 July
 
09:00 EDT
Athlete Pools and WhereaboutsKevin Haynes, Deputy Director, Standards and Harmonization, WADA

Dan-Thanh Tran, Senior Manager, Ethical Sport Enterprises, Canadian Centre for Ethics in Sport (CCES)
CISP Series

Anti-Doping Organizations (ADOs)
Register here
9 July
10:00 EDT

SESIÓN 7: Casos prácticos (in Spanish)

Session 7: Case workshop
Maria Jose Pesce Cutri, Director, WADA Latin America Office

Tharinda Puth, Manager, Legal Affairs, WADA

Emiliano Simonelli, Chief Compliance Manager, WADA

Juan Lauria, Manager, WADA Latin America Office

Spanish-language Series

NADOs and members of Disciplinary/Appeal Panels

By invitation only

Please contact WADA’s Latin America Office Coordinator, Edna Serra at edna.serra@wada-ama.org
15 July
 
8:00 EDT
Dried Blood Spot (DBS) Testing and AnalysisMarcia MacDonald, Deputy Director, Science & Medicine, WADA; Chair of DBS Steering Committee Jordi Segura, Scientific collaborator of Institut Hospital del Mar d’Investigacions Mèdiques (IMIM); Chair of DBS Analysis & Storage Working Group Qingping Yan, Deputy Director of Operation and Management Dept., CHINADA; Chair of DBS Collection & Transport Working GroupAnnual Symposium Series

ADOs
Register here
15 July
 
10:00 EDT
Introducción al nuevo Estándar Internacional de Educación y su implementación (in Spanish)
 
Webinar on the new International Standard for Education and its Implementation
Ariadna Camargo, Coordinator, Education, WADA

Tony Cunningham, Senior Manager, Education, WADA
Spanish-language Series

ADOs in Latin America
Register here
17 July
 
10:00 EDT
Implementing an Effective Testing ProgramThomas Capdevielle, Head of Testing & Compliance and Deputy Head, Athletics Integrity Unit Matthew Fedoruk, Chief Science Officer, USADA George Tsamis, Senior Manager, Standards and Harmonization, WADACISP Series

ADOs
Register here
23 July
 
8:30 EDT
Cyber Security Essentials for Anti-Doping OrganizationsAndrew Collins, Chief Information Officer, Sport Integrity Australia Jorge Leyva, Chief Executive Officer, Institute of National Anti-Doping Organizations (iNADO) Frédérique Horwood, Lead Counsel, Privacy and Data Governance, WADA (Moderator)CISP Series

ADOs
Register here
29 July
 
9:00 EDT
Key Takeaways of the 2021 International Standard for Results Management (ISRM)Julien Sieveking, Director, Legal Affairs, WADA Ross Wenzel, Attorney-at-law, Kellerhals Carrard; main drafter of the ISRMAnnual Symposium Series

All stakeholders
Register here

We also take the opportunity below to remind stakeholders of the remaining webinar to be held in June from the June ‘live’ webinar schedule that was published on 20 May.

Date / TimeSession TitleSpeakersWebinar Series & Target audienceRegistration Link
22 June
 
09:00 EDT
TUEs: Core Principles and Changes to the 2021 International Standard for TUEsKatia Alloun, Manager, TUEs, WADA
 
David Healy, Manager, TUEs, WADA
 
Alan Vernec, Medical Director, WADA
CISP Series

ADOs
Register here

To register for any or all of the above webinars, please simply click on the Registration Links provided.

Every mid-month, WADA will communicate its live webinar schedule for the following month, prompting stakeholders to register and participate.

Should you have any questions regarding the above, please contact WADA at: selva.balasingam@wada-ama.org.

Best regards,

World Anti-Doping Agency


18/06/20 WADA PUBLISHES FINAL DESIGNED VERSION OF ATHLETES’ ANTI-DOPING RIGHTS ACT

Montreal, 18 June 2020

Dear Colleagues,

The World Anti-Doping Agency (WADA) is pleased to publish, in English and French, the final designed version of the Athletes’ Anti-Doping Rights Act (Act), which WADA’s Athlete Committee developed over two and half years in consultation with thousands of athletes and stakeholders worldwide.

The purpose of the Act, which is based on the 2021 World Anti-Doping Code (Code) and its related International Standards that take effect on 1 January 2021, is to ensure that the rights of all athletes worldwide to participate in doping-free sport are clearly set out, accessible, and universally applicable. The document was approved by WADA’s Executive Committee on 7 November 2019 during the World Conference on Doping in Sport in Katowice, Poland.

Developed by athletes, for athletes, the Act provides an outline of rights provided by the 2021 Code and International Standards in terms of equality of opportunity, fair testing programs, medical treatment, justice, accountability, education, data protection and more. It also makes recommendations around athletes’ rights to be part of a system that is free from corruption, that they are appropriately represented in terms of governance and decision-making, and that they have a right to legal aid.

WADA Athlete Committee Chair Ben Sandford said: “We are incredibly grateful to all the athletes and other stakeholders who contributed to developing the Athletes’ Anti-Doping Rights Act. It is vital that athletes and anti-doping organizations know what rights athletes have, how to access them, and where to go for remedy. We hope that the Act will become a valuable resource for athletes and contribute to making sport cleaner and fairer. We call upon the anti-doping community worldwide to support its implementation and its promise.”

WADA President Witold Bańka, who is a former international-level 400m runner, said: “WADA is an athlete-centered organization and everything that we do is to protect athletes’ right to access Clean Sport. I applaud the Athlete Committee’s efforts in developing the Anti-Doping Rights Act, which helps ensure that athletes are aware of their rights and can exercise them, which is vital to the success of Clean Sport.”

This Act is made up of two parts. Part one sets out rights that are found in the Code and International Standards. Part two sets out recommended athlete rights, which are not found in the Code or Standards but are rights that athletes recommend that anti-doping organizations adopt for best practice.

Best regards,

World Anti-Doping Agency


17/06/20 WADA AND FRQ INVITE APPLICATIONS FOR RESEARCH PROJECTS ON THE DEVELOPMENT OF BIOMARKERS

Montreal, 17 June 2020 – The World Anti-Doping Agency (WADA) and the Fonds de recherche du Québec (FRQ) are pleased to announce a special Request for Applications (RFA) for targeted research projects that aim to develop biomarkers of doping. This RFA is connected to the Memorandum of Understanding (MOU) that WADA and the FRQ announced on 16 May 2018 focused on advanced areas of anti-doping scientific research. Under the terms of the MOU, WADA and the FRQ agreed to contribute every year for five years (2018-2022) in order to fund important research projects related to anti-doping.

The development of novel biomarkers of doping is a key priority for anti-doping research. The challenges for the development and implementation of new biomarkers for anti-doping testing not only involve specific analytical approaches and omics technologies, but also require complementary expertise and research approaches that have been advanced in Quebec for the development of clinical biomarkers.

As part of this RFA, WADA and the FRQ aim to promote research on biomarkers of doping that integrates expertise in anti-doping science with Quebec expertise in areas such as biostatistics; bioinformatics; clinical pharmacology; development of diagnostic tests; and, design/analysis of clinical trials. Specifically, applications should aim to develop:

  1. Biomarkers of relevant prohibited substances or methods; or
  2. Biomarkers of known confounding factors encountered in anti-doping testing.

To submit applications, individuals are asked to create an account on the WADAGrants platform. Please note that the research team must contain at least one member based in Quebec. Collaboration between research groups is encouraged, including integration of expertise in both anti-doping science and development of biomarkers for clinical use.

The deadline for proposal submission is 5 October 2020 (24:00 GMT).

For further information, please contact WADA’s Science Department at science@wada-ama.org.


16/06/20 WADA PUBLISHES FINAL VERSIONS OF 2021 WORLD ANTI-DOPING CODE AND INTERNATIONAL STANDARDS IN ENGLISH AND FRENCH

Montreal, 16 June 2020

Dear Colleagues,

The World Anti-Doping Agency (WADA) is pleased to publish the final versions of the 2021 World Anti-Doping Code (Code) and International Standards (Standards), which will come into force on 1 January 2021. These final versions include limited changes from those that WADA published on 26 November 2019, which were the versions that were approved by the Agency’s Foundation Board (Board) and Executive Committee (ExCo), respectively, on 7 November 2019, during the Agency’s World Conference on Doping in Sport that was held in Katowice, Poland.

In the interest of full transparency, unless otherwise noted as an exception, the table below provides the following links for the Code and the relevant Standards:

  1. The final 2021 versions (in English and French, WADA’s two official languages).
     
  2. Summary documents (in English only) outlining the limited changes that were made from the 26 November 2019 versions to the final versions being published today.

    It is important to note that none of these limited changes affect in any way the sense, meaning or interpretation of the versions approved in Katowice. Rather, they were required to:
  • adapt and align clauses to changes approved in other clauses;
  • remove inconsistencies;
  • correct references to other Code or International Standards articles; and
  • make grammatical and formatting modifications.  
  1. A redline version outlining all the changes from the current versions in force to the final versions being published today (in English and French).
Final 2021 Versions
 
[In English and French]
Summary documents outlining the limited changes from the 26 November 2019 versions to the final versions published today
 
[In English Only]
Redline version outlining all changes from the current versions in force to the final versions published today
 
[In English and French]
Exceptions
World Anti-Doping CodeLinkLink
International Standard for Code Compliance by Signatories (ISCCS)LinkLink
International Standard for Education (ISE) (New)LinkN/A as is a new Standard
International Standard for Laboratories (ISL)N/A – see exception columnN/AAs communicated in November 2019, the ISL followed a different path than the other Standards.

A revised version 10.0 of the ISL — which was reviewed in order to reflect and incorporate relevant changes and to update the document in line with new technical, scientific and regulatory developments — was approved by the ExCo in May 2019; and, became effective on 1 November 2019. Subsequently, a revised version 11.0 of the ISL was drafted to ensure consistency with the 2021 Code and the other Standards. The amended draft 11.0 was circulated for stakeholder consultation from 10 December 2019 to 4 March 2020. Further to stakeholder feedback, the final draft is being finalized and will be presented for ExCo approval in September 2020.
International Standard for the Protection of Privacy and Personal Information (ISPPPI)N/AN/AOn 2 June 2020, WADA launched a Limited Supplementary Stakeholder Consultation Phase, which closes on 30 June.Stakeholders have until 2 July 2020 to provide feedback; after which, the final version of the ISPPPI will be published.
International Standard for Results Management (ISRM) (New)LinkN/A as is a new Standard
International Standard for Testing and Investigations (ISTI)LinkLink
International Standard for Therapeutic Use Exemptions (ISTUE)LinkLink

International Standard for the List of Prohibited Substances and Methods (Prohibited List)

As it relates to the Prohibited List, it is reviewed annually via a separate stakeholder process, which is underway.

Obtaining printed copies of the Code

In keeping with WADA’s sustainability efforts, in recent years the Agency has minimized print in favor of making its publications available digitally. However, given the importance of the Code, which will live for a number of years and be used on a daily basis by the Agency’s stakeholders, in the coming months, we will be:

  • Mailing out a limited quantity of printed English or French copies to Code Signatories;
  • Making English and French print-ready versions available on our website for stakeholders to print locally; and
  • Putting a mechanism in place for stakeholders and others that may wish to purchase printed copies in English and/or French.

Code Implementation Support Program

In closing, WADA wishes to draw your attention once again to the Agency’s Code Implementation Support Program (CISP), which went live on 4 May 2020. This program was developed to prepare Signatories for implementation of the Code and Standards that come into effect on 1 January 2021. The CISP includes:

  • resources that are available via the Agency’s Anti-Doping eLearning platform (ADeL); and
  • a series of live webinars, hosted by WADA personnel and external experts, to support Code/Standard implementation efforts for targeted audiences and/or regions. The Agency is also hosting live webinars in place of some sessions that would have otherwise been delivered during the Agency’s Annual Symposium, which was due to be held in March 2020 but was cancelled due to COVID-19.

Should you have questions or feedback regarding the Code and Standards, please contact code@wada-ama.org; or, questions or feedback related to the CISP, please contact 2021CISP@wada-ama.org.

Best regards,

World Anti-Doping Agency


15/06/20 WADA UPDATE ON ITS FOLLOW-UP OF McLAREN INVESTIGATION INTO THE INTERNATIONAL WEIGHTLIFTING FEDERATION

Montreal, 15 June 2020 – Following its initial statement on 4 June, the World Anti-Doping Agency (WADA) confirms that on 9 June it received some evidentiary information from the McLaren Independent Investigation Team, which recently completed an investigation into the International Weightlifting Federation (IWF).
 
WADA has since started to analyze the newly received information, which covers the period 2009-2014, to see what further action may be warranted in relation to anti-doping matters highlighted by the investigation. WADA is committed to ensuring that all athletes who are identified as having breached the rules, are brought to justice. The Agency has also made a request to the McLaren Investigation Team to share the remainder of the relevant information as described in Professor McLaren’s report published on 4 June, in particular so it can assess whether anything should be done from a compliance perspective.
 
In addition, WADA’s independent Intelligence & Investigations Department, which has collaborated with the McLaren team throughout, will continue its own ongoing investigation related to the sport of weightlifting.
 
WADA President, Witold Bańka, said: “WADA is appalled by the behavior exposed by the McLaren Investigation Team. The Agency condemns all interference with anti-doping procedures with the utmost vigor. These revelations are incredibly upsetting for clean athletes, for WADA and for all advocates of clean sport.
 
“As is recognized by the McLaren report, I am confident that recent strengthening of global anti-doping rules, and growing powers being afforded to WADA as the global anti-doping regulator, would ensure that, today, this kind of behavior could be dealt with as a matter of anti-doping organization compliance within much shorter timelines. Through the new International Standard for Code Compliance by Signatories, which took effect in April 2018, WADA can now address delayed results management as a matter of compliance.
 
“Cheats must be brought to justice and WADA will continue to ensure all cases are properly followed up by World Anti-Doping Code Signatories. This strengthens my resolve to bolster WADA’s financial capacity so that the Agency has the resources it needs to bring cases to the Court of Arbitration for Sport directly on a regular basis. We want to fully exercise the powers that we now have under anti-doping rules.”
 
Thanks to information obtained by the McLaren investigation team through access to IWF’s servers and other sources of evidence, the Agency wrote to the IWF on 12 June to request immediate action on all cases, with priority being given to those that are close to the statute of limitations. The IWF is the entity responsible to ensure that proper results management is conducted under the World Anti-Doping Code and WADA will monitor that process closely.

11/06/20 WADA LAUNCHES WEBINAR SERIES
FOR ATHLETES

Montreal, 11 June 2020 – Today, the World Anti-Doping Agency (WADA) is pleased to announce the launch of a series of athlete-led webinars to be held over the coming months. This series, which is an initiative of  WADA’s Athlete Committee, is intended to provide a platform for interactive engagement by the Agency with athletes worldwide on anti-doping matters. 
 
The first webinar, titled COVID-19 and Clean Sport, will be held on 3 July at 09:00 EDT; and, will focus on the impact of COVID-19 on athletes and the anti-doping system. The panelists will include the following athletes and experts:

  • Ben Sandford: Chair, WADA Athlete Committee
  • Dr. Alan Vernec: Medical Director, WADA
  • Dr. Andrea Gotzmann, Chairwoman of the Executive Board, National Anti-Doping Agency of Germany
  • Benjamin Cohen: Director General, International Testing Agency
  • Tim Ricketts, Director, Standards & Harmonization, WADA

These panelists will engage participants on the following topics:

  • the current situation in relation to testing;
  • what athletes can expect may be modified with respect to health and safety protections as testing ramps up again; and
  • how Anti-Doping Organizations are innovating and maintaining other elements of their detection and deterrence programs in the face of reduced testing.

Athletes are invited to register for this first webinar, by clicking here. Anti-Doping Organizations worldwide are encouraged to relay this announcement on to their athletes.
 
End May, WADA and its Athlete Committee published a Q&A document for athletes on the matter of COVID-19 to update them about the evolving situation related to the protection of athlete health and how clean sport can persevere during these challenging times. This first webinar will be a continuation of these efforts as WADA and its Athlete Committee strive to ensure that as many athletes as possible are informed about this evolving topic.
 
“Despite the many challenges athletes are facing as a result of COVD-19, we want to provide assurance that anti-doping is not at a standstill,” said WADA Athlete Committee Chair, Ben Sandford. “WADA’s Athlete Committee wants to provide athletes with up-to-date information about the impact that COVID-19 is having on Clean Sport; and, we also need to continue to hear from athletes about what specifically concerns them and how we may be able to address those concerns. Beginning with the topic of COVID-19, we hope that this series of webinars will be an effective platform to share information and hear from athletes about how we can best support them and further improve the global anti-doping system.”

The next webinars in the series for athletes will be announced successively on WADA’s website and via social media.
 
Should you have any questions or comments, please contact Stacy Spletzer-Jegen, WADA’s Senior Manager, Athlete Relations & Communications, at: stacy.spletzer@wada-ama.org.


10/06/20 WADA DELAYS CALL FOR PROPOSALS FOR 2021 SOCIAL SCIENCE RESEARCH GRANT PROGRAM TO OCTOBER

Montreal, 10 June 2020 

Dear Colleagues,

The World Anti-Doping Agency (WADA) announces that the Agency has delayed its call for proposals for its 2021 Social Science Research Grants Program (Program) by six months to October 2020 in order to better accommodate the academic community in light of COVID-19.

As reported to WADA’s Executive Committee (ExCo) in May 2020, WADA’s Education Department —  along with the Agency’s Social Science Review Panel and Education Committee — took this decision primarily in response to feedback that researchers, which were awarded grants as part of the 2020 Program, are currently experiencing delays in starting their projects due to campus closures; restricted access to, and contact with, research subjects; and, in some cases, an inability to obtain the required authorization to finalize grant contracts. The Agency will leverage this delay to further develop its Social Science Research Strategy (Strategy).

WADA Director of Education, Amanda Hudson, said: “As the COVID-19 pandemic continues to have an impact around the globe, WADA has taken the decision to delay its call for proposals for its 2021 Social Science Research Grant Program to October 2020. We want to accommodate the challenges that researchers are confronting with the current situation; and, use this opportunity to further our Social Science Research Strategy; including by resetting our Program timelines to align with the global academic calendar, which should afford potential candidates a suitable amount of time to prepare their applications.”

“In this context, WADA encourages the academic community to engage in early dialogue with their respective Anti-Doping Organizations (ADOs) to identify social science research needs and prepare applications that partner with the anti-doping community. As the Agency continues to develop its Strategy, we will be keen to support greater collaboration between practitioners and academics to improve the integration of research outcomes into practice.”

Increasing and enhancing research-led anti-doping education remains one of WADA’s strategic priorities and, as such, this delay will have no financial impact on the Agency’s social science research budget.

In the meantime, WADA’s Strategy continues to be developed and will be submitted to the Agency’s ExCo meeting in November. It will provide guidance to researchers and ADOs for the overall direction of WADA’s social science research efforts for the coming four years; including, an articulation of the Agency’s research priorities.

For further information regarding the Social Science Research Grants Program, please visit the Social Science Research section on WADA’s website or contact the Agency’s Education Department at education@wada-ama.org.

Best regards,

World Anti-Doping Agency

05/06/20 WADA PUBLISHES ADO GUIDANCE FOR REMOTE EDUCATION PROGRAMS IN LIGHT OF COVID-19

Montreal, 5 June 2020

Dear Colleagues,
[Anti-Doping Organizations]

Today, the World Anti-Doping Agency (WADA) is pleased to provide Anti-Doping Organization (ADO) Guidance for Remote Education Programs in light of COVID-19, which the Agency developed in consultation with its Education Committee. This document is the latest in a series of such Guidance documents that we have developed for ADOs, which outline how we can best protect the health of athletes while protecting their right to doping-free sport. It aims to support you in carrying out remote anti-doping education programs for athletes, Athlete Support Personnel (ASP) and other stakeholders during COVID-19.

Along with many businesses around the world, WADA and many ADOs have implemented remote working practices. This of course has impacted the delivery of some aspects of anti-doping programs, including education. While you are strongly advised to follow the instructions of your relevant healthcare authorities to ensure the proper protection of athletes and ASP, WADA believes that adjusted education programs may still be carried out at this time. In fact, it may be a good opportunity to engage for education purposes, as many athletes and ASP may find themselves with additional time on their hands.

This Guidance document highlights the many techniques that can be implemented to deliver education within an anti-doping community impacted by social distancing. Distance learning techniques such as eLearning can enable people to undertake remote education, on their own and at a time that is convenient to them. Use of information technologies and other digital communication tools can help sustain an athlete’s interest and make the learning process more engaging. You may wish to consider these techniques and others so that this time can be used positively to educate athletes and those around them.

With this, WADA encourages you to adapt your education programs under these pandemic circumstances in order to keep protecting and promoting Clean Sport. We recognize that the use and access to technology differs per audience and country around the globe; and therefore, have proposed some alternative ideas within the Guidance to help overcome these limitations.

We hope that you find this Guidance helpful. Should you have any questions or comments, please feel free to reach out to Education@wada-ama.org or WADA’s Regional Offices. In the meantime, we wish you well during these challenging times and encourage your ongoing efforts to educate athletes and others about Clean Sport.

WADA will continue to liaise with you and athletes in the interest of publishing updates regarding the Agency’s response to COVID-19 as the situation evolves.

Best regards,

World Anti-Doping Agency


03/06/20 WADA SIGNS AGREEMENT WITH CONFERENCE OF MINISTERS OF YOUTH AND SPORTS OF FRENCH-SPEAKING COUNTRIES

Montreal, 3 June 2020 – Today, the World Anti-Doping Agency (WADA) and the Conference of Ministers of Youth and Sports of French-speaking Countries (CONFEJES) signed a partnership agreement that strengthens the integrity of sport and helps tackle doping within the 43 CONFEJES member countries.

Signed by WADA Director General, Olivier Niggli, and CONFEJES Secretary General, Bouramah Ali Harouna, the agreement ensures that CONFEJES will incentivize its members to ratify and implement the terms of the UNESCO International Convention against Doping in Sport as well as the principles of the World Anti-Doping Code (Code).

In addition, under the terms of the agreement, CONFEJES undertakes to encourage its members to harmonize their national anti-doping policies with the Code and related International Standards, while also reviewing all aspects of their programs to ensure they comply with the relevant guidelines and international best practices.

CONFEJES will also encourage its members that do not have National Anti-Doping Organizations (NADOs) to establish and adequately resource them, while also supporting the work and projects of the Regional Anti-Doping Organizations (RADOs) in their respective regions.

Mr. Niggli said: “This agreement is yet another step forward for clean sport around the world. It ensures a closer relationship of collaboration between WADA and all Francophone Governments of the world, many of which are located in Africa, with the end goal being greater success among those countries in fulfilling their anti-doping commitments. 

“Sport is such an important social force all over the world and must be protected from those who would cheat the system. Under this agreement, CONFEJES is making a strong statement on behalf of the Francophone nations of the world that they support the global anti-doping program and are united in their resistance to doping in sport.”

Mr. Ali Harouna said: “CONFEJES is delighted to formally engage with WADA through this agreement, in support of the protection of the rights of our athletes and the upholding of clean sport. A co-operation agreement between the two organizations was first signed in 2007, and this new agreement will undoubtedly contribute towards achieving the common goal of eradicating doping from sport in the CONFEJES member countries.

“We look forward to collaborating further with WADA and to pooling our efforts and resources to ensure this partnership strengthens the global fight against doping in sport.”

Throughout the implementation of this agreement, CONFEJES will also support the necessary training of those working in anti-doping in their member countries, cooperate with WADA in its Code compliance monitoring and conduct education and awareness activities on the protection of clean sport within the Francophone world, including the promotion of values-based education in school environments in the member countries.

For its part, WADA will provide support and collaborate with CONFEJES on various projects aimed at implementing the Code and building capacity by providing expert technical assistance on an ongoing basis through advice, education, training and research while also involving CONFEJES in various initiatives being taken by WADA around the world.


02/06/20 WADA LAUNCHES LIMITED SUPPLEMENTARY STAKEHOLDER CONSULTATION PHASE FOR THE 2021 INTERNATIONAL STANDARD FOR THE PROTECTION OF PRIVACY AND PERSONAL INFORMATION

Montreal, 2 June 2020

Dear Colleagues,

Today, the World Anti-Doping Agency (WADA) launches a Limited Supplementary Stakeholder Consultation Phase for the 2021 International Standard for the Protection of Privacy and Personal Information (ISPPPI).

On 26 November 2019, WADA published the 2021 World Anti-Doping Code (Code) and International Standards (Standards), which had been subject of a three-phase consultation process that concluded on 4 March 2019. These documents were approved by the Agency’s Foundation Board and Executive Committee (ExCo), respectively, during WADA’s World Conference on Doping in Sport held from 5-7 November 2019. They will come into force on 1 January 2021.

On 1 November 2019, WADA received a letter from the Presidency of the Council of the European Union presenting the position of the Council Working Party on Sport in response to the European Data Protection Board’s (EDPB’s) observations regarding the Code and Standards. The EDPB’s observations focused principally on the ISPPPI.

While this letter was received after the closure of the two-year consultation process, the ISPPPI drafting team carefully reviewed it and concluded that certain modifications to the Standard would provide useful clarifications for all Anti-Doping Organizations (ADOs) and would further improve the 2021 ISPPPI.

Accordingly, effective today, WADA is opening a Limited Supplementary Stakeholder Consultation Phase for the ISPPPI and encourages Stakeholders to provide feedback by 2 July 2020. Because the 2021 ISPPPI has already been approved by the ExCo — following which there were minor editorial changes that resulted in the following version — the consultation phase will be limited to the following articles where modifications are being proposed:

  1. Minor drafting modifications to Articles 4.1, 4.5 and 5.3 to ensure the ISPPPI is properly interpreted as being mandatory, as providing minimum requirements which may need to be supplemented by ADOs, and as always requiring that the principle of data minimization be respected. 
  2. Modifications to Article 11.5 to align the process to resolve a non-conformity with the International Standard for Code Compliance by Signatories.
  3. Modifications to Annex A to define maximum retention times.

Following the consultation phase, the ISPPPI drafting team will consider the feedback received and will submit the revised version for approval to WADA’s September 2020 ExCo meeting for entry into force on 1 January 2021, alongside the revised Code and the other Standards.

To Submit Feedback 

The 2021 ISPPPI’s Limited Consultation can be accessed via WADAConnect, the Agency’s online consultation platform. As indicated above, we would ask you to provide feedback no later than 2 July 2020. For more information related to WADAConnect, please refer to the simple user guide.

Stakeholders are kindly asked, to the extent possible, to draw on practical experiences and propose recommendations that would benefit the fight for clean sport worldwide. In addition, stakeholders are kindly asked to be as specific and clear as possible in their submissions, i.e. by proposing concrete text replacing the existing draft.

We look forward to receiving your feedback.

Thank you – best regards,

World Anti-Doping Agency


25/05/20 WADA PUBLISHES UPDATED QUESTION AND ANSWER DOCUMENT FOR ATHLETES RELATED TO COVID-19

Montreal, 25 May 2020

Dear Colleagues,

Today, the World Anti-Doping Agency (WADA) is pleased to publish a Question and Answer (Q&A) document related to anti-doping and COVID-19, which is an update to the document that the Agency published on 23 March 2020. Once again, it was developed in consultation with WADA’s Athlete Committee.

WADA Director General Olivier Niggli said: “As the situation continues to evolve, WADA is pleased to provide further clarity to athletes in relation to anti-doping and COVID-19, particularly given that in some regions of the world, the public health environment is such that Anti-Doping Organizations have started to resume normal testing activities. Regardless of the situation countries or regions may be facing, WADA continues to urge Anti-Doping Organizations to place athlete health at the forefront of their anti-doping efforts. To this end, athletes should be aware that, on 6 May, the Agency also updated its COVID-19 guidance for Anti-Doping Organizations, which outlines how Anti-Doping Organizations can best protect the health of athletes while protecting their right to doping-free sport. 

“WADA is conscious of the fact that the amount of testing activity will continue to vary globally given the regional differences in terms of public health restrictions. Therefore, the Agency will continue to keep a close eye on developments so that we can continue to work collaboratively with Anti-Doping Organizations to strike the appropriate balance between the protection of health and that of sport during these challenging times.”

The updated Q&A covers matters such as:

  • Testing during COVID-19
  • Minimizing the risk of contracting or transmitting the virus
  • Filing of whereabouts information
  • Validating Therapeutic Use Exemptions
  • Maintaining the integrity of the global anti-doping system
  • Refusing to comply with testers at this time
  • Confidence in the anti-doping system

WADA will continue to liaise with athletes and Anti-Doping Organizations in the interest of publishing updates regarding the Agency’s response to COVID-19 as the situation evolves.

Best regards,

World Anti-Doping Agency


20/05/20 WADA PUBLISHES ‘LIVE’ WEBINAR SCHEDULE FOR JUNE AS PART OF ITS 2021 CODE IMPLEMENTATION
SUPPORT PROGRAM

Montreal, 20 May 2020

Dear Colleagues,

Further to the World Anti-Doping Agency’s (WADA’s) communication of 4 May, which announced the official launch of WADA’s 2021 Code Implementation Support Program (CISP), the Agency is pleased to publish the following schedule for its series of ‘live’, English-only webinars, that will be held in June.

Date / TimeSession TitleSpeakersTarget audienceRegistration
Link
3 June
 
08:00 EST
The new International Standard for Education (ISE) and Guidelines
 
[Please note: This webinar is identical to the webinar held on 15 May.]
Karri Dawson, Senior Director of Quality Sport at the Canadian Centre for Ethics in Sport; WADA Education Committee member; and, member of the ISE drafting team

Tony Cunningham, Senior Manager, Education, WADA
 
Anti-Doping OrganizationsRegister here
10 June
 
09:00 EST
Risk Assessment and Test Distribution PlanKarine Henrie, Senior Manager, Standards and Harmonization, WADA

Francesca Rossi, Director of the Testing Department, Agence française de lutte contre le dopage (AFLD)
 
Anti-Doping OrganizationsRegister here
22 June
 
09:00 EST
Therapeutic Use Exemptions (TUE): Core Principles and Changes to the 2021 International Standard for TUEsAlan Vernec, Medical Director, WADA

David Healy, Manager, TUE, WADA 

Katia Alloun, Manager, TUE, WADA 
 
Anti-Doping OrganizationsRegister here

We also take the opportunity below to remind stakeholders of the ‘live’, English-only webinars, which were previously announced and that are still to be held in May.

Date / TimeSession TitleSpeakersTarget audienceRegistration Link
26 May
 
09:00 EST
The Most Impactful Changes to the 2021 World Anti-Doping CodeCo-drafters of the Code:

Ulrich Haas, Professor of Procedural and Private Law, University of Zurich   

Richard Young, Partner, Bryan Cave Leighton Paisner, LLP
All stakeholdersRegister here
27 May
 
08:00 EST
The Athletes’ Anti-Doping Rights Act – How can Anti-Doping Organizations support its Implementation and PromiseBen Sandford, Lawyer, Sandford and Partners; and, WADA Athlete Committee Chair

Stuart Kemp, Deputy Chief Operating Officer, WADA
 
All stakeholdersRegister here

WADA developed the CISP to help World Anti-Doping Code (Code) Signatories prepare for implementation of the 2021 Code and International Standards (Standards) that come into effect on 1 January 2021.

In addition to the CISP resources that are already available on WADA’s Anti-Doping eLearning platform (ADeL), including ‘pre-recorded’ webinars, on a monthly basis, WADA is holding ‘live’ webinars, hosted by WADA personnel and external experts, to further support Code/Standard implementation efforts for targeted audiences and/or regions.

The Agency will also hold ‘live’ webinars in place of some of the sessions that would have otherwise been delivered during the Agency’s Annual Symposium, which was due to be held in March 2020 but was cancelled due to COVID-19. This includes the webinar referenced above on the Athletes’ Anti-Doping Rights Act; and, will include another one that updates stakeholders regarding the redevelopment of the Anti-Doping Administration and Management System (ADAMS).

To register for any or all of the above webinars, please simply click on the Registration Links provided.

Every mid-month, WADA will communicate its live webinar schedule for the following month, prompting stakeholders to register and participate.

Should you have any questions regarding the above, or specific questions or feedback related to the CISP, please contact WADA at: 2021CISP@wada-ama.org.

Thank you and best regards,

World Anti-Doping Agency


13/05/20 WADA PUBLISHES 2019 MONITORING PROGRAM FIGURES

Montreal, 13 May 2020

Dear Colleagues,

Today, the World Anti-Doping Agency (WADA) is distributing the 2019 Monitoring Program Figures to stakeholders, as per the World Anti-Doping Code (Code).

The document – which is being shared on a confidential basis –  provides data for substances, by sport, which were not on the 2019 List of Prohibited Substances and Methods (Prohibited List) but that were monitored during 2019 in order to detect patterns of misuse in sport; and, potential inclusion on the Prohibited List.

Article 4.5 of the Code states that “WADA, in consultation with signatories [of the Code] and governments, shall establish a monitoring program regarding substances which are not on the Prohibited List, but which WADA wishes to monitor in order to detect patterns of misuse in sport. […] WADA shall make available to International Federations and National Anti-Doping Organizations, on at least an annual basis, aggregate statistical information by sport regarding the additional substances.”

Should you have any questions, concerns or any other feedback about these 2019 Monitoring Program Figures, please contact Ms. Hai-Yen Huynh at WADA’s Science & Medical Department at hai-yen.huynh@wada-ama.org.

Best regards,

World Anti-Doping Agency


07/05/20 WADA PUBLISHES ‘LIVE’ WEBINAR SCHEDULE FOR MAY AS PART OF ITS 2021 CODE IMPLEMENTATION
SUPPORT PROGRAM

Montreal, 7 May 2020

Dear Colleagues,

Further to the World Anti-Doping Agency’s (WADA’s) communication of 4 May, which announced the official launch of WADA’s 2021 Code Implementation Support Program (CISP), the Agency is pleased to publish the following schedule for a series of ‘live’, English-only webinars, that will be held this month.

Date / TimeSession TitleSpeakersTarget AudienceRegistration Link
15 May
09:00 EST
The new International Standard for Education (ISE) and GuidelinesKarri Dawson, Senior Director of Quality Sport at the Canadian Centre for Ethics in Sport; WADA Education Committee member; and, member of the ISE drafting team

Tony Cunningham, Senior Manager, Education, WADA
Anti-Doping OrganizationsRegister here
 
26 May
09:00 EST
The Most Impactful Changes to the 2021 World Anti-Doping CodeCo-drafters of the Code:

Ulrich Haas, Professor of Procedural and Private Law, University of Zurich 

Richard Young, Partner, Bryan Cave Leighton Paisner, LLP
All stakeholdersRegister here
27 May
08:00 EST
The Athletes’ Anti-Doping Rights Act – How can Anti-Doping Organizations support its Implementation and PromiseBen Sandford, Lawyer, Sandford and Partners; and, WADA Athlete Committee Chair

Stuart Kemp, Deputy Chief Operating Officer, WADA
All stakeholdersRegister here 

WADA developed the CISP to help Code Signatories prepare for implementation of the 2021 Code and International Standards (Standards) that come into effect on 1 January 2021.

In addition to the CISP resources that are already available on WADA’s Anti-Doping eLearning platform (ADeL), including ‘pre-recorded’ webinars, on a monthly basis, WADA will also hold ‘live’ webinars, hosted by WADA personnel and external experts, to further support Code/Standard implementation efforts for targeted audiences and/or regions.

The Agency will also hold ‘live’ webinars in place of some of the sessions that would have otherwise been delivered during the Agency’s Annual Symposium, which was due to be held in March 2020 but was cancelled due to COVID-19. This includes the webinar referenced above on the Athletes’ Anti-Doping Rights Act; and, will include in particular another one that updates stakeholders regarding the redevelopment of the Anti-Doping Administration and Management System (ADAMS).

To register for any or all of the above webinars, please simply click on the Registration Links provided.

With the exception of the current month, going forward, every mid-month WADA will communicate its live webinar schedule for the following month, prompting stakeholders to register and participate.

Should you have any questions regarding the above, or specific questions or feedback related to the CISP, please contact WADA at: 2021CISP@wada-ama.org.

Thank you and best regards,

World Anti-Doping Agency


04/05/20 WADA’S 2021 CODE IMPLEMENTATION SUPPORT PROGRAM ‘GOES LIVE’

Montreal, 4 May 2020

Dear Colleagues,

Following on from the World Anti-Doping Agency’s (WADA’s) communication of 23 April, WADA is pleased to announce that its Code Implementation Support Program (CISP) is now officially ‘live’.

WADA developed the CISP to help World Anti-Doping Code (Code) Signatories prepare for implementation of the 2021 Code and International Standards (Standards) that come into effect on 1 January 2021.

CISP Resources available on ADeL

As of today, the following types of CISP resources are available via the Agency’s Anti-Doping eLearning platform (ADeL):

  • Factsheets
  • Video tutorials
  • Checklists
  • Presentations; and
  • Pre-recorded webinars

These resources are focused on understanding the main changes and what Signatories can do to implement the 2021 Code and Standards. To start with, resources will be offered in English with French and Spanish being made available in the coming months.

When visiting ADeL, which requires registration, Signatories can navigate via their role or via the Code or Standard and resources can be downloaded or shared with colleagues.

Our video below provides insight into what is available and how to access the resources when visiting ADeL.


WADA Director of Education, Amanda Hudson, said: “WADA is delighted to officially launch the Code Implementation Support Program to assist Signatories in implementing the 2021 Code and Standards.”

“Our Program, led by the Education Department, was developed by an internal multi-disciplinary project team including representatives from WADA’s Regional Offices. Collectively, the CISP project team has created a range of new resources for Signatories that we encourage anti-doping personnel to view and use. Beyond this, WADA, through this program, will continue to develop and provide information and resources for Signatories on ADeL. Our aim is to help Signatories implement the Code and Standards through material that is easy to understand and in an accessible format.”

Live Webinar Series

In addition to the CISP resources that are available on ADeL as of today, to further assist Signatories, WADA will hold a series of live webinars, hosted by WADA personnel and external experts, to support Code/Standard implementation efforts for targeted audiences and/or regions. The Agency will also host live webinars in place of some sessions that would have otherwise been delivered during the Agency’s Annual Symposium, which was due to be held in March 2020 but was cancelled due to COVID-19. These will include in particular a webinar on the Athletes’ Anti-Doping Rights Act; and, another that provides an update regarding the redevelopment of the Anti-Doping Administration and Management System (ADAMS).

Over the coming days, WADA will communicate its webinar schedule for May, prompting stakeholders to register and participate. Thereafter, the Agency will publish its schedule on a monthly basis.

Next steps in the CISP

The CISP team will now turn its attention to reviewing all existing WADA resources that are available for Signatories, ensuring that they are updated in line with the 2021 Code and Standards; after which, they will be made available via ADeL. This supports WADA’s aim of making ADeL the central educational resource center for Signatories – creating a ‘go to’ place for help and information.

Should you have any questions regarding the above, or specific questions or feedback related to the CISP, please contact WADA at: 2021CISP@wada-ama.org.

Thank you and best regards,

World Anti-Doping Agency


17/04/20 MAURITANIA BECOMES 189th COUNTRY TO RATIFY UNESCO ANTI-DOPING CONVENTION

Montreal, 17 April 2020 – The World Anti-Doping Agency (WADA) is pleased to announce that the Islamic Republic of Mauritania (Mauritania) has become the 189th State Party to ratify the UNESCO International Convention against Doping in Sport (UNESCO Convention). This leaves just six countries worldwide that have yet to complete their ratification of the UNESCO Convention.

WADA President Witold Bańka said: “WADA is pleased to welcome Mauritania into the Clean Sport Community. In ratifying this convention, it joins 98% of world governments that have already pledged their support to the anti-doping movement.

“We would particularly like to acknowledge the efforts that have been made by the Sports Minister of Mauritania to bring this to fruition. This is a positive step for sports in the country as it looks at further progressing its National Anti-Doping Organization while remaining an important member of Africa’s Zone I Regional Anti-Doping Organization. WADA remains committed to assisting and supporting Mauritania’s efforts to plan, develop and implement the necessary infrastructure for a sustainable and effective anti-doping program.”

The Convention, which was adopted on 19 October 2005, is the practical instrument by which governments formalize their commitment to the fight against doping. It allows governments to align their domestic policies with the World Anti-Doping Code, thus harmonizing the rules governing anti-doping in sport and public legislation. Under UNESCO standards, the Convention has set records in terms of the speed with which it was prepared, adopted and ratified.

See the list of countries that have ratified the UNESCO Convention.


09/04/20 WADA CELEBRATES ‘PLAY SAFE ON PLAY TRUE DAY 2020’ WITH THE GLOBAL CLEAN SPORT COMMUNITY

Montreal, 9 April 2020 – Today, the World Anti-Doping Agency (WADA) celebrates Play Safe on Play True Day 2020 with athletes, National and Regional Anti-Doping Organizations, Sports Federations, Major Event Organizers and other anti-doping stakeholders from the global Clean Sport community.

Since 2014, in April, WADA and the anti-doping community worldwide have celebrated ‘Play True Day — a day that is dedicated to Clean Sport and is intended to raise awareness among athletes, the sporting public and others about the importance of protecting Clean Sport. The inspiration for Play True Day stems from a WADA-hosted Education Conference in 2013, which was attended by 17 Latin American countries. While the celebration started as a small Latin American initiative, last year, the Agency’s digital and social media campaign reached over six million people with numerous individuals and organizations taking part from around the globe.

This year, given the impact that the COVID-19 pandemic is having around the globe, WADA seized the opportunity to engage the global anti-doping community – and all stakeholders in the fight to protect Clean Sport – in solidarity around the theme Play Safe on Play True Day 2020, asking them to participate in a digital and social media campaign by sharing what they are doing and why to curb the spread of the virus.

WADA President Witold Bańka said: “I wish to thank everyone who is taking part in raising awareness about the importance of Playing Safe for Play True Day 2020. This year’s campaign is once again reaching all corners of the globe, showing how we as the Clean Sport community are doing our part to fight COVID-19 and protect public health. WADA joins the world in navigating these uncertain times and in being grateful to the healthcare workers and all others who are working selflessly to help us navigate this difficult moment in history. We salute this global team effort on Play True Day and remain well prepared for the day when anti-doping efforts can return to full force.”

To participate

 WADA encourages its stakeholders to share personalized photo and video messages using specially-created branded frames and a Play Safe Pledge to show what particular cause, person or group of people they are playing safe for. The Agency also encourages the use of the hashtags #PlayTrue #PlaySafe and #PlayTrueDay in order to maximize the impact of the event on social media. All materials are available in English, French and Spanish.

To find out more about the events being promoted as part of Play Safe on Play True Day 2020, please visit the official Play True Day website and follow the campaign in real-time via our dedicated Play True Day social media wall.


03/04/20 WADA UPDATE ON AGENCY’S COMPLIANCE MONITORING ACTIVITIES IN LIGHT OF COVID-19

Montreal, 2 April 2020

Dear Colleagues,
[World Anti-Doping Code Signatories]

We at the World Anti-Doping Agency (WADA) hope that you and your families are staying safe and healthy during these difficult times as the impact of the COVID-19 pandemic continues to evolve globally. 

We are aware that COVID-19 has had a significant impact on anti-doping programs around the world, and in particular that testing has been significantly reduced or put on hold due to the cancellation of events; and, government and health authority measures including states of emergency and the lockdown of some countries. We have also been informed that many Anti-Doping Organizations (ADOs) are working remotely and continuing to do what they can under the circumstances.

In a similar fashion, WADA staff has operated from home for the past three weeks and will continue to do so until at least 1 May.  

As outlined in WADA’s 20 March ADO Guidance regarding COVID-19, the Agency fully acknowledges the complexities of this unprecedented situation and will ensure that its compliance monitoring program provides a level of flexibility and understanding based on the circumstances.

Following a conference call meeting of the Compliance Review Committee (CRC) on 30 March, a number of flexible measures were approved to reflect the various situations and stages of compliance that an ADO may be engaged in during the pandemic. These measures will be reviewed at the next CRC meeting in July; and, further guidance will be provided based on the status of the pandemic and the impact on each affected sport and country at that time.

In the coming days, the following World Anti-Doping Code (Code) Signatories will be informed individually by WADA that they are being afforded flexibility; and, about the next steps that have been agreed by the CRC.

  1. Those that currently have corrective actions where the deadline has already expired in March or is about to expire in April, May or June; and
  2. Those that are already in a compliance procedure.

For all other compliance matters where a Signatory may have been due to receive an Information Request (IR), Mandatory Information Request (MIR), a Corrective Action Report (CAR) as part of WADA’s continuous monitoring program or a CAR from a recently conducted in-person or desk audit, the content will be communicated to the ADO directly by the relevant WADA Regional Office.

Subject to the specifics of their corrective actions, WADA will encourage these Signatories to start implementing their corrective actions without any of the timelines outlined in the International Standard for Code Compliance by Signatories (ISCCS) being imposed. Following return to normal activities, Signatories will receive their CAR, which will reflect any non-conformities that they were able to address during the crisis period, as well as new timelines. The status of these flexible arrangements will be assessed by the CRC at its July meeting with due consideration of the evolution of the pandemic.   

On a related note, WADA is encouraged by the increase in the number of draft anti-doping rules that ADOs have submitted to the Agency for review over the past few weeks to align with the 2021 Code. We strongly recommend that ADOs that have not yet started working on their 2021 rules, do so. The implementation timeline of 1 January 2021 for the 2021 Code and International Standards remains in force.

Should you have any queries on the above, please do not hesitate to contact us at compliance@wada-ama.org.

We thank you for your ongoing efforts and collaboration in continuing to advance, where possible, anti-doping programs during these unprecedented times.

Sincerely,

World Anti-Doping Agency


31/03/20 WADA LAUNCHES STAKEHOLDER CONSULTATION PROCESS REGARDING TECHNICAL LETTER ON ETHYLMORPHINE

Montreal, 31 March 2020

Dear Colleagues,

The World Anti-Doping Agency (WADA) invites stakeholders to participate in a consultation process regarding the new Technical Letter TL22 – Ethylmorphine. This document includes guidance regarding the detection of the threshold substance morphine at a concentration higher than the Decision Limit in urine samples, which may result from the administration of the permitted drug ethylmorphine.

Stakeholders are invited to review this Technical Letter and provide comments by 10 April 2020, using WADA’s online consultation platform, WADAConnect.

Under the International Standard for Laboratories (ISL), WADA’s Technical Letters provide specific direction to WADA-accredited laboratories; WADA-approved laboratories for the Athlete Biological Passport; and, other stakeholders on particular issues regarding the analysis, interpretation and reporting of results for specific Prohibited Substance(s) and/or Prohibited Method(s) or on the application of specific laboratory procedures.

For any questions related to the above, we invite you to contact science@wada-ama.org.

We thank you in advance for your feedback.

Best regards,

World Anti-Doping Agency


31/03/20 WADA REMOVES INTERNATIONAL TAEKWONDO FEDERATION FROM WORLD ANTI-DOPING CODE NON-COMPLIANT LIST

Montreal, 31 March 2020 – The World Anti-Doping Agency (WADA) announces that, following a circular vote of its Executive Committee (ExCo), the Agency has today removed the International Taekwondo Federation (ITF) from the list of Signatories that are non-compliant with the World Anti-Doping Code.

The ITF was asserted non-compliant by WADA’s ExCo at its meeting of 23 September 2019, and this non-compliance became effective on 15 October 2019 after the ITF chose not to challenge the assertion of non-compliance, which was based on its failure to report to WADA on compliance by completing and submitting its Code Compliance Questionnaire (CCQ).

Since then, the ITF has implemented the corrective measure required to address its non-compliance, namely the completion and submission of the CCQ to WADA. A Corrective Action Report will be issued shortly by WADA following the review of the responses provided in the CCQ and the federation will be advised that continued cooperation will be required in order to maintain its compliant status.

[Please note that the ITF is not World Taekwondo, which is the Olympic federation for the sport of Taekwondo. ITF is a Signatory to the Code but is not recognized by the International Olympic Committee or the Global Association of International Sports Federations. There are currently three Code Signatory International Federations (IFs) for the sport of Taekwondo – World Taekwondo and two other IFs, both of which are called International Taekwondo Federation or ITF. The IF in this case is the ITF based in Austria. The two IFs called International Taekwondo Federation became Signatories to the Code prior to the adoption by WADA’s Executive Committee of a policy setting the conditions to be fulfilled by new organizations that wish to become Signatories.]


30/03/20 WADA PUBLISHES MEMBERSHIP OF STANDING COMMITTEES FOR 2020

Montreal, 30 March 2020 – Today, the World Anti-Doping Agency (WADA) publishes the membership of WADA’s five Standing Committees for 2020, which was recently confirmed by the Agency’s Executive Committee (ExCo) via circulatory voting. 

  1. Athlete Committee   
  2. Compliance Review Committee
  3. Education Committee
  4. Finance and Administration Committee     
  5. Health, Medical and Research Committee  

WADA President Witold Bańka said: “WADA is very grateful to the dozens of very able volunteers who provide their time and expertise to the Agency’s Standing Committees. The Committees play a key advisory role in policy and priority development for the Agency. The members’ commitment in applying their competencies is crucial to advancing the Agency’s mission as the leader of Clean Sport.”
 
The Standing Committee Chairs were appointed on 23 January 2020; and, following these appointments, the Committee memberships were then proposed to the ExCo for their approval, with new members taking office on or before 1 March.
 
In accordance with WADA’s Statutes concerning Standing Committee composition and rotation, on an annual basis, the Agency seeks nominations from its stakeholders for candidates to fill vacancies. The next call for vacancies (for 2021) will be released in May 2020.


27/03/20 WADA PUBLISHES INDEPENDENT OBSERVER TEAM REPORT FROM 2019 PAN AMERICAN GAMES

Montreal, 27 March 2020 – The World Anti-Doping Agency (WADA) has published its Independent Observer (IO) Team’s Report regarding the anti-doping program at the 2019 Pan American (Pan Am) Games held in Lima, Peru, from 26 July to 11 August 2019.

As it has done for many major events since 2000, WADA sent a team to monitor the anti-doping program that was run by Pan Am Sports and the Lima 2019 Organizing Committee with the aim of reinforcing confidence in athletes and the public as to the quality, effectiveness and reliability of the Games’ anti-doping program.

In addition to collaborating with Pan Am Sports and the Lima 2019 Organizing Committee, and providing general support prior to the Games, the team also provided real-time feedback during the Games designed to optimize the efficiency and effectiveness of the program in compliance with the World Anti-Doping Code and International Standards.

Led by Ilaria Baudo, WADA Senior Manager, Standards and Harmonization, the four-person team was composed of experts in anti-doping from across the Americas who observed and provided feedback on all aspects of doping control. This included the implementation of general anti-doping policies and procedures; test distribution planning; implementation of the out-of-competition and in-competition testing programs; athlete selection and notification for testing; Therapeutic Use Exemptions procedures; sample collection procedures; the transport of samples and their chain of custody; and, the results management process – including hearings that were held during the IO Team’s presence.

Ms. Baudo said: “The WADA Independent Observer team would like to commend Pan Am Sports and the Lima 2019 Organizing Committee for the anti-doping program put in place during the 2019 Pan American Games. The organizers made particular efforts to increase risk-based and out-of-competition testing in the lead-up to the Pan Am Games, as well as implement recommendations made by the IO Team throughout the course of the Games. These efforts ensured both the effectiveness and integrity of the anti-doping program being implemented. We would particularly like to thank Dr. Bernardo Chernilo, President of the Medical Commission of Pan Am Sports, and its members, and Dr. Victor Carpio, Chief Executive Officer of the Comisión Nacional Antidopaje de Perú (CONAD), and his team, who were key to the success of the program.”

As is the case following all IO Team missions, the report includes a number of recommendations for Pan Am Sports and WADA itself – all designed to enhance anti-doping activities at future Games.


26/03/20 WADA PUBLISHES FIRST CODE COMPLIANCE ANNUAL REPORT

Montreal, 26 March 2020 – Today, the World Anti-Doping Agency (WADA) published its first-ever World Anti-Doping Code (Code) Compliance Annual Report for 2019 (Report), as well as WADA’s accompanying Compliance Strategy that was endorsed by WADA’s Executive Committee in late 2019(1).
 
One of WADA’s primary roles as the global regulatory body for anti-doping is to monitor effective implementation of the Code and its six(2) related International Standards (Standards) by over 350 Anti-Doping Organizations (ADOs) such as, National Anti-Doping Organizations (NADOs), International Federations (IFs) and Major Event Organizations.

WADA’s Chief Operating Officer, Frédéric Donzé, who oversees the Agency’s compliance activities, said: “WADA is pleased to publish its first-ever Compliance Annual Report for 2019. This Report is an element of the new Compliance Strategy and another important piece of WADA’s commitment to transparency. Among other objectives, the Report is intended to clearly outline the achievements and challenges of WADA’s Compliance Monitoring Program, which aims to reinforce the standard of Code Signatory organizations’ work worldwide.”   
 
Key findings of Signatory compliance monitoring for 2019
 
As outlined in the 26-page Report, the key findings of Signatory compliance monitoring for 2019 include the following:

  • WADA operated its compliance activities under the International Standard for Code Compliance by Signatories (ISCCS) and the accompanying Prioritization Policy for its first full year following its coming into force in April 2018.
     
  • Significant, high-profile, WADA-led investigations have contributed to a number of compliance activities by WADA departments, Standing Committees and governing bodies. In particular, the Russian investigation has required an unprecedented amount of human and financial resources.
     
  • WADA now has at its disposal a number of effective and robust compliance monitoring programs. In 2019, WADA launched three new compliance monitoring programs – the Major Event Organization (MEO) Code Compliance Questionnaire (CCQ), the Continuous Monitoring Program, and the Desk Audit Program.
     
  • Over 3,000 corrective actions were implemented by Signatories in 2019 with testing identified as the main source of non-conformities. Strategies have been developed to assist Signatories, including through a number of easy to use templates and checklists that are available on WADA’s Anti-Doping e-Learning platform (ADeL).
     
  • Unsurprisingly, a clear link between improving the quality of testing programs and financial resources has been identified. A better understanding of costs associated with quality testing programs is required to assist Signatories to increase their budgets and resources.
     
  • The creation of the International Testing Agency (ITA) – which is working with a growing number of IFs – and the implementation of partnerships between developed and developing NADOs have significantly contributed to the compliance of the relevant Signatories’ activities.

About the Report

The purpose of the Report is, in particular, to:

  • Provide a clear and integrated report outlining the achievements and challenges of the Compliance Monitoring Program, measuring objectives against key performance indicators through quantitative and qualitative analysis including areas for improvement.
     
  • Detail the interpretation and implications of the findings, trends and lessons learned over time towards ADO’s compliance maturity as defined in the Compliance Strategy.
     
  • Identify opportunities for continual improvement that will be the foundation for the following year’s Compliance Annual Plan. This cycle will be repeated annually as WADA seeks to develop compliance maturity through continual improvement of its own compliance activities and the global anti-doping system.

 Notes: 

(1) In light of the evolving situation with COVID-19, WADA and Anti-Doping Organizations (ADOs) worldwide are adjusting the way in which they conduct their daily anti-doping operations. Following consultation with ADOs and other stakeholders, on 20 March, WADA issued ADO Guidance, which is aimed at ensuring the health and safety of athletes and all those that are touched by anti-doping operations; and, protecting the integrity of the global anti-doping system. The Agency is conscious of the fact that COVID-19 will have impacts on the Compliance Strategy and Annual Plan referenced above, as well as on the conduct of anti-doping programs by Signatories worldwide, which will be monitored and considered accordingly. WADA’s Compliance Monitoring Program provides a level of flexibility and understanding based on the circumstances.
 
(2) Two additional Standards – on education and on results management – will be introduced in January 2021.


25/03/20 WADA WELCOMES DISMISSAL OF RUSSIAN CYCLISTS’ LAWSUIT

Montreal, 25 March 2020 – The World Anti-Doping Agency (WADA) welcomes the recent decision by the Superior Court of Justice of Ontario, Canada, dismissing a lawsuit commenced by three Russian cyclists against WADA and Canadian Professor Richard H. McLaren, O.C.

The cyclists claimed damages they alleged to have suffered as a result of their exclusion from the 2016 Rio Olympic Games by the International Olympic Committee (IOC). Specifically, they claimed that they were excluded from the Games as a result of the findings made by Professor McLaren in the Independent Person Report, commissioned by WADA, which considered allegations of widespread doping and manipulation of doping controls within Russia.

In response to the filing of the claim, WADA and Professor McLaren successfully brought motions for summary judgement dismissing the cyclists’ claim. The summary judgment motions were heard before the Hon. Justice Faieta in Toronto on 16 May 2019 and a ruling was issued on 11 February 2020. In granting summary dismissal, the court ruled that the issues raised by the Russian cyclists were essentially sports-related matters that fell within the exclusive jurisdiction of, and had to be resolved by, the Court of Arbitration for Sport (CAS) in Lausanne, Switzerland. The court also held that the filing of the claim in Ontario was an abuse of process.

Specifically, the Hon. Justice Faieta held: “This was a dispute that the plaintiffs placed before the CAS for adjudication. Having failed to obtain a declaration from the IOC that they be granted entry to Rio 2016, the plaintiffs should not be permitted to re-litigate the factual matrix of this dispute in this court by dressing up it up as a tort claim.”

He added: “To allow this action to proceed would undermine the Olympic Movement and, in particular, the dispute resolution provisions found in the Olympic Charter by signaling to the international community that domestic courts are willing to entertain disputes that, at their core, are matters connected to the Olympic Games that should be determined exclusively by a specialized tribunal in accordance with the provisions of the Olympic Charter or other provisions approved by the IOC.”

WADA Director General Olivier Niggli said: “WADA welcomes the decision to dismiss this claim. It is an important ruling that upholds CAS decisions, which are accepted and supported by the entire sports movement. This judgement rightly closes the door on attempts to re-litigate matters through the filing of domestic claims.”

“I am pleased that this case is over. Our investigation was thorough, professional and our findings were beyond question,” said Professor McLaren, who teaches law at Western University in Ontario. “CAS is an independent institution specifically set up to resolve sports-related disputes. The plaintiffs’ claims always belonged there for resolution. Not in the provincial court system.”

Legal costs and disbursements were also awarded in favor of WADA and Professor McLaren. The appeal period has expired and this matter is at an end.


24/03/20 WADA STATEMENT ON OLYMPIC AND PARALYMPIC GAMES TOKYO 2020 POSTPONEMENT

Montreal, 24 March 2020 – The World Anti-Doping Agency (WADA) supports the sensible decision of the International Olympic Committee (IOC) and the Tokyo 2020 Organizing Committee to postpone the Tokyo 2020 Games until next year.

WADA President Witold Bańka said: “The health and safety of the athletes remains the number-one priority for WADA and the anti-doping community, and it is clear that the correct decision has been taken in this challenging and unprecedented situation. As we all come to terms with the impact of this pandemic, it is clear that there are a number of challenges being faced related to the testing of athletes at this time. We will continue to monitor that situation to mitigate the effect of any interruptions to the program.”

As outlined in recent days, WADA is working closely with Anti-Doping Organizationsathletes and other stakeholders to ensure the integrity of the global anti-doping program is maintained as far as possible during this time and to ensure that the system returns to full power as quickly and effectively as possible once this crisis has abated. With an eye on 2021, WADA looks forward to collaborating with the IOC, the International Paralympic Committee, the local organizing committee and others to plan activities related to the Olympic and Paralympic Games, including pre-Games testing, education, the Independent Observer program and athlete outreach, which were in place for the 2020 Games that will now also be postponed. 


23/03/20 WADA RESPONDS TO ATHLETE QUERIES CONCERNING ANTI-DOPING IN LIGHT OF COVID-19

Montreal, 23 March 2020 – Today, the World Anti-Doping Agency (WADA) responded to athlete queries concerning anti-doping in light of the ongoing COVID-19 pandemic by publishing a Question and Answer (Q&A) document that it developed in consultation with its Athlete Committee. This follows on from WADA’s COVID-19 guidance that was issued on 20 March to Anti-Doping Organizations (ADOs) worldwide.
 
WADA President Witold Bańka said: “WADA and the global anti-doping community are prioritizing public health, safety and social responsibility. As we continue to meet the challenges of this pandemic, the health of athletes and all those involved in clean sport, will continue to be front-of-mind.
 
“WADA acknowledges how difficult this situation has been and will continue to be for athletes as they deal with the strict measures that have been put in place around the world, which are disrupting their training programs and creating uncertainty as to what is in store for their upcoming competitions. The anti-doping community has banded together to adjust its daily operations by suspending or reducing some of its programs, including testing and other activities. As difficult as this is for everyone, we must stay strong. We will get through this situation and everyone hopes that we can return the global anti-doping system to full power as soon as we emerge.”
 
Chair of the WADA Athlete Committee Ben Sandford said: “In these difficult times, we must all do our part to stay safe, keep others safe and look out for each other. We are athletes, but first of all we are human. It is important that we listen to our government health authorities and do our part to minimize the likelihood of transmission and impact on society. The situation clearly goes well beyond anti-doping and sport and this document is designed to address some specific concerns that athletes may have right now as we navigate the path ahead.
 
“Athletes should be aware that testing can continue where appropriate, where possible and with the necessary health and hygiene protocols in place. It is important to ensure the integrity of the overall system is maintained as much as possible. WADA will continue to identify any gaps in the program and advise relevant ADOs accordingly so that they can adjust their testing programs going forward.”
 
The Q&A covers issues such as:

  • Ongoing testing
  • Minimizing the risk of contracting or transmitting the virus
  • Filing of whereabouts information
  • Validating Therapeutic Use Exemptions
  • Maintaining the integrity of the anti-doping system
  • Refusing to comply with testers at this time

WADA will continue to liaise with athletes and ADOs in the interest of publishing updates regarding the Agency’s response to COVID-19 as the situation evolves.


20/03/20 WADA ISSUES ADO GUIDANCE IN CONNECTION
WITH COVID-19

Montreal, 20 March 2020

Dear Colleagues,
[Anti-Doping Organizations]

Since the World Anti-Doping Agency (WADA) last communicated to Anti-Doping Organizations (ADOs) on the matter of testing on 6 March, the SARS-Cov-2 (COVID-19) pandemic has continued to evolve into an even greater health and societal emergency that requires effective action by everyone around the world to minimize the likelihood of transmission and the impact on society.

WADA is monitoring the situation based on expert information from the World Health Organization and from other reliable sources. Most countries are putting strict measures in place, which include border closures, quarantine/self-isolation, cancellation of flights, social movement restrictions, etc. As a result, many sporting events have been cancelled or postponed. This has forced WADA and its stakeholders to adjust daily operations by instituting teleworking; and, in the case of many ADOs, suspending or reducing doping control programs (including testing and other activities).

Following the advice of government and health authorities

Throughout, the Agency has been urging all ADOs to follow the advice of government and health authorities to ensure proper protection of athletes and doping control personnel, while protecting the integrity of doping control programs, particularly in the lead-up to the 2020 Tokyo Olympic and Paralympic Games. 

This remains the aim, and WADA’s vision of a world where all athletes can compete in a doping-free sporting environment remains the same. However, we all agree that the protection of public health must take precedence; and so, we must put stronger measures in place as a global anti-doping community.

In keeping with governmental measures that have been, and are being, put in place around the world, WADA has evaluated the global anti-doping program in collaboration with ADOs, including National Anti-Doping Organizations (NADOs), International Federations (IFs), Major Event Organizations (MEOs); and, other organizations such as the International Testing Agency (ITA) –— which is leading the pre-Tokyo 2020 Olympic Games Task Force on behalf of the International Olympic Committee (IOC) –— as well as laboratories to determine how we, as a community, can best operate in this challenging environment.

Prioritizing health and safety for all

We are grateful to ADOs that have outlined how they are being impacted and what measures they are putting in place. Given the differences specific to each country, it is difficult to establish one overarching set of recommendations or guidelines. However, based on information and experience to date, WADA is recommending that ADOs consider the following ‘Guidance’ regarding key elements of the World Anti-Doping Program.

It is important to remember that, first and foremost, ADOs should follow the recommendations (or requirements) of their national government and health authorities related to all activities. If this information is not available, then ADOs may want to approach their government authorities to seek their guidance. While ADOs may be adjusting their operations given COVID-19, athletes continue to remain subject to all provisions of the World Anti-Doping Code and must comply accordingly.

Our overarching priority remains the same –— to ensure the health and safety of athletes and all those that are touched by our community’s operations. In order to do this and protect the integrity of the global anti-doping system, we must endeavor to take a coherent approach across the system, which demonstrates solidarity among the community; and, aims to give athletes confidence that they remain at the core of our mission. 

Accordingly, WADA encourages open and continuous dialogue amongst all its stakeholders so that we can continue to monitor and adjust. Should you have questions or concerns, please feel free to contact your respective WADA contact in Montreal or in one of the Agency’s regional offices. The Agency commits to support and communicate as required as we in the Clean Sport community navigate these difficult times together.

Best regards and stay healthy,

World Anti-Doping Agency


20/03/20 WADA UPDATES ITS COVID-19 GUIDANCE FOR ANTI-DOPING ORGANIZATIONS

Montreal, 20 March 2020 – The World Anti-Doping Agency (WADA) has issued updated guidance for Anti-Doping Organizations (ADOs) in light of the ongoing COVID-19 pandemic.

WADA developed the guidance following consultation with ADOs, including National Anti-Doping Organizations (NADOs), International Federations and Major Event Organizations as well as other organizations, such as the International Testing Agency (which is leading the pre-Tokyo 2020 Olympic Games Task Force on behalf of the International Olympic Committee) and accredited laboratories, to determine how the anti-doping community can best operate in this challenging environment.

The guidance was refined following a teleconference meeting today of the WADA NADO Advisory Group, which provides expert advice in promoting effective doping control strategies and plans.

The updated ADO guidance covers a number of areas that may be affected by COVID-19, including the provision of whereabouts information, sample collection and transport to laboratories, sample analysis, education programs, investigations, result management, therapeutic use exemptions, compliance and other activities and obligations covered by the World Anti-Doping Program. While the document provides guidance specific to athletes, WADA is developing another resource that will address some specific concerns raised by athletes, which we aim to publish early next week and which will be adapted over time.

At a time when most countries are putting in place strict measures, this new situation for all is undoubtedly affecting the anti-doping system. Border closures, mandatory quarantines or isolations, cancellations of flights, social movement restrictions, office closures and cancellation of sporting events are all hindering the normal day-to-day work of those involved in anti-doping.

WADA President Witold Bańka said: “The sports world is dealing with an unprecedented situation. COVID-19 has forced all anti-doping stakeholders, including WADA, to adjust the way daily operations are conducted. But this matter goes way beyond anti-doping and sport – it is a global emergency – and our first priority must be public health, safety and social responsibility.

“As we have done throughout this global crisis, WADA will continue to liaise with ADOs, providing leadership and support so that the health of all concerned can be protected and the integrity of the world anti-doping system can be maintained as much as possible. It will also be crucial that the system can return to full power as quickly as possible once the various restrictions are lifted.

“During this time, I would like to acknowledge how difficult it is for athletes, too, who face disruptions to their training programs and uncertainty as to what the future holds for their competitions.”

WADA Director General Olivier Niggli said: “WADA has developed this guidance in collaboration with, and with the support of ADOs and other key stakeholders, understanding that these are difficult times for sport. ADOs must, in the first instance, follow the directives and advice of their respective governments and health authorities in order to play their part in preventing the further spread of the virus. Athletes and everyone else involved in the anti-doping system can be assured that their health is our number-one concern.

“Athletes should also bear in mind that testing will continue only where appropriate and possible and, at this time, with the necessary health and hygiene protocols in place. The situation is changing every day.

“However, there are a number of other tools that are available to assist us in protecting clean sport during periods of limited testing. The Athlete Biological Passport, in particular, will continue to be an important program for us in the coming weeks and months, together with the long-term storage of samples collected before, during and after the pandemic, as well as the collection and review of any intelligence received that could lead to target testing, specific analysis or the opening of an investigation.”

WADA will continue to work closely with all ADOs to monitor anti-doping program implementation and encourages ADOs to continue to advise the Agency of any amendments that they are making to their wider programs so that WADA can coordinate, advise and assist as necessary.

Where it has been determined that there has been an absence or diminished level of testing on athletes in areas of higher risk, this information will be conveyed to ADOs that would benefit from such information so they can adjust their testing programs accordingly going forward. 

WADA will continue to publish updates regarding its response to COVID-19 as the situation evolves.


16/03/20 WADA UPDATE REGARDING ACCREDITED AND APPROVED LABORATORIES IN LIGHT OF COVID-19

Montreal, 16 March 2020

Dear Colleagues,
[Anti-Doping Organizations and Laboratories]

In connection with the COVID-19 pandemic, the World Anti-Doping Agency (WADA) wishes to share some important information regarding WADA-accredited laboratories as well as those approved by WADA for blood analysis in connection with the Athlete Biological Passport.
 
Last week, four accredited laboratories, in Rome (Italy), Montreal (Canada), Madrid and Barcelona (Spain), indicated they were temporarily suspending operations due to the ongoing crisis. WADA anticipates that more laboratories, particularly in Europe, may follow suit.
 
WADA has been in touch with all four laboratories to ensure that the integrity of the anti-doping samples is maintained during this period of closure. To that end, any laboratory that makes the decision to suspend activities must:Inform its clients immediately of this decision and instruct them not to deliver any more samples for analysis if samples cannot be properly handled and stored.Establish a procedure whereby samples that are already on their way to the laboratory can be securely received and either redirected to another accredited laboratory or safely stored frozen for when the laboratory’s analytical activity resumes.Devise a strategy for safe analysis of the samples once normal activities resume, bearing in mind that some of the thawed samples may contain the virus.In addition, WADA kindly asks Anti-Doping Organizations (ADOs) not to send samples to laboratories that have suspended operations until further notice (unless specifically requested to do so by the laboratory itself) and check with other laboratories in advance to make sure they are still accepting samples for analysis.
 
ADOs should refer to the Accredited Laboratories section of WADA’s website where the Agency will publish similar disruptions as the situation evolves.
 
WADA will continue to monitor this exceptional situation closely and make the necessary decisions and recommendations that will prioritize the health of all those involved in the protection of clean sport. Laboratories are encouraged to advise WADA of any amendments they are making to their activities so that WADA can coordinate, assist and advise the anti-doping community as necessary.
 
Thank you for your cooperation and best regards,
 
World Anti-Doping Agency

12/03/20 WADA CALLS ON US SENATE TO CONSIDER WIDELY HELD CONCERNS ABOUT RODCHENKOV ACT

Montreal, 12 March 2020 – The World Anti-Doping Agency (WADA) notes the decision by the United States Senate Committee on Commerce, Science and Transportation to approve the Rodchenkov Anti-Doping Act of 2019 for referral to and consideration by the US Senate.

WADA will continue to work with US authorities to provide information as needed and to explain some important reservations that a number of other Governments, sports organizations and Anti-Doping Organizations (ADOs) share about the bill as it is currently drafted. To that end, WADA has repeatedly reached out to the Chair of the Committee to arrange such a meeting but, to date, no response has been received from his office.

WADA supports Governments using their legislative powers to protect clean athletes in the fight against doping and the Rodchenkov Act is no exception. Specifically, WADA considers positive the proposed measures outlined in the bill to assist anti-doping by facilitating the sharing of information between US law enforcement entities and the United States Anti-Doping Agency and by providing protection to whistleblowers.

However, some other very important elements of the bill will, if approved with no changes, have unintended consequences that have the potential to disrupt the globally recognized legal anti-doping framework and to undermine WADA’s capacity to fulfill its mission as the global anti-doping regulator. WADA and many other organizations around the world, including the Council of Europe and the International Olympic Committee, have a concern around the issue of extra-territoriality in the bill.

WADA President Witold Bańka said: “WADA calls on the US Senate to consider widely held and legitimate concerns about the Rodchenkov Act. The bill in its current form could lead to overlapping laws in different jurisdictions that would compromise having a single set of rules for all athletes, all sports and all anti-doping organizations that are subject to the World Anti-Doping Code. This harmonization of rules is at the very core of the global anti-doping program.

“A second unintended consequence is rather than assisting WADA and law enforcement engage whistleblowers as the legislation intends, the bill will actually impede the capacity to use whistleblowers by exposing them to multiple jurisdictions and preventing ‘substantial assistance’ deals. This will thus greatly compromise WADA’s and other ADOs’ investigation capacity. 

“A third unintended consequence could be the emergence of other extra-territorial jurisdictions worldwide and their misuse for purposes other than anti-doping, for example to discriminate against athletes of specific nationalities. This would likely lead to retaliation by stakeholders concerned and set off a chain reaction, which would be detrimental to anti-doping and athletes from all countries, including the US.”

WADA wishes also to understand, if, as claimed by its promoters, the stated aim of the legislation is to protect athletes, why it excludes vast areas of US sport, in particular the professional leagues and all college sport.


09/03/20 WADA ADVISORY REGARDING TESTING WORLDWIDE IN LIGHT OF THE COVID-19 VIRUS

Montreal, 6 March 2020

Dear Colleagues,

In connection with the Covid-19 virus, following the World Anti-Doping Agency’s (WADA’s) 21 February 2020 announcement concerning testing of Chinese athletes; and, WADA’s 28 February announcement that it was cancelling its Annual Symposium in Lausanne, the Agency wishes to share additional important and relevant information with the anti-doping community as it relates to anti-doping activity world-wide in light of Covid-19. 

WADA continues to monitor the situation closely with particular regard to how the virus may impact the conduct of testing activity. To that end, WADA encourages all Anti-Doping Organizations (ADOs) to follow the advice of local health authorities to ensure proper protection of athletes and doping control personnel alike. WADA urges ADOs to prioritize health and safety while protecting the integrity of robust doping control programs, which are of paramount importance in the lead-up to the Tokyo Olympic and Paralympic Games.

To support this important balance as the situation develops, WADA will monitor testing activity in affected regions closely to detect any possible testing ‘gaps’ which may need to be addressed. If it is determined, for example, that there has been an absence or diminished level of testing on athletes in higher risk areas, this information will be conveyed to the International Olympic Committee, the International Paralympic Committee, as well as any other ADO with a major event in the coming months that would benefit from such information to adjust their testing programs accordingly. This includes the Pre-Olympic Games Task Force being led by the International Testing Agency (ITA).

WADA will continue to monitor this exceptional situation closely and make the necessary decisions and recommendations that will prioritize the health of all those involved in the protection of clean sport. WADA encourages ADOs to advise WADA of any amendments they are making to their testing programs so that WADA can coordinate and assist as necessary.

Thank you for your cooperation and best regards,

World Anti-Doping Agency


06/03/20 WADA ANNOUNCES THAT THE MEXICO CITY LABORATORY HAS CEASED OPERATIONS

Montreal, 5 March 2020 – The World Anti-Doping Agency (WADA) announces that the Laboratorio Nacional de Prevencion y Control del Dopaje-CONADE – the WADA-accredited Laboratory in Mexico City, Mexico (the Laboratory) – has ceased operations; and therefore, is no longer conducting anti-doping analyses as a WADA-accredited Laboratory.

While the Laboratory ceased its operations effective 15 November 2019, this official WADA announcement follows weeks of sustained efforts by the Agency to inform the Mexican Public Authorities of the benefits of maintaining an accredited Laboratory in Mexico.

WADA is satisfied that, in accordance with the International Standard for Laboratories (ISL), the Laboratory took all necessary measures to notify its clients of its decision to cease operations and assist all relevant Testing Authorities with the transfer of samples, where required, to another WADA-accredited Laboratory. Throughout, WADA monitored the measures taken by the Laboratory in regard to the above ISL requirements in order to ensure continued high-quality sample analysis and storage of samples, and to preserve athletes’ confidence in this process and the wider anti-doping system.

In accordance with the ISL, WADA is responsible for accrediting and re-accrediting anti-doping Laboratories, thereby ensuring that they maintain the highest quality standards. This monitoring process is conducted in compliance with ISO 17025 Standard assessment and in conjunction with independent national accreditation bodies that are full members of the International Laboratory Accreditation Cooperation (ILAC).


05/03/20 WADA UPDATE REGARDING COURT OF ARBITRATION FOR SPORT PROCEEDINGS TO RESOLVE RUSADA NON-COMPLIANCE DISPUTE

Montreal, 5 March 2020

Dear Colleagues,

The World Anti-Doping Agency (WADA) understands that stakeholders wish to be kept informed as it relates to WADA’s 9 January 2020 request to the Court of Arbitration for Sport (CAS) to resolve the dispute related to the non-compliance case against the Russian Anti-Doping Agency (RUSADA). On 9 December 2019, WADA’s Executive Committee (ExCo) unanimously endorsed the recommendation made by the Agency’s independent Compliance Review Committee (CRC) that RUSADA be declared non-compliant with the World Anti-Doping Code (Code) for a period of four years.
 
While WADA appreciates the desire for more information given the potential impact that the CAS proceedings’ outcome will have on sporting events, the matter is in the hands of CAS; and, under Article R43 of the CAS Code rules, the parties, the arbitrators and CAS must not disclose to any third party any facts or other information relating to the dispute or the proceedings without the permission of CAS. Therefore, the Agency simply cannot comment further. However, please rest assured that WADA is committed to an efficient resolution of the proceedings.
 
The request for arbitration in RUSADA’s case was filed in accordance with the process outlined in the International Standard for Code Compliance by Signatories (ISCCS, Article 10.4.1) and it will be resolved by the CAS Ordinary Arbitration Division. In accordance with Article 23.5.9 of the Code, any CAS decision in relation to the non-compliance, the proposed consequences and/or the proposed reinstatement conditions will be binding and must be recognized and enforced by all Code Signatories.

Best regards,

World Anti-Doping Agency

04/03/20 WADA LAUNCHES ONLINE APPLICATION SYSTEM FOR ANTI-DOPING ORGANIZATIONS TO APPLY FOR FLEXIBILITY IN THE IMPLEMENTATION OF THE TECHNICAL DOCUMENT FOR SPORT SPECIFIC ANALYSIS (TDSSA) MINIMUM LEVELS OF ANALYSIS

Montreal, 4 March 2020

Dear Colleagues,

The World Anti-Doping Agency (WADA) is pleased to announce that – further to the amendments made to the Technical Document for Sport Specific Analysis (TDSSA) following the stakeholder consultation process conducted in 2019 – it has developed an online application system for Anti-Doping Organizations (ADOs) to apply for flexibility in the implementation of the Minimum Levels of Analysis (MLAs) for the sports and disciplines contained within the TDSSA. 

An ADO can qualify for flexibility in the implementation of the TDSSA MLAs based on the following two scenarios:

  • The implementation of a haematological module of the Athlete Biological Passport (ABP); and
  • Other non-ABP related criteria e.g. prioritization of target testing, collaboration with other ADOs, use of intelligence in the implementation of an ADO’s anti-doping program, etc*.

The application process is located within the Code Compliance Center (CCC – previously the Code Compliance Questionnaire) platform through which ADOs are required to answer a number of questions against set criteria (listed in Article 6 of the TDSSA) as well as upload supporting documents – including their Risk Assessments, Test Distribution Plans and Registered Testing Pools. On completion of the application, and based on the answers to the questions, ADOs will receive a pre-approved level of flexibility (up to a maximum of 50%) for the implementation of the MLAs for the sports or disciplines they seek flexibility for. This pre-approved flexibility is subject to review by WADA. 

ADOs that are interested in applying for flexibility in the implementation of the MLAs should contact WADA to outline their intentions at tdssa@wada-ama.org. WADA will subsequently open access to the online application by sending an “Invitation Notification” to interested ADOs. For more information, ADOs are encouraged to read the Application for Flexibility User Guide before contacting WADA.

Revised TDSSA Testing Guides

To further support implementation of version 5.0 of the TDSSA, WADA would like to remind ADOs to utilize the updated Testing Guides for Erythropoiesis Stimulating Agents (ESAs)Growth Hormone (GH) and Growth Hormone Releasing Factors (GHRFs). ADOs are encouraged to consult these Guides to support their testing strategies when applying analysis for these categories of substances within the scope of the TDSSA.

Should you have any questions relating to the above, please do not hesitate to contact tdssa@wada-ama.org.

Best regards,

World Anti-Doping Agency


03/03/20 WADA COMPLIANCE – RAISING THE STANDARD OF ANTI-DOPING ORGANIZATIONS’ WORK WORLDWIDE

WADA’s role as the global regulatory body
 
WADA’s primary role as the global regulatory body is to develop, harmonize and coordinate anti-doping rules and policies across all sports and countries. Accordingly, one of the Agency’s main responsibilities is to ensure and monitor effective implementation of the Code and its six* related International Standards (Standards).
 
While it is a challenge for WADA to draft and then agree the Code and Standards with its almost 700 Signatories worldwide – which includes in particular National Anti-Doping Agencies (NADOs), International Federations (IFs) and Major Event Organizations (MEOs) – ensuring that these Signatories comply with the rules is a whole other challenge.
 
WADA’s Compliance Monitoring Program
 
Prior to 2016, WADA wanted to ensure that Signatories implemented the Code and Standards into their rules, regulations, legislation and programs. In 2016, WADA re-focused its efforts on ensuring that Code Signatories not only had compliant rules in place but that they were also implementing compliant anti-doping programs, which WADA could monitor.
 
To do so, WADA initiated development of an ISO-certified Code Compliance Monitoring Program, which aims to reinforce athlete and public confidence in the standard of ADOs’ work worldwide.
 
In terms of Program governance, it includes an external, independent Compliance Review Committee (CRC) and an internal Compliance Taskforce (Taskforce). The CRC provides expert advice, recommendations and guidance to WADA’s Executive Committee, Foundation Board and Taskforce on individual cases and compliance activities. It includes an independent Chair, two compliance experts from non-sporting areas, an athlete representative, a government representative and a Sport Movement representative. The Taskforce consists of an internal working group of WADA staff from different departments and offices whose activities are centralized and coordinated. If any non-conformity is identified, the Taskforce facilitates an open dialogue with the Signatory concerned and recommends corrective actions. Support and assistance are provided to help the Signatory address all non-conformities within an agreed timeframe.
 
The Program includes the following four components:
 

  1. The Code Compliance Questionnaire was launched in 2017 as a tool to measure compliance of Signatories against the mandatory requirements of the Code and Standards. WADA reviews all returned questionnaires and develops detailed corrective action plans designed to assist Signatories in enhancing their anti-doping programs. The next questionnaire is planned for 2022.
  2. Audits, which WADA launched in 2016. The Agency conducts in-person and desk (remote) audits of Signatories by trained individuals from WADA and external experts in anti-doping, in which Signatories’ programs are closely reviewed against the requirements set out in the Code and Standards.
  3. Continuous Monitoring Program, which WADA launched in 2016, complements the questionnaire and audits by monitoring a number of key program areas on which WADA has information and data.
  4. WADA continues to review Signatories’ anti-doping rules, regulations and, where applicable (i.e., where a country decides to implement the Code through legislation), legislation to ensure compliance with the Code and International Standards. Individualized assistance and guidance are also provided by WADA in this area.

In addition, WADA uses other sources of information to monitor and assess the quality of anti-doping programs, including ADAMS, investigations and any other intelligence collected or received. WADA continually provides Signatories with assistance and guidance in implementing and complying with the Code and International Standards.

Underpinning the process has been the International Standard for Code Compliance by Signatories (ISCCS), which came into effect on 1 April 2018, and which clearly sets out the ways WADA supports Signatories in achieving, maintaining and, where applicable, regaining Code compliance. It also provides a necessary and robust legal framework for cases of non-compliance, highlighting a range of graded, predictable and proportionate sanctions for cases of non-compliance by Signatories. Due to the high number of Signatories, the ISCCS includes provision for WADA to best utilize its resources by prioritizing.

Some of the members of WADA’s Compliance Team at the Agency’s Montreal Headquarters.
A Reflection on the Evolution of Anti-Doping

Frédéric Donzé, WADA’s Chief Operating Officer who oversees the Compliance Monitoring Program, says: “This is a very ambitious undertaking. At its core, compliance is about adherence to the global anti-doping rules by Code Signatories – those that are responsible for applying and enforcing them. The ultimate goal of compliance is to level the playing field, that is, to ensure that every Signatory complies with its obligations, and therefore every athlete is subject to the same rules, no matter the sport or geographic location.

“And, if those Signatories or athletes choose to break the rules, everyone is clear on what the consequences would be. It is clear to us that the responsibility needs to be shared. Without Signatories adhering to the agreed-upon rules, how can the athletes be asked to do the same?

“We believe it is a very important step that those who are not meeting the required levels of rules or program implementation are encouraged and supported to meet the requirements and, in the cases where support and help cannot bring them where they should be, that they can be held accountable and can face consequences,” says Donzé.

WADA Director, Standards and Harmonization, Tim Ricketts, says: “Clean sport is evolving. The 2017 Code Compliance Questionnaire identified issues in areas such as developing an intelligence and investigations policy, how ADOs develop doping risk assessment, how they create an effective registered testing pool, how they conduct target testing and deploy sport-specific analysis, and how they retain samples and re-analyze them. A decade ago, if you had asked an anti-doping expert what anti-doping covered, they would have said it was a mix of a few pillars: education, testing and, where doping is found, sanctions.

“Some areas of anti-doping have higher levels of non-compliance than others, particularly around the establishing an effective testing program through a detailed risk assessment followed by the establishment of Test Distribution Plan. From the results of the last questionnaire and the audits conducted to date, we have been able to further tailor our support, including by developing more than 15 templates and checklists to assist Signatories meet their compliance obligations, with several more in the pipeline,” says Ricketts.

Since 2016, WADA has carried out a total of 46 audits of International Federations and National Anti-Doping Organizations, 18 in 2019 alone. The audits and the questionnaire have seen nearly 6,000 corrective actions implemented by Signatories. That is 6,000 individual improvements – some small and technical by nature, others more significant – made to the global anti-doping program that would not otherwise have been achieved.

As WADA increases its compliance monitoring activities it is anticipated that non-conformities by Signatories will reduce as the global anti-doping system continues to improve.
Partnering with Impact

Since 2015, WADA has opened 155 compliance procedures. “In the majority of cases, all non-conformities were addressed by the deadline (usually three months) with only 22 ADOs being declared as non-compliant,” says WADA’s Chief Compliance Manager, Emiliano Simonelli. “This shows how significant WADA’s policy of assistance and guidance has been in strengthening the overall system.”

Deputy Director (Audits and Monitoring Program), Standards and Harmonization, Kevin Haynes, says: “It is important to remember that compliance monitoring does not operate in isolation. It works hand in hand with program development and capacity building, and the daily work that WADA conducts with NADOs, IFs and Regional Anti-Doping Organizations worldwide to grow and improve anti-doping in sports and countries where it may be less developed. It also works in close collaboration with WADA’s Intelligence and Investigations Department, which is better equipped to identify non-technical non-conformities or corrupt practices.

Code Compliance Monitoring is a key component of WADA’s strategic priorities. 
“We also collaborate with umbrella organizations of Signatories and other monitoring bodies, such as the Council of Europe, to further enhance the global level of ADO compliance. It is a truly enormous task to cover all sports across the whole world, especially given our limited resources, so to be able to rely on the cooperation of others is very important.”

With its vigilant, ongoing and collaborative nature, the Program has enhanced and will strive to continue to raise the standard for anti-doping worldwide.

*Two additional Standards – on education and on results management – will be introduced in January 2021.

‘Spotlight’ previously focused on WADA’s innovative anti-doping education program.


02/03/20 WADA REMINDS STAKEHOLDERS THAT THE REVISED INTERNATIONAL STANDARD FOR TESTING AND INVESTIGATIONS IS NOW IN EFFECT

Montreal, 2 March 2020

Dear Colleagues,

The World Anti-Doping Agency (WADA) reminds stakeholders that the revised International Standard for Testing and Investigations (ISTI) entered into force yesterday, 1 March 2020. The revised version, which was approved by WADA’s Executive Committee (ExCo) on 4 November 2019 and was first published on 3 December 2019, is an exceptional revision to the ISTI. It is in advance of other approved revisions that will come into force on 1 January 2021 along with the 2021 World Anti-Doping Code and other International Standards that were approved by WADA’s Foundation Board and ExCo in November 2019

The revision to the ISTI that came into force on 1 March 2020 is specifically related to the requirement for urine samples to meet a suitable specific gravity for analysis. Now, the minimum volume of urine required for analysis will remain at 90ml; however, if an athlete can provide 150ml of urine or more, the minimum specific gravity measurement (using a refractometer) will be lowered to 1.003 or above instead of the previous 1.005 or above.

If the athlete provides a sample with a volume greater than 90ml but less than 150ml, the specific gravity measurement of 1.005 (using a refractometer) will remain applicable. 

Athletes who provide a sample with a specific gravity measurement lower than the above measurements will be required to continue to provide additional samples until they reach a suitable specific gravity measurement.

The flowchart below is designed to assist stakeholders with the revised procedure:

This revision, which was endorsed by WADA’s Laboratory Expert Group, recognizes significant enhancements in the sensitivity of laboratory analytical methods made over the past 20 years and will reduce the amount of time some athletes spend in doping control stations, making the process more athlete-friendly, while presenting a potential saving in resources for Anti-Doping Organizations.

It is also important to note that this revision to the specific gravity measurement will be applied during the Tokyo 2020 Summer Olympic and Paralympic Games.

Should you have any questions regarding the above revision to the ISTI, please feel free to contact Wendy.Butts@wada-ama.org.

Best regards,

World Anti-Doping Agency


02/03/20 WADA CANCELS 2020 ANNUAL SYMPOSIUM IN LIGHT OF CORONAVIRUS

Montreal, 28 February 2020 – As the current outbreak of the Coronavirus Disease (COVID-19) continues to develop, the World Anti-Doping Agency (WADA) regrets to announce the cancellation of the Agency’s Annual Symposium and related Athlete Session that were to be held at the SwissTech Convention Center in Lausanne, Switzerland on 17-18 and 19 March 2020 respectively. 

WADA took this decision based on the Swiss Federal Office of Public Health’s (FOPH’s) announcement today banning large-scale gatherings of more than 1,000 people in Switzerland until 15 March 2020.

WADA President Witold Banka said: “WADA is disappointed to announce the cancellation of its Annual Symposium, which has become the annual event for anti-doping practitioners. It was a difficult decision as the event attracts almost 1,000 participants from around the world every year; however, it was necessary to ensure the health and safety of the Agency’s staff and stakeholder community. The Agency commits to ensuring that most of the elements of the Symposium program are delivered via alternative means over the coming weeks and months.”

The Symposium, which was to be delivered under the theme “Bringing the 2021 Code and Standards into Action”, was primarily aimed at assisting World Anti-Doping Code (Code) Signatories in their adjustment to, and implementation of, the 2021 Code and International Standards, which will enter into force on 1 January 2021. WADA is confident that, over the coming weeks and months, it will be able to complement its previously announced 2021 Code Implementation Support Program (CISP) to include the elements of the Symposium program via webinars and other channels. The CISP is being developed in coordination with Code Signatories and other partners through 2020.

It should be noted that WADA is reaching out separately to Symposium participants and other stakeholders that are impacted by this cancellation. WADA regrets any inconvenience that this necessary decision may cause to those impacted.

As it relates to the Coronavirus, WADA will continue monitoring thesituation based on expert information from the World Health Organization and will put other measures in place as needed related to staff and stakeholder travel connected to the Agency’s mission.


28/02/20 WADA STATEMENT REGARDING CAS PUBLIC HEARING – WADA V. SUN YANG & FINA

Montreal, 28 February 2020 – The World Anti-Doping Agency (WADA) welcomes the ruling of the Court of Arbitration for Sport (CAS) in relation to WADA’s appeal against the Fédération Internationale de Natation (FINA) disciplinary panel decision in relation to an incident that led to a doping control involving Chinese swimmer Sun Yang not being completed as planned.

WADA had lodged the appeal on the basis that Sun Yang voluntarily refused to submit to sample collection as per the terms of the World Anti-Doping Code (Code) and the related International Standard for Testing and Investigations. WADA notes the sanction handed down by CAS and is satisfied that justice in this case has been rendered.

WADA Director General Olivier Niggli said: “WADA decided to appeal the original FINA ruling having carefully reviewed it and having concluded that there were a number of points that seemed to be incorrect under the Code. Today’s CAS ruling confirms those concerns and is a significant result. We will now need to take time to review the decision in full, and we will continue to review diligently all anti-doping decisions taken by Code Signatories to ensure they are in line with the Code and, when warranted, to exercise our independent right of appeal.”


27/02/20 WADA PUBLISHES INDEPENDENT OBSERVER TEAM REPORT FROM 2019 AFRICAN GAMES

Montreal, 27 February 2020 – The World Anti-Doping Agency (WADA) has published its Independent Observer (IO) Team’s Report regarding the anti-doping program at the 2019 African Games held in Rabat, Morocco, from 19-31 August 2019.

As it has done at a number of major events since 2000, WADA sent a team to monitor the anti-doping program that was run by the Association of National Olympic Committees of Africa (ANOCA) with the aim of reinforcing confidence in athletes and the public as to the quality, effectiveness and reliability of the Games’ anti-doping program.

In addition to collaborating with ANOCA and providing general support prior to the Games, the team also provided ANOCA with real-time feedback designed to optimize the efficiency and effectiveness of the program in compliance with the World Anti-Doping Code and International Standards.

Led by Sophie Berwick, an anti-doping consultant, the four-person team was composed of experts in anti-doping from the African continent who observed and provided feedback on all aspects of doping control. This included the implementation of general anti-doping policies and procedures; test distribution planning; implementation of the out-of-competition and in-competition testing programs; athlete selection and notification for testing; Therapeutic Use Exemptions procedures; sample collection procedures; the transport of samples and their chain of custody; and, the results management process – including hearings that were held during the IO Team’s presence.

Ms. Berwick said: “The 12th African Games were geared towards promoting fair play and working with internal and external stakeholders to protect clean athletes and promote clean sport. The anti-doping program that was implemented during these Games was a massive step forward in terms of quality and execution, and it is our hope that Ghana – who will host the 13th edition of the African Games in 2023 – as well as all African countries hosting Major Events, will support and commit further to the fight against doping in sports, by making use of this report and ensuring that the fight against doping continues to progress in the region.”


24/02/20 FINAL REMINDER TO REGISTER FOR WADA’s
2020 ANNUAL SYMPOSIUM

Montreal, 24 February 2020

Dear Colleagues,

The World Anti-Doping Agency (WADA) wishes to remind you that this Wednesday, 26 February, is the deadline to register for the 16th edition of the Agency’s Annual Symposium  which will be held at the SwissTech Convention Center in Lausanne, Switzerland on 17-18 March 2020followed by an Athlete Session on 19 March. After this date, all new registrations will be charged a 400 CHF registration fee.

Under the theme “Bringing the 2021 Code and Standards into action”, the 2020 Symposium will open with remarks by WADA President, Witold Bańka, and Director General, Olivier Niggli. Presenters will thereafter aim to support World Anti-Doping Code (Code) Signatories in their adjustment to, and implementation of, the 2021 Code and International Standards (Standards), which will enter into force on 1 January 2021.

Registration for the Symposium

Should you wish to register for the Symposium and/or the Athlete Session on 19 March (which is exclusively dedicated to athletes, athlete representatives and administrators of athlete representative bodies), please do so on the Symposium Website by this Wednesday,26 February 2020. The website contains all relevant information regarding the event, including the program, how to register, and how to book your hotel accommodations.

Please note that in an effort to harmonize the registration process across all WADA events, the Agency has recently updated its registration terms and conditions. We strongly recommend that all stakeholders review them before registering.

Delegate App

Once registered, approved participants will receive a notification inviting them to download the delegate app. Via smartphone or tablet, the app will allow participants to access:

  • A personalized agenda with session timings, locations and descriptions
  • Speaker biographies
  • A full list of participants
  • A floor plan and additional event information

Delegates using the app will also be able to add others to their ‘favorites’ and can contact other participants directly to organize meetings in advance of the Symposium.

We encourage participants to make the most of this delegate app in order to maximize communications and networking opportunities in and around the event.

To access the App, simply search for “EW ToGo” on the App Store for iPhones or on Google Play for Android devices.

Note: If you had downloaded the app for previous editions of the Symposium, you will need to delete and re-download the app in order to access the updated version for the 2020 Symposium.

Advisory regarding the coronavirus (COVID-19)

Regarding the coronavirus outbreak in China and elsewhere around the world, please note that WADA is closely monitoring the situation, in particular in light of the upcoming Symposium.

WADA takes the health and safety of its Symposium participants very seriously and therefore, is carefully assessing the travel risk based on expert information from the World Health Organization and the Swiss Federal Office of Public Health

As per the Swiss Federal Office of Public Health, none of the samples collected in Switzerland revealed positive for the COVID-19 and therefore, there is no entry restriction to Switzerland. Accordingly, the World Health Organization has also not issued any travel restrictions to Switzerland.

Given this information, at this stage, WADA intends to carry on with the Symposium. The Agency will however continue to monitor the situation and commits to updating stakeholders should its assessment of the situation change. 

In the meantime, for travel advice in connection with the coronavirus, please visit the World Health Organization website.

Best regards,

World Anti-Doping Agency


21/02/20 WADA UPDATE REGARDING TESTING OF CHINESE ATHLETES IN LIGHT OF CORONAVIRUS

Montreal, 21 February 2020 – The World Anti-Doping Agency (WADA) confirms that the China Anti-Doping Agency (CHINADA) will resume testing this week following a temporary suspension, initiated on 3 February, of its testing program on mainland China due to the coronavirus, also known as Covid-19.

WADA, the global regulator of anti-doping, has been closely monitoring the situation and has remained in regular contact with CHINADA throughout in order to maintain the integrity of the anti-doping program in China. To that end, CHINADA has advised that it will resume testing missions within China this week, on a phased basis. Priority will be given to testing elite level athletes from higher-risk categories and sports.

The safety of athletes and sample collection personnel involved in the doping control process within China is the key priority. This needs to be balanced with the importance of ensuring that Chinese athletes remain subject to a rigorous testing program for the duration of the coronavirus situation.

CHINADA has implemented a supplementary set of doping control guidelines to be followed during this period. These additional guidelines for CHINADA’s Doping Control Officers are designed as a precaution, to minimize the risk of infection. CHINADA will gradually expand the testing scope based on the progress of China’s epidemic prevention and control while also monitoring the whereabouts of Chinese athletes to maintain the integrity of the doping control system.

While testing on mainland China was temporarily suspended, it should be noted that CHINADA continued to plan and conduct testing on Chinese athletes training and competing outside of China. In January 2020, CHINADA conducted more than 1,200 tests, including 114 urine samples and 80 blood samples from Chinese athletes training abroad. A further 165 urine samples and 113 blood samples are planned to be collected in February across seven countries and nine Olympic sports.

CHINADA will shortly make contact with those Anti-Doping Organizations (ADOs) that have the right to collect samples from Chinese athletes in China and, under this strict protocol, is willing to accept missions from those organizations, in addition to those organized by CHINADA under its own program. 

To supplement CHINADA’s testing outside China, WADA has written to all International Federations and National Anti-Doping Organizations calling on them to further support this effort in relation to testing Chinese athletes competing or training outside of China, as is their right under the World Anti-Doping Code.

The anti-doping system allows for cooperation between ADOs – including National Anti-Doping Organizations, International Federations, Major Event Organizations etc. – to ensure that the integrity of the program is upheld and that athletes are still being properly tested.


20/02/20 WADA UPDATE REGARDING CHINADA’s TEMPORARY SUSPENSION OF TESTING DUE TO CORONAVIRUS

Montreal, 20 February 2020

Dear Colleagues,
[International Federations (IFs) and National Anti-Doping Organizations (NADOs)]

The World Anti-Doping Agency (WADA) wishes to update you regarding the 3 February announcement of the China Anti-Doping Agency’s (CHINADA’s) temporary suspension of their testing program on mainland China due to the new coronavirus, also known as Covid-19.

WADA has been closely monitoring the situation and is in regular contact with CHINADA to maintain the integrity of the anti-doping program in China. To that end, we are pleased to inform you that CHINADA has advised that it will resume testing missions within China this week, on a phased basis. Priority will be given to testing elite level athletes from higher-risk categories and sports.

The safety of athletes and sample collection personnel involved in the doping control process within China is a key priority. This needs to be balanced with the importance of ensuring that Chinese athletes remain subject to a rigorous testing program for the duration of the coronavirus situation.

While sample collection will resume this week, CHINADA has implemented a supplementary set of doping control guidelines to be followed during this period. These additional guidelines for CHINADA Doping Control Officers (DCOs) are designed as a precaution, to minimize the risk of infection. CHINADA will gradually expand the testing scope based on the progress of China’s epidemic prevention and control while also monitoring the whereabouts of Chinese athletes to maintain the integrity of the doping control system.

The enhanced DCO guidelines include the following:

  • DCOs selected to conduct missions shall be those that have no travel records, no contact with people from affected areas or suspect areas.
  • DCOs are required to monitor their health for 14 days and undertake medical screening from a hospital prior to being appointed to missions.
  • Each sports training centre will prepare a sterile room to be used for doping control.
  • DCOs shall wear a medical protective mask and gloves throughout the whole procedure and change for each athlete tested.
  • Athletes and their representatives are also required to wear medical protective equipment.
  • CHINADA has set up a ‘Doping Control and Epidemic-Prevention Experts Panel’, consisting of anti-doping experts and anti-epidemic specialists in clinical medicine. DCOs have been trained in anti-epidemic procedures and shall report to this panel after each testing mission.

CHINADA will shortly make contact with those Anti-Doping Organizations that have the right to collect samples from Chinese athletes in China and, under this strict protocol, is willing to accept missions from those organizations, in addition to those organized by CHINADA under its own program, at the sports training centers where testing will begin. 

While testing on mainland China was temporarily suspended, it should be noted that CHINADA had continued to plan and conduct testing on Chinese athletes training and competing outside of China. In January 2020, CHINADA conducted more than 1,200 tests, including 114 urine samples and 80 blood samples from Chinese athletes training abroad. A further 165 urine samples and 113 blood samples are planned to be collected in February across seven countries and nine Olympic sports.

For IFs

To supplement CHINADA’s testing outside China, WADA calls on all IFs to further support this effort by considering testing Chinese athletes that are competing in your international events. In addition, we strongly encourage those IFs that have Chinese athletes in your Registered Testing Pools to monitor their whereabouts closely to ensure that if there are opportunities to test those athletes outside of China, such testing opportunities are seriously considered. For testing on athletes located inside China, please contact CHINADA.

For NADOs

To supplement CHINADA’s testing outside of China, WADA calls on all NADOs to further support this effort by offering your assistance to conduct testing on Chinese athletes that may be training in your country. This can be done by contacting CHINADA or through your own initiative. As a reminder, under the World Anti-Doping Code, your NADO is permitted to test foreign athletes that are training in your country. 

WADA thanks you for your collaborative effort and support during this difficult situation and commits to updating you as the situation progresses further.

Should you have any queries on this matter, please do not hesitate to contact testing@wada-ama.org.

Sincerely,

World Anti-Doping Agency


13/02/20 WADA PUBLISHES LIST OF CONFIRMED PRESENTERS FOR ANNUAL SYMPOSIUM

Montreal, 13 February 2020

Dear Colleagues,

The World Anti-Doping Agency (WADA) is pleased to publish a list of confirmed presenters for the Agency’s 16th Annual Symposium – taking place at the SwissTech Convention Center in Lausanne, Switzerland on 17-18 March 2020.

Under the theme “Bringing the 2021 Code and Standards into action”, the 2020 Symposium will open with remarks by WADA’s President, Witold Bańka, and Director General, Olivier Niggli. Thereafter, the presenters will mainly address practical implementation of the World Anti-Doping Code (Code) and International Standards (Standards), which will enter into force on 1 January 2021.

Confirmed Presenters

The list of confirmed presenters includes representatives from Anti-Doping Organizations and experts from the global anti-doping community – including legal professionals, scientists and researchers, and features the following individuals, among many others:Yang Yang – Vice-President, WADAUlrich Haas – Professor of Procedural and Private Law, University of ZurichBen Sandford – Chair, WADA Athlete CommitteeRichard Young – Attorney and main drafter of the 2021 CodeAudrey Kinahan – Chair, WADA Prohibited List Expert GroupTerence Wan – Chair, WADA Laboratory Expert GroupAndrea Petroczi – Chair, WADA Prevalence Working Group For the full list of presenters, along with their biographies and scheduled presentations, please consult the Presenters section of the Symposium website. 

Registration for the Symposium

Should you wish to register for the Symposium and/or the Athlete Session on 19 March (which is exclusively dedicated to athletes, athlete representatives and administrators of athlete representative bodies), please do so on the Symposium Website by 26 February 2020. The website contains all relevant information regarding the event, including the program, how to register, and how to book your hotel accommodations.

Please note that in an effort to harmonize the registration process across all WADA events, the Agency has recently updated its registration terms and conditions. We strongly recommend that all stakeholders review them before registering.

Optional tourist activities

Should you wish to register for one of the Symposium’s optional tourist activities – a Guided City Tour of Lausanne or a Walk through the Lavaux vineyards & wine tasting – we invite you to do so as soon as possible in the “My Program” section of the Symposium website.

WADA looks forward to welcoming you in Lausanne as the Agency partners with all its stakeholders to bring the 2021 Code and Standards into action.

Best regards,

World Anti-Doping Agency


12/02/20 WADA AND THE UNIVERSITÉ DE SHERBROOKE LAUNCH A RESEARCH CHAIR ON ANTI-DOPING IN SPORT

Montreal, 11 February 2020 – Today, at an event in Montreal, the World Anti-Doping Agency (WADA) and the ‘Université de Sherbrooke’ (University) officially launched the University’s Research Chair on Anti-Doping in Sport (Chair). 
 
The Chair and related graduate program in the field of humanities—which were developed in partnership by the two organizations, but which will be independently led by the University—aim to develop globally-recognized expertise in the field of anti-doping through an approach focused on advancing research and knowledge transfer.
 
In May 2019, WADA announced that its Foundation Board approved creation of the Chair; and that, as part of this partnership, the Agency committed to an investment of USD 200,000 per year for five years that the University would match. In order to ensure the long-term sustainability of the Chair, the University will work to raise additional funds from the public and private sectors.

From right to left, WADA Director General Olivier Niggli with representatives from the University of Sherbrooke: Jean-Pierre Perreault, David Pavot, Vincent Joli-Coeur, and François Coderre.

WADA Director General, Olivier Niggli, said: “Research and Education have long been strategic priorities for WADA. We believe that this partnership with the Université de Sherbrooke’s Research Chair on Anti-Doping in Sport will provide a big boost towards WADA’s mission to lead a collaborative worldwide movement for doping-free sport. Over the years, WADA has invested millions in social science research that specifically measures the effectiveness of existing anti-doping strategies and interventions; and, informs more effective doping prevention strategies. In parallel, WADA is increasing access to education and information programs worldwide with the goal of preventing intentional or unintentional use of prohibited substances and methods.

“WADA is very proud of this partnership that strengthens the Agency’s presence in our host community since 2002; and, reiterates our commitment to Quebec’s research and academic communities. The Université de Sherbrooke is renowned in Canada and internationally for its capacity to create applied research programs and chairs with a variety of partners. We are confident that it is well positioned to bring unique expertise and a perspective to the anti-doping community that is supported by research; and, in so doing, contribute to making Montreal a global center of excellence for anti-doping.ˮ

The Chair will provide applied research to the anti-doping community. It will bring an interdisciplinary focus in anti-doping; particularly, in the field of humanities—most notably in management, law, education and sociology. In addition to the Chair, the graduate program—via a master’s degree on anti-doping in sports—will attract students and train anti-doping professionals from around the world, increasing the capacity of the anti-doping system. The launch date of these programs will be communicated by the University in due course.

Professor David Pavot, holder of the Research Chair on Anti-Doping in Sport, said: “WADA’s environment is made up of international organizations as well as national anti-doping agencies and sports federations. The fight against doping has an impressive number of levels. This association with WADA opens the door to a universe of remarkable depth.”

Stéphane Paquet, CEO of Montréal International, said: “We are truly proud to have helped the World Anti-Doping Agency in creating this new research chair with the Université de Sherbrooke. The presence of a flagship organization like WADA helps to strengthen the leadership of Greater Montréal in the fight against doping, in addition to increasing the international prestige of our region.”

About WADA

Formed in 1999, the World Anti-Doping Agency (WADA) is an international independent agency composed and funded equally by the Sports Movement and Governments of the world. As the global regulatory body, WADA’s primary role is to develop, harmonize and coordinate anti-doping rules and policies across all sports and countries. Its key activities include: ensuring and monitoring effective implementation of the World Anti-Doping Code and its related International Standards; scientific and social science research; education; intelligence and investigations; and, building anti-doping capacity with anti-doping organizations worldwide. WADA is headquartered in Montreal, Canada and has offices in Cape Town, Lausanne, Montevideo, Tokyo and Warsaw.

About the Université de Sherbrooke

The Université de Sherbrooke (UdeS) is one of Quebec’s three major research hubs. Recognized for its innovation, UdeS is a leading partner of upper-level and regional governments to promote social, cultural and economic development. It also stands out through strong growth in its research activities in recent years, its success in technology transfer, as well as its initiatives in entrepreneurship and open innovation in collaboration with industry and the social sector.


5/02/20 QUESTION AND ANSWER DOCUMENT ON
RUSADA NON-COMPLIANCE

Montreal, 5 February 2020

Dear Colleagues,

Since the World Anti-Doping Agency’s (WADA’s) Executive Committee decision of 9 December 2019 regarding RUSADA compliance and the conference call that WADA held for International Federations and Major Event Organizations on 13 December 2019, some representatives have asked for a Question & Answer document to complement the information that was made available at the time. This message is simply to draw your attention to the Q&A document that is available on WADA’s website.

Best regards,

World Anti-Doping Agency


3/02/20 WADA ASKS FOR RUSADA DISPUTE HEARING TO BE HELD IN PUBLIC

Montreal, 3 February 2020 – Today, the World Anti-Doping Agency (WADA) submitted a formal request to the Court of Arbitration for Sport (CAS) that the hearing to resolve the dispute related to the non-compliance case against the Russian Anti-Doping Agency (RUSADA) be held in public.

WADA Director General Olivier Niggli said: “WADA’s investigations on Russia, and this latest case of non-compliance, have generated huge interest around the world. It is WADA’s view – and that of many of our stakeholders – that this dispute at CAS should be held in a public forum to ensure that everybody understands the process and hears the arguments.”

Background:

When RUSADA was reinstated as compliant with the World Anti-Doping Code by WADA’s Executive Committee (ExCo) in September 2018, there were conditions attached. One of these was that the Russian authorities had to grant WADA Intelligence and Investigations (I&I) access to the authentic Laboratory Information Management System data and underlying raw analytical data contained within the Moscow Laboratory.

In January 2019, WADA I&I retrieved 24 terabytes of data from the Laboratory and then embarked on a painstaking forensic examination to determine whether they were authentic and complete. During this process, both WADA I&I and independent forensic investigators confirmed manipulation and deletion of some of the data had been carried out after RUSADA’s reinstatement.

In September 2019, WADA’s independent Compliance Review Committee opened a non-compliance case against RUSADA and, following an in-depth review, recommended to WADA’s ExCo that under the International Standard for Code Compliance by Signatories that came into force on 1 April 2018, RUSADA be declared non-compliant for a period of four years and that various consequences be imposed. These consequences included that Russia would not be allowed to participate in, host or bid for various covered events, including the Olympics, Paralympics and Code Signatories’ World Championships, for the same four-year period. On 9 December 2019, the ExCo unanimously agreed to uphold the CRC recommendation.

Within the 21-day deadline, RUSADA indicated it was disputing the decision and so, on 9 January 2020, WADA filed a formal request for arbitration with CAS in Lausanne, Switzerland, to resolve the dispute. The matter is now in the hands of CAS. In accordance with Article 23.5.9 of the Code, any CAS decision in relation to the non-compliance, the proposed consequences and/or the proposed reinstatement conditions will be binding and must be recognized and enforced by all Code Signatories.

A detailed ‘Chronology of the Russian Doping Crisis’ and a set of frequently asked questions are attached as complementary information relating to the Russian doping crisis.


30/01/20 REMINDER: REGISTER FOR WADA’S 2020 ANNUAL SYMPOSIUM

FULLY DEDICATED SESSION FOR ATHLETES ON
19 MARCH 2020

Montreal, 30 January 2020
 

Dear Colleagues,

As first communicated on 29 November 2019, the World Anti-Doping Agency (WADA) wishes to remind you that online registration is currently open for the 16th edition of the Agency’s Annual Symposium. The Symposium, which will be held at the SwissTech Convention Center in Lausanne, Switzerland on 17-18 March 2020 will, due to the success of last year’s format, follow with an entirely dedicated Athlete Session on 19 March.

The WADA Symposium, which is the main event on the global anti-doping calendar, gathers anti-doping practitioners from around the world and provides them with the opportunity to interact and learn from one another. This year’s Symposium will once again welcome athletes, representatives from Anti-Doping Organizations, Governments, WADA-accredited Laboratories and Athlete Passport Management Units; as well as, other stakeholders such as the media, researchers and service providers — all that are integral to clean sport.

Under the theme “Bringing the 2021 Code and Standards into action”, the 2020 Symposium will open with remarks by WADA’s new President, Witold Bańka, and Director General, Olivier Niggli; and, thereafter, aim to assist World Anti-Doping Code (Code) Signatories in their adjustment to, and implementation of, the 2021 Code and International Standards (Standards), which will enter into force on 1 January 2021. This will include sessions that:

  • Provide an overview of the most impactful changes to the Code;
  • Outline what is expected of ADOs in preparation for the 2021 Code and Standards coming into force;
  • Focus on specific International Standards;
  • Feature athletes talking about the Athletes’ Anti-Doping Rights Act;
  • Outline how Governments can further contribute to anti-doping;
  • Look at key topics, such as social science research, doping prevalence, detection methods and ‘Next Gen’ ADAMS; and
  • To cap off day one, a session that gives participants the opportunity to interact directly with Messrs. Bańka and Niggli; as well as, WADA’s new Vice President, Ms. Yang Yang.

Athlete Session

As it relates to the dedicated Athlete Session on 19 March, under the leadership of WADA’s Athlete Committee, the Agency will once again welcome participation of athlete representatives and administrators of athlete representative bodies. Anti-Doping Organizations are kindly asked to encourage the participation of athlete representatives, who are invited to participate in the Symposium and in the Athlete Session free of charge, in order to maximize athlete attendance and voices. With former elite athletes Witold Bańka and Yang Yang having assumed their roles as WADA President and Vice-President on 1 January 2020, a strong focus will be put on athletes’ engagement in the protection of Clean Sport during these three days.

Registration and accommodation bookings

Should you wish to register for the Symposium and/or the Athlete Session (which is exclusively dedicated to athletes, athlete representatives and administrators of athlete representative bodies), please do so on the Symposium Website by 26 February 2020. The website contains all relevant information regarding the event, including the preliminary program, how to register and how to book your hotel accommodations.

The deadline for hotel bookings through the Symposium Website is 31 January 2020.

Please note that in an effort to harmonize the registration process across all WADA events, the Agency has recently updated its registration terms and conditions. We strongly recommend that all stakeholders review them before registering.

WADA looks forward to welcoming you in Lausanne as the Agency partners with all stakeholders to bring the 2021 Code and Standards into action.

Best regards,

World Anti-Doping Agency


24/01/20 WADA LAUNCHES E-LEARNING COURSE FOR MEDICAL PROFESSIONALS

Montreal, 24 January 2020 – In another effort for the protection of clean sport, the World Anti-Doping Agency (WADA) is pleased to launch the ADeL for Medical Professionals course on its Anti-Doping e-Learning Platform (ADeL) today to coincide with UNESCO’s International Day of Education.

This new online course is aimed at medical professionals, which includes sports physicians or any other professional involved in the diagnosis, treatment or rehabilitation of athletes; such as, physiotherapists, general practitioners, sports nutritionists and pharmacists. Recognizing the important role they all play in protecting clean sport, the course outlines how medical professionals can operate effectively in line with the anti-doping rules; how they can support athletes in meeting their responsibilities under the World Anti-Doping Code (Code); and, therefore, how they can help prevent doping.
 

WADA Director General, Olivier Niggli, said: “WADA is very pleased to launch ADeL for Medical Professionals on UNESCO’S International Day of Education. Among other things, this course reaffirms education as a fundamental activity in the protection of Clean Sport. Clean Sport education plays a key role in protecting athletes, and increasing access to relevant, research-based education for all our stakeholders is one of our key priorities.”

WADA Director, Education, Amanda Hudson, added: “We are confident that this course will benefit medical professionals working with athletes, helping them understand anti-doping and how their medical practice, decision-making and advice must always support a Clean Sport ethos. Medical professionals that are educated regarding anti-doping can benefit athletes by providing them with accurate anti-doping advice and positively influencing their values and behaviors. These are core responsibilities under the Code. WADA encourages Anti-Doping Organizations to promote ADeL for Medical Professionals within their respective communities and to support their need to be educated.”

WADA has also developed a special course titled ADeL for Medical Professionals at Major Games in collaboration with the International Olympic Committee (IOC)This course, which can also be accessed on the ADeL platform, focuses on the specific knowledge required of medical professionals, such as team doctors that are attending a major sporting event, and includes guidance on managing and bringing medication to the Olympic Games as well as information on the IOC’s No-Needle Policy. Completion of the ADeL for Medical Professionals at Major Games course is a pre-requisite for team doctors registering for the upcoming Tokyo 2020 Olympic and Paralympic Games.

To complete both courses, simply register on ADeL or log in to your existing account and scroll to the Library section. The courses are mobile-friendly and can be easily accessed through smart phones or tablets. In addition, WADA has created an ADeL User Guide in order to help users navigate through the platform.

While the course is initially being launched in English, WADA will work with stakeholders around the world to translate ADeL for Medical Professionals into further languages.

For any questions or to provide feedback on these two ADeLresources, or any other ADeL resource, please direct your emails to adel@wada-ama.org.


23/01/20 WADA EXECUTIVE COMMITTEE APPOINTS NEW STANDING COMMITTEE CHAIRS, RECEIVES UPDATE REGARDING RUSADA COMPLIANCE CASE

Montreal, 23 January 2020 – Today, the World Anti-Doping Agency’s (WADA’s) Executive Committee (ExCo) held an extraordinary meeting that was graciously hosted by the International Olympic Committee (IOC) at the Olympic House in Lausanne, Switzerland. Welcomed by IOC President Thomas Bach, the 12 members of the ExCo discussed in particular the appointment of five new WADA Standing Committee Chairs, as well as a number of other topics including the Russian Anti-Doping Agency (RUSADA) compliance case, the provisional suspension of the Moscow Laboratory, and consideration of WADA’s new Strategic Plan for 2020-24.
 
In his first ExCo meeting as WADA President, Witold Bańka said: “It is very encouraging to see the high level of commitment expressed by the ExCo members around the table today. The Agency is at an important stage, beginning a new era. As we continue to implement major governance reforms and to develop a forward-looking Strategic Plan, I am confident we will face our challenges effectively for the promotion of the values of clean sport and the protection of athletes around the world.”
 
Appointments of Standing Committee Chairs
 
With the terms of the Chairs of WADA’s five Standing Committees having come to an end on 31 December 2019 (except for the Compliance Review Committee, whose Chair remained in place until this ExCo meeting to ensure continuity of the CRC activities), the ExCo approved the following new Chair appointments with immediate effect:

  1. Athlete Committee: Ben Sandford, New Zealand
  2. Education Committee: Kady Kanouté Tounkara, Mali
  3. Health, Medical and Research Committee: Lars Engebretsen, Norway
  4. Finance and Administration Committee: Ser Miang Ng, Singapore
  5. Compliance Review Committee (CRC): The Hon. James Wood, Australia

[Biographical information regarding the new Chairs can be found here.]
 
Mr. Bańka said: “WADA welcomes the new Standing Committee Chairs to these important advisory roles within WADA. It is clear that the Agency is acquiring a depth of experience and knowledge in their areas of expertise, including from two former elite athletes, which we and Clean Sport will benefit from significantly. We are grateful for their commitment and look forward to working with them in their new roles.”
 
The Standing Committees, which report into the ExCo, act as advisory committees to WADA, providing guidance for the Agency’s programs. Before being appointed by the ExCo, all candidates to the positions of Chairs of these committees were subject to a robust and independent process of review and assessment by WADA’s inaugural Nominations Committee. The Nominations Committee stemmed from the Agency’s governance reforms endorsed by the Board in November 2018.
 
As it relates to the vacant seats on the Standing Committees, the Committee Chairs will now consider the applications for vacant seats in their respective Committees with WADA’s President and Director General and propose members for consideration and endorsement by the ExCo via circular vote in February/March 2020.
 
Concerning other governance matters, the Nominations Committee provided recommendations to the ExCo with respect to the profiles expected for the two independent members that will join the ExCo later this year, with the objective of complementing the existing characteristics and skills of the current members. Candidates for these two seats will be nominated respectively by Governments and the Sport Movement, vetted by the Nominations Committee, and ultimately appointed by the Board at its meeting in May.
 
RUSADA Compliance
 
The ExCo members received an update on the compliance case against RUSADA from the outgoing Chair of the CRC, Jonathan Taylor. As communicated on 9 January, WADA filed a formal request for arbitration with the Court of Arbitration for Sport (CAS) to resolve the dispute. From then, third parties had 10 days to apply to intervene in the matter, under the terms of Article 23.5.7 of the World Anti-Doping Code. The process is now in the hands of CAS and once a panel is nominated and issues timelines, WADA will file a full brief without delay, in accordance with the rules.
 
The ExCo was also updated on the Chair’s decision, announced on 22 January, to provisionally suspend the WADA-approved status of the Moscow Laboratory, pending formal disciplinary action. This provisional suspension prohibits the Moscow Laboratory from carrying out any work related to the analysis of blood samples in connection with the Athlete Biological Passport (ABP) program.
 
WADA’s 2020-24 Strategic Plan
 
In addition, the ExCo was updated on the development of a new WADA Strategic Plan for 2020-24 and provided feedback to WADA Management with the objective of submitting this plan for approval by the Board at its meeting in May. The plan will form the basis of WADA’s strategic activities over the next five years as it continues to lead a collaborative worldwide movement for doping-free sport


22/01/20 WADA PROVISIONALLY SUSPENDS APPROVED STATUS OF MOSCOW LABORATORY

Montreal, 22 January 2020 – The World Anti-Doping Agency (WADA) announces that it has provisionally suspended the WADA-approved status of the National Anti-Doping Laboratory of Moscow (Moscow Laboratory), Russia, with immediate effect, pending formal disciplinary action.

This provisional suspension prohibits the Moscow Laboratory from carrying out any work related to the analysis of blood samples in connection with the Athlete Biological Passport (ABP) program and will remain in place pending disciplinary proceedings to be carried out by an independent Disciplinary Committee.

On 21 January 2020, the WADA Laboratory Expert Group (LabEG) made a recommendation to the Chair of the Executive Committee (ExCo), Witold Bańka, to impose a provisional suspension in application of the International Standard for Laboratories (ISL), and Mr. Bańka agreed to do so with immediate effect. Under the terms of the ISL, a Disciplinary Committee will be mandated to make a recommendation to Mr. Bańka regarding the status of the laboratory’s ABP approval.

This step was taken in light of the ExCo decision of 9 December 2019 that the Russian Anti-Doping Agency (RUSADA) again be declared non-compliant with the World Anti-Doping Code due to the discovery by WADA of manipulation of some of the data extracted from the Moscow Laboratory in January 2019, in breach of the conditions of RUSADA’s reinstatement in September 2018. The LabEG considered the intentional alteration and deletion of laboratory data prior to and during the time it was being forensically copied by WADA as a serious violation of the Code of Ethics of the ISL.

During the period of suspension, all ABP samples collected prior to the date of the provisional suspension may be analyzed by the Moscow Laboratory and the laboratory will need to contact all relevant Testing Authorities to determine whether any stored ABP samples need to be transported to a WADA-accredited or ABP-approved laboratory for further analysis.

WADA revoked the Moscow Laboratory’s full accreditation in 2015 following the exposure of Russia’s institutionalized doping program. In order to ensure the continuity of the haematological module of the ABP in Russia and, bearing in mind it is practically impossible for laboratories to interfere with the blood variables of samples due to the nature of the analytical equipment and the ABP principles in place, the Moscow Laboratory was approved for ABP analysis only, in May 2016. The laboratory’s accreditation for all other anti-doping activities remained revoked, as per the process.

According to the ISL, WADA is responsible for accrediting and re-accrediting anti-doping laboratories or approving them for ABP analysis only, thereby ensuring that they maintain the highest quality standards. This monitoring process is conducted in conjunction with International Organization for Standardization (ISO) assessment by independent national accreditation bodies that are full members of the International Laboratory Accreditation Cooperation (ILAC).


22/01/20 WADA LAUNCHES ITS NEW ‘TESTING CENTER’ – A ‘NEXT GEN’ ADAMS MODULE THAT WILL HELP STRENGTHEN TESTING PROGRAMS WORLDWIDE

Montreal, 22 January 2020 – The World Anti-Doping Agency (WADA) is pleased to announce that, effective today, WADA’s new ‘Testing Center’ is available for use by Anti-Doping Organizations (ADOs) via WADA’s ‘Next Gen’ Anti-Doping Administration & Management System (ADAMS).  

Testing Center provides an improved means for ADOs to control, plan (forecast) and manage their testing programs. It replaces ADAMS ‘Classic’ Test Distribution Planning tool, which has been operational for years and required modernizing.  

Test Distribution Planning is a key component of the International Standard for Testing and Investigations (ISTI).  Under the ISTI, ‘WADA, in consultation with International Federations and other ADOs, will adopt a Technical Document (the Technical Document for Sport Specific Analysis – TDSSA) that establishes by means of a risk assessment which Prohibited Substances and/or Prohibited Methods are most likely to be abused in particular sports and sport disciplines. Starting with a risk assessment, each ADO with Testing authority shall develop and implement an effective, intelligent and proportionate test distribution plan that prioritizes appropriately between disciplines, categories of Athletes, types of Testing, types of Samples collected, and types of Sample analysis.’

WADA Director General, Olivier Niggli, said: “WADA is confident that its new Testing Center will help strengthen doping control programs worldwide. This new module is part of WADA’s ‘Next Gen’ ADAMS project, which is one of WADA’s strategic priorities that involves a complete rebuild of ADAMS to ensure that it is optimized technically and securely to support athletes and the global anti-doping program. ‘Next Gen’ prioritizes mobility of ADAMS use, enhanced connectivity, reliability, performance and general usability.”

WADA Deputy Chief Operating Officer, Stuart Kemp, said: “The new Testing Center is a powerful new tool that demonstrates that ADAMS ‘Next Gen’ will deliver tangible benefits to ADOs world-wide. It improves the integrity and accuracy of data reported from ADAMS, reduces human error, provides faster and increasingly standardized processes; and, reduces the resources required to administer day-today anti-doping activities. We hope Testing Center brings efficiencies to the anti-doping community through a new dashboard, real-time data and reporting; and, we look forward to receiving user feedback. Comments will help us drive further improvements over time.”

Testing Center follows on the heels of WADA’s ‘Athlete Central’ Whereabouts App, which was launched in November 2019 and has received positive feedback from athletes. In keeping with ‘Next Gen’s’ project plan, the Agency will be launching more modules, upgrades and enhancements during the course of 2020.

For more information regarding the Testing Center, please visit WADA’s website.